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Sample preparation is considered to be the most time-consuming step for a quantitative 
analytical process. Many analytical laboratories deal with several hundreds of samples on a 
daily basis; therefore, the manual analysis of the samples in a linear sequence is demanding 
and impractical. During the last decade, automated and high-throughput sample preparation 
strategies, such as automated multi-well plate format systems, have gained popularity in order 
to address this issue.   
Solid phase microextraction (SPME) is a non-exhaustive sample preparation technique 
in which the SPME device is directly exposed to the sample. Selective extraction of 
compounds takes place based on the degree of distribution of the analyte between the SPME 
coating and the sample matrix. Since the extraction and desorption steps are the most time-
consuming steps of the SPME method, the parallel extraction and desorption of multiple 
samples on a multi-well plate format would contribute to significant time efficiency and 
throughput.  
This thesis involves the utilization of an automated 96-well format SPME system 
coupled with LC–MS/MS. Therefore, the system is able to obtain improved reproducibility 
and sample throughput through the automation and simultaneous analysis of up to 96 samples, 
respectively. 
Solid phase microextraction is an equilibrium-based sample preparation method and 
employs a small volume of an extractive phase that may provide limited recovery for the 
analysis of trace amount of compounds. To address the issue of sensitivity, the studies 
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reported in this thesis utilized thin-film geometry for increasing the volume of extractive 
phase, and consequently improving the sensitivity and efficiency of the system.  
Most available commercialized SPME coatings are mainly designed for gas 
chromatography applications and are limited in addressing the needs for the efficient 
extraction of those polarity ranges of compounds, which are analyzed in liquid 
chromatography systems. In addition, these coatings usually suffer from drawbacks such as 
physical instability, swelling in organic solvent, lack of inter-lot reproducibility, and high cost. 
The initial research of this thesis involves the evaluation of different strategies for the 
development of highly stable coatings for the automated 96-blade (thin-film) SPME system 
coupled with liquid chromatography–tandem mass spectrometry (LC–MS/MS). Sol-gel 
technology was used for the preparation of octadecyl (C18)-silica gel thin-film 96-blade 
SPME system. Various factors (e.g., sol-gel composition, aging time, coating preparation 
speed, coating thickness, and drying conditions), affecting the quality of the C18-silica gel 
thin-film coating, were studied and optimized. The results show that the stability and 
durability of the silica gel coating are functions of the coating’s thickness and drying 
conditions. The evaluation of the C18-silica gel SPME extractive phase resulted in stable 
physical and chemical characteristics and long-term reusability with a high degree of 
reproducibility.  
The adhesion of macromolecules, such as particulates and proteins, to the coating 
surface can significantly influence the kinetics of the extraction and the amount of analyte 
extracted by the coating. Therefore, (as described in X‎Chapter 3 X of this thesis) biocompatible 
polyacrylonitrile (PAN) polymer was used for the preparation of particle-based extractive 
phases in order to improve the biocompatible characteristics of SPME coatings for the 
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extraction from biological samples. As the main goal of this thesis consists of developing 
highly stable coatings for the automated 96-blade SPME system, different immobilization 
strategies (dipping, brush painting, and spraying) were evaluated. The spraying was found to 
be the optimal method in terms of stability and reusability for long-term use.  
The increased volume of the extraction phase in the thin-film C18-PAN coating resulted 
in significant enhancement in the extraction recovery when compared to that of conventional 
rod fiber geometry. Furthermore, the optimized C18-PAN coating demonstrated improved 
biocompatibility, stability, and reusability for the extraction of benzodiazepines from human 
plasma in comparison with those of C18-silica gel coating.  
Due to irreversible attachments of blood cells on the coating surface, it is challenging to 
reuse the typical biocompatible SPME coatings for direct immersion extraction from whole 
blood over the long-term. To improve the biocompatible properties of the C18-PAN SPME 
coating for long-term direct analysis from whole blood, different modification strategies were 
studied and evaluated. The modification of the coating with an extra layer of biocompatible 
polyacrylonitrile polymer along with the application of a new washing strategy resulted in 
significant improvement in the blood compatibility of the original coating in long-term use. 
The PAN-over C18-PAN coating provided at least 30 reproducible extractions from whole 
blood (relative standard deviation (RSD) = 12% for n = 6) without loss of efficiency and 
without blood cell attachment on the coating surface. 
‘Extracted blood spot’ (EBS) sampling was introduced as a novel approach to overcome 
the limitations of dried blood spot (DBS) sampling. EBS includes the application of a 
biocompatible SPME coating (instead of filter paper/card in DBS) for spot sampling of blood 
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or other biofluids. In EBS, four steps of sampling, analytes’ isolation and pre-concentration, 
and sample clean-up are combined in one single step.  
The compatibility of EBS sampling with different analytical methods was demonstrated 
via LC–MS/MS and direct analysis in real time (DART) – MS/MS systems. The utilization of 
EBS as a fast sampling and sample preparation method resulted in a significant reduction of 
matrix effects (ion suppression) through the isolation of analytes and a cleaner sample that is 
less susceptible to interference caused by complex matrix components. 
Many studies (e.g., metabolomics) necessitate the analysis of compounds with a wide 
range of polarity and from different classes. The lack of proper stationary phases for the 
simultaneous analysis of both polar and non-polar compounds necessitates the repetition of the 
analytical process with different SPME coatings for each group of analytes. This is not only 
time-consuming but is also limited by the available volume of the sample and the stability of 
the analytes of interest. In this thesis, this issue was addressed through the development of 
modified polystyrene-divinylbenzene (PS-DVB)-PAN and phenylboronic acid (PBA)-PAN 
96-blade SPME coatings. The coatings were evaluated for the extraction of analytes in a wide 
range of polarity (log P = 2.8 to –3.7) and demonstrated efficient extraction recovery for both 
polar and non-polar groups of compounds. The PS-DVB-PAN and PBA-PAN coatings 
presented chemical and mechanical stabilities and reproducible extraction efficiencies for 
more than 100 usages in phosphate-buffered saline (PBS) and human plasma.  
The traditional sample preparation techniques for food analysis are time-consuming and 
lack efficiency. In addition, the lack of proper sample clean-up in these techniques may result 
in co-elution of matrix interferences with the analyte of interest, and consequently 
suppression/enhancement of the analyte’s signal in LC–MS analysis that may result in 
vii 
significant errors in quantitative data. As a result, this thesis reports, for the first time, on the 
application of an automated SPME-LC–MS/MS system for food analysis. The PS-DVB-PAN 
96-blade SPME system was optimized for the extraction of the phenolic compounds from 
grape, berry, and wine samples. The developed method was evaluated in terms of recovery, 
reproducibility and reliability, and the results of the SPME-LC–MS/MS analysis were 
compared with the solvent extraction technique coupled with LC–MS/MS. The developed 96-
blade SPME method achieved excellent recovery and reproducibility for the extraction of 
grape, berry, and wine samples, and a significant reduction of ion suppression/enhancement of 
analytes was obtained through efficient clean-up of the sample matrix from interfering 
components. In addition, the SPME method provided valuable insights on the existence of 
binding/adsorption interactions of the phenolic compounds with the binding matrix in the food 
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1.1 7BThe importance of sample preparation for biofluid analysis 
Biofluid analysis consists of quantitative methods for the determination of low and 
high molecular weight species in a given biological system (e.g., living cells, plants, animals, 
and human bodies). The quantification of analytes such as drugs, metabolites, hormones, 
toxins, and nutrition ingredients in biofluids is necessary in the fields of drug discovery and 
development, medicine, therapeutic drug monitoring, toxicology, and food analysis.
1-4
 
Depending on the type of application, the analysis of complex biological fluids can be very 
challenging: this might be due to low concentrations of the analyte of interest in the sample 
(e.g., sub or low part per billion) that can contain thousands of other components including 
salts, acids, bases, peptides, proteins, drugs, endogenous metabolites, and numerous other 
organic components.
5
 When dealing with instrumental methods with low analytical 
selectivity and sensitivity, the abundant components present in the sample, which have 
chemical properties similar to those of the analytes, can potentially interfere with the analysis 
of the analyte of interest, and consequently result in an unsuccessful analysis and/or 
unreliable analytical results.  
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) has gained 
popularity over the last few decades due to its high sensitivity and selectivity; it has become 
the method of choice for bioanalytical applications.
2,3
 Liquid chromatography provides 
2 
chromatographic separation of the analyte from other sample components, and tandem mass 
spectrometry presents selective quantitation of analytes by multi-step mass spectrometry 
based on their mass-to-charge ratio. However, in most cases there are limitations for direct 
injection of a biological sample into an LC–MS/MS system, including: (i) clogging of the 
instrument compartment due to the presence of large particulates in untreated biological 
samples or the precipitation of some sample components in contact with the LC mobile 
phase, (ii) deterioration of the performance of the chromatographic column due to the 
presence of contaminants, and (iii) incorrect analytical results due to ionization 
suppression/enhancement (called the matrix effect) in the presence of co-extracted 
components from the sample.
1, 6
  
Different mechanisms have been proposed to explain the matrix effect, including: (i) a 
decrease in the evaporation efficiency of the spray droplet and reduction in the capability of 
the analytes to reach the gas phase, (ii) competition between the analyte and the interfering 
compounds for ionization, and (iii) neutralization processes.
7
 It is important to verify and 
minimize the possibility of the matrix effect during method development and validation of 
LC–MS methods, since it can significantly influence the precision, accuracy, and reliability 
of the method. Selection and optimization of a proper sample preparation method, 
optimization of LC conditions, and application of an appropriate analytical calibration 




In fact, the sample preparation of the biological samples is completed with three major 
goals: (i) cleaning up the sample by removing unwanted matrix components that can 
interfere with the analysis of the analyte of interest (improving method specificity and 
3 
reliability), (ii) concentrating the analyte to improve the limit of detection of the analytical 
method (improving method sensitivity), and (iii) exchanging the analyte from the sample 
into an organic solvent compatible with the chromatographic system. In addition, as a result 
of sample clean-up, sample preparation presents better chromatographic column and mass 
spectrometer performance and life time in LC–MS applications. 
1.2 8BSample preparation methods for biofluid analysis 
During the last several decades, many different sample preparation approaches have 
been developed for biofluid analysis. Ultrafiltration, dialysis, and protein precipitation (PPT) 
are sample preparation methods mainly used to remove proteins from biological samples.
9, 10
 





 solid phase extraction (SPE),
15,16
 solid phase 
microextraction (SPME),
13, 17, 18
 stir bar sorptive extraction (SBSE),
19, 20
 and microextraction 
in a packed syringe (MEPS)
21
 are much more efficient techniques in terms of producing 
cleaner extracts for analysis. In addition, immunoaffinity extraction,
22, 23
 molecularly 
imprinted polymer (MIP)-based extraction,
24, 25
 and membrane-based extraction
26, 27
 are also 
efficient sample preparation techniques with high specificity and selectivity. These 
techniques function on the basis of selective isolation of the analyte of interest from the 
complex biological matrix. Among all the above-mentioned sample preparation techniques 
PPT, LLE, and SPE are currently the most predominate sample preparation techniques for 





The principle of PPT is based on the addition of an organic solvent or inorganic acid to 
the biological samples and the removal of proteins.
28
 This method is fast and easy to 
develop, but it suffers from poor sample clean-up and a high possibility of matrix effects.
8 
The LLE method is based on the addition of an appropriate water-immiscible organic solvent 
to the biological sample, and the extraction is performed by partitioning of the analyte into 
the organic layer (with higher solubility toward the analyte) and leaving the interferences, 
such as salts and proteins, in the aqueous layer. The LLE suffers from consumption of large 
volumes of organic solvent and the formation of emulsions, which result in the loss of 
analyte.
11
 In SPE, a solid extractive phase contained in a cartridge or disk is used to extract 
the analyte of interest from the biological sample. After introducing the sample to the SPE 
cartridge, any loosely adsorbed matrix interferences are washed by a weak solvent and the 
elution of the analyte of interest is obtained using a small amount of an appropriate solvent. 
The SPE method suffers from the possibility of clogging the packed bed sorbent with any 
large biomolecules and particulates present in the sample; therefore, additional steps of pre-




1.3 9BSolid-phase microextraction (SPME) 
Solid-phase microextraction (SPME) is an equilibrium-based sample preparation 
method that permits integration of sampling, sample clean-up, and pre-concentration in a 
single step. The method was developed to address the need for rapid and solvent-free sample 
preparation for both laboratory and on-site analysis. SPME was originally designed for the 
extraction of organic compounds in combination with GC analysis.
30, 31
 However, over the 
5 
past two decades this technique has gained popularity in both GC and LC applications for the 
extraction of different classes of compounds from various matrixes in diverse scientific fields 
(e.g., environmental, food, pharmaceutical, forensic, and clinical areas of study).
32-34
 In this 
technique, a small volume of extractive phase (which is immobilized on a solid support) is 
exposed to the sample for a well-defined period of time. In SPME, the extraction is 
performed by the isolation of analytes which have a high affinity toward the coating. The 
extraction is based on the diffusion of the analytes from the sample matrix to the extraction 
phase through a boundary layer with the ultimate goal of reaching equilibrium between 
phases.
31
 After extraction, the extracted analytes on the SPME coating are desorbed using 
thermal desorption by direct insertion of fiber into a chromatographic injector (i.e., GC 
applications) or solvent desorption (e.g., LC applications). The extraction process can be 
carried out via headspace (HS) extraction through exposing the SPME coating to the vapor 
phase above the sample matrix (extraction of volatile and semi-volatile compounds) or by 
direct immersion of the SPME extractive phase with the sample matrix (extraction of non-
volatile or low-volatile analytes). 
Over the years, several implementations of SPME such as fiber, in-tube, stir bar, vessel 
walls, disk/membrane, and suspended particles have been introduced (XFigure  1.1X). However, 





1.3.1 43BAdvantages of SPME for biofluid analysis 
Solid phase microextraction presents remarkable benefits over traditional sample 
preparation methods for the analysis of biological samples, which are discussed in detail in 
this section.  
 
Figure  1.1 Configurations of solid phase microextraction. Figure reproduced from reference with the 
permission of the publisher.
 35 
 
Since SPME is an equilibrium-based extraction method and utilizes a small volume of 
the extractive phase, it takes advantage of the selective extraction of analytes from the 
sample matrix. This extraction selectivity in SPME provides a high degree of clean-up of 
unwanted interferences from samples, which minimizes the possibility of matrix effect (a 
critical concern in LC–MS applications). Therefore, the choice of extractive phase and its 













 In addition, SPME is an open-bed system where an extractive phase is coated on the 
outer surface of a solid support. One of the most beneficial features of the open-bed system 
is the opportunity for the application of a large sample volume without the limitation of 
breakthrough volume. This feature provides selective equilibrium-based extraction of the 
analytes of interest, even those that are not successfully retained in an equivalent packed-bed 
system. Another beneficial aspect of an open-bed sorbent is the ability to perform direct 
extraction from complex matrixes (including dense fluids and colloidal suspensions) without 
any need for sample pretreatment or concerns regarding clogging or contamination (which is 
common in conventional packed-bed extractive systems).
29
  
The traditional methods for studying free and total concentrations of analytes and 
ligand-receptor binding (i.e., equilibrium dialysis, ultrafiltration, and ultracentrifugation) 
involve the physical separation of unbound and bound ligands, followed by the analysis 
step.
36
 Comparatively, SPME, as a microextraction sample preparation technique, offers the 
determination of both free and total concentrations of the analytes from a single biofluid 
sample using proper calibration strategies. This technique results in significant time and cost 
savings compared to traditional methods where two separate analyses are performed.
1, 37
  
In addition, proper configuration of SPME can be applied for direct in vivo sampling 
from a living system (e.g., sampling from plants or circulating blood of an animal) without 
the need to isolate a defined sample volume. This format of SPME is particularly attractive 
for metabolomics studies as it decreases the overall number of experimental steps and also 




1.4 10BIntroduction to the fundamentals of solid phase microextraction 
Since the work described in this thesis deals with the analysis of non-volatile species 
from biological fluids, direct immersion extraction and solvent desorption modes were 
utilized throughout the study; therefore, the main focus of the theoretical principles described 
in this section is based on these application modes. 
1.4.1 44BSolid versus liquid coatings 
There are substantial differences between the performance of liquid (absorbent) and 
solid (adsorbent) SPME coatings. The extraction of an analyte into the liquid SPME coating 
[e.g., polydimethylsiloxane (PDMS) and polyacrylate] is based on partitioning, in which the 
analyte is absorbed by the coating. In this case, if the coating is thin and a reasonable amount 
of time is spent for the extraction, the molecules are able to penetrate the whole volume of 
the coating. XFigure  1.2 (a) demonstrates the mechanism of sorption for liquid SPME 
coatings.  
In contrast, solid SPME coatings [e.g., divinylbenzene (DVB)/PDMS, 
Carboxen/PDMS, and Carbowax (CW)/DVB] have a “glassy” or “crystalline” structure that 
results in considerably lower diffusion coefficients for the analytes within the coating (XFigure 
 1.2X (b and c)).
17, 35
 In solid SPME coatings, the extraction mechanism is based on physical 
interactions/trapping of the analytes on the pores or high surface areas of the coating; 
therefore, analytes can only be adsorbed on the pores and cannot diffuse within the entire 
volume of the coating. The micropores (<20 Å) and mesopores (20–500 Å) are ideal for 
trapping small and mid-size analytes and usually retain the analytes until either energy is 
applied or they are displaced by a solvent. However, macropores (> 500 Å), which exist 
9 
primarily on the surface of the materials, can adsorb larger analytes through different 
interactions such as hydrogen bonding, pi-pi bonding or van der Waals. Due to the limited 
sites of adsorption on the solid coatings, they have a competitive extraction mechanism; 
therefore, if a long extraction time is applied, compounds with poor affinity toward the 
coating are frequently displaced with those with a higher affinity or those present in the 




(a) (b) (c) 
Figure  1.2 Sorption mechanisms for (a) liquid SPME coating, (b) solid SPME coating with large pores, 





One way to overcome the limitation of solid SPME coatings is the application of pre-
equilibrium extraction, so that the total amount of analytes accumulated by the porous 






methods should be applied in order to determine the initial analyte concentration in the 
sample.  
In general, liquid SPME coatings are more frequently used because of the linear 
dynamic ranges associated with their linear absorption isotherms. Solid coatings have 
chemisorption properties that result in irreversible adsorption of analytes to the surface of the 
coating, and possible loss or modification of the analytes during extraction and/or desorption. 
On the other hand, solid SPME coating exhibits a high degree of selectivity and sensitivity 




1.4.2 45BTheoretical principles of solid phase microextraction 
Equilibrium extraction for liquid SPME coatings: A microextraction system is 
considered to reach equilibrium between the sample and the coating when an increase in 
extraction time does not result in any further increases in the amount of analyte extracted by 
the coating (within experimental error). In the case of direct immersion extraction using the 
liquid based SPME coating, the amount of analyte extracted by the coating at equilibrium 










 Equation 1.1 
where 
0
sC  represents the initial concentration of a given analyte in the sample, sV  represents 
the sample volume, fV  represents the SPME coating volume, and fsK  represents 
distribution constant of the analyte between the SPME coating and sample matrix. The 
11 
distribution constant ( fsK ) is defined as the ratio of the analyte concentration in the coating 
to the analyte concentration in the sample at equilibrium (Equation 1.2). 
fsK =

sf CC /  Equation 1.2 
The magnitude of fsK depends on the nature of the analyte and the SPME extractive 
phase, and some specific properties of the sample matrix such as temperature, pH, and ionic 
strength. Therefore, it is critical to control and preserve these factors during extraction.
17
  
Equilibrium extraction for solid SPME coatings: In case of solid adsorptive coatings 

















Equation 1.3   
 
where maxfC  represents the maximum concentration of active sites on the solid coating, 

fC  represents the equilibrium concentration of a given analyte on the fiber, and AfsK  
represents the analyte’s adsorption constant at equilibrium. The adsorption constant is 
defined as the ratio of the surface concentration of the adsorbed analyte on porous solid 
extractive phase to the concentration of the analyte in the sample at equilibrium ( AfsK =

sAf CS / ). Equation 1.3 demonstrates that when the equilibrium concentration of the analyte 
is much lower than the concentrations of the active sites on the coating (

fC << maxfC ), the 




fC  is sufficiently large, it results in the saturation of the active sites, and 
consequently nonlinear adsorption isotherms.35  
Equilibrium extraction from heterogeneous samples: When extraction is performed 
from a multi-phase system or a heterogeneous sample which consists of an aqueous phase 
with suspended solid particles (having various interactions with the analyte), Equation 1.1 
















 Equation 1.4   
where isK  represents the distribution constant of the analyte between the ith phase and the 
sample matrix with volume of iV , and the rest of the terms are the same as defined for the 
previous equations. For instance, for the extraction of samples containing volatile species, 
the ith phase can be headspace, and contribution of this phase should be taken into account 
for volatile compounds. In complex matrixes, the ith phase can represent a binding matrix 
such as proteins and macromolecules present in biological samples (e.g., plasma and blood). 
In case of the multi-phase matrix the microextraction process can be considered complete 
when the analyte has reached equilibrium with all the existing phases.  
 It is clear from Equation 1.4 that when dealing with complex matrixes the analytes in 
the heterogeneous sample partition/interact with multi-phase systems and are less available 
for extraction. This effect depends on the analyte’s affinity to the competing phases and the 
volume of the competing phases. Therefore, the amount of analyte extracted by SPME is 
influenced by the sample matrix and is proportional to the unbound (free) concentration of 
13 
the analyte under study. This result is considered to be the reason for the aforementioned 
advantage of SPME for the determination of both free (unbound) and total (bound + 
unbound) concentrations of analytes from a single biofluid sample. In this case, utilization of 
individual matrix-free and matrix-matched calibrations is required for determining the free 
and total concentrations of the analytes, respectively.
35
 
Pre-equilibrium extraction: If analytical sensitivity is not an issue, the extraction time 
less than the equilibrium time can be used to increase the sample throughput. The amount of 
analyte extracted in pre-equilibrium extraction is based on the time of accumulation of the 











)1()1(  Equation 1.5 
where t represents the time for pre-equilibrium extraction and a represents a time constant. 
The magnitude of time constant depends on various factors such as the distribution constant, 
the mass transfer coefficients, sample volume, and volume and surface area of the SPME 
coating. As with the case of the equilibrium extraction, the equation of pre-equilibrium 
extraction indicates that the amount extracted by SPME at the time of pre-equilibrium is 
proportional to the initial sample concentration. Therefore the initial concentration of the 
analyte in sample can be calculated, provided that agitation conditions and extraction time 
are controlled precisely and kept constant.
40, 41
 
Negligible extraction: When the sample volume is too large or the amount of analyte 




sffse CVKn   Equation 1.6 
Equation 1.6 is applied in the case of direct on-site or in vivo sampling (such as direct 
sampling from a lake, or sampling from circulating biological fluid in a living system, 
respectively), where the sample volume is too large and the amount of analyte extracted 
becomes independent of the sample volume.
17 
Exhaustive extraction: When the product of the distribution constant and coating 
volume is much larger than the sample volume (i.e. fsK fV >> sV ), Equation 1.1 can be 
modified to: 
0
sse CVn   Equation 1.7 
Equation 1.7 indicates that the entire concentration of the analyte in the sample matrix 
is extracted into the SPME coating. In this case, the initial concentration of the target analyte 




1.4.3 46BKinetics of solid phase microextraction 
Theoretically, the time required to reach equilibrium is infinite, but from a practical 
point of view the equilibrium time is defined as the required time to extract 95% of the 
analyte. The speed of extraction in SPME is determined by the kinetics of the extraction 
process. The kinetics theory identifies the extraction rate as the “bottleneck” of SPME, and 
indicates strategies for improving the rate of extraction.
35
 For static extraction systems, the 
analytes must first diffuse through an ever-broadening depleting layer in the sample matrix 
and then through the fiber coating. In this case, the mass transfer of analytes from the 
15 
progressively thicker depleted layer to the fiber coating determines the overall extraction 
speed; as a result, very long extraction times are expected. However, agitation of the sample 
increases the mass transfer of the analytes and results in an improved rate of extraction and 
reduction in extraction time. In practical agitation conditions, independent of the degree of 
agitation in the system, there is always a stationary thin layer of sample around the SPME 
coating. As the distance from the SPME coating surface rises, the movement of the sample 
fluid slowly increases until it corresponds with the bulk flow in the sample.  
To model the mass transport under practical agitation conditions, the progression in 
fluid motion and molecules’ convection in the space surrounding the coating surface can be 
described as a static layer zone with distinct thickness, called a boundary layer (δ). The 
thickness of the boundary layer is determined by both the rate of convection (agitation) in the 
sample and the diffusion coefficient of the analyte. When the extraction rate is determined by 












 Equation 1.8 
In this equation, δ represents the thickness of the boundary layer, Ds represents the diffusion 
coefficient of the analyte in the sample matrix, b represents the coating thickness, and fsK  
represents the distribution constant. According to Equation 1.8, the time required to reach 
equilibrium depends on the agitation conditions (thickness of boundary layer), affinity of the 
analyte toward the coating (distribution constant), physicochemical properties of the analyte 
(diffusion coefficient), and the thickness of the SPME coating. Therefore, thin coatings and 
efficient agitation conditions are recommended for the best sample throughput. It should be 
16 
noted that an analyte with a high Kfs value will have a long equilibrium time, even with a thin 
boundary layer (rapid agitation).
35
 
1.4.4 47BCalibration in SPME 
Calibration is a process that relates the measured analytical signal to the concentration 
of the analyte in the sample matrix. Since SPME is a non-exhaustive sample preparation 
technique, in order to obtain accurate and reliable quantitative results, it is critical to employ 
appropriate calibration methods. The choice and suitability of a SPME calibration technique 
depends on various factors such as the type of applications and analytical instruments. 
Several calibration approaches have been proposed for SPME including: traditional 
calibration methods (external, internal, and standard addition calibrations), equilibrium 
extraction, exhaustive extraction, pre-equilibrium extraction, and diffusion-based calibration. 
Diffusion-based calibration methods consist of Fick’s first law of diffusion, interface and 
cross-flow models, and kinetic calibration methods (standard in-fiber and standard-free 
calibration). The details regarding each calibration system are well documented in the 
literature.
40, 41
 For the studies discussed in this thesis, external, internal or standard addition 
calibration techniques have been employed, depending on the type of applications. 
1.5 11BAutomation of sample preparation for LC applications 
Sample preparation is known as the ‘bottleneck’ in most analytical protocols. A survey 
on chromatographic analysis shows that sample preparation contributed to approximately 
two thirds of the total time of analysis.
42
 Many biological and environmental applications 
deal with numerous samples for analysis, and the manual analysis of the samples in a linear 
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sequence would be impractical. Improving sample throughput is therefore vital in order to 
achieve fast sample preparation methods. High sample throughput can be achieved by 
analyzing several samples simultaneously or via increasing the sampling rate.
43
 Over the past 
several decades, the automation of sample preparation has been an important objective for 
laboratories to address the limitations of demanding sample preparation strategies.
44
 
Automation of the analytical methods provides a number of advantages including reduced 
analysis time (both for routine analysis and method development), faster sample throughput, 
and greater reproducibility through reduction of human error.
45
 Depending on the required 
task, the choice of the automation may differ in complexity.  
During the past twenty years, the applications of the automated high-throughput SPE 
methods have increased dramatically.
34, 46-53





for bioanalysis and provided significant improvements in 
parallel sample preparation techniques.
54, 55
 However, 384 and 1536 well-plates are also 
available to further improve the sample throughput,
43, 56, 57
 but the 96-well format is 
commonly used for the parallel sample preparation. Since the
 
introduction of the 96-well 
format SPE system, various automatic workstations have been commercialized with different 
extractive phase chemistries and diverse complexities and applications.
44, 55, 58-63
  
Online SPE format is another approach for the automation of the SPE system. In this 
format, the sample is directly injected into an SPE cartridge, followed by direct elution of the 
analytes into an analytical LC column and subsequent MS analysis. The on-line SPE 
techniques are beneficial in terms of strong selectivity and sensitivity; but, they have lower 
sample throughput than the 96-well formats and can suffer from carryover effects.
64
 The 
success of the 96-well format SPE has inspired the application of this format for other 
18 




1.5.1 48BAutomation of solid phase microextraction 
The solvent-free nature and the syringe device format of SPME facilitate its 
combination with gas chromatography (GC) and permit the direct introduction of an SPME 
device into a GC injector. Since the 1990s, commercial autosamplers capable of completing 




 In 1995, the first coupling of SPME to an LC system was achieved through the manual 
introduction of an SPME device into the path of the LC mobile phase (using an injection tee 
for solvent desorption).
71
 However, this method suffers from a lack of automation, the 
chance of sample leak at the LC interface, and the possibility of the loss of analytes. 
Automation of SPME in conjunction with LC analysis was primarily introduced through the 
development of the automated in-tube SPME approach by Eisert and Pawliszyn in 1997.
49
 
The principle of automated in-tube SPME involves the placement of a coated capillary 
within the path of the LC system (typically between the injection needle and the loop of the 
autosampler). Then, in several cycles the sample is automatically drawn into and ejected 
from this in-tube SPME coating. The process of circulating the sample facilitates agitation in 
the system in order to enhance mass transfer and partitioning of the analytes into the 
extractive phase. After the extraction, the analytes can be desorbed by directing the flow of 




 However, in-tube SPME provides a high degree of automation and sensitivity, the 
process suffers from a lack of high-throughput.
72
  
Typically the extraction and desorption steps are the most time-consuming steps of an 
SPME-LC analytical process. Therefore, it is more efficient to perform parallel extraction 
and desorption steps for multiple samples. To address this requirement, during previous 
years, high-throughput SPME-LC analysis has been successfully achieved via the 
development of robotic autosamplers and the utilization of multi-well plate formats.
1, 37, 43, 73, 
74
  
In 2005, O'Reilly et al. first proposed the approach of performing high-throughput 
parallel SPME analysis on a 96-well format.
45
 In 2007, a simple semi-automated proof-of-
concept study was reported using an array of eight commercial PDMS-DVB SPME coatings. 
This study evaluated the applicability of automated SPME for bioanalysis by comparison 
against the accepted automatic 96-well format LLE.
75
 The results indicated that SPME 
achieved a good performance with higher accuracy and precision as compared to LLE. 
However, due to the high expense of a single commercial SPME fiber, building a 96-fiber 
array is considered cost-prohibitive. This limitation was overcome by Hutchinson et al. 
through the introduction of a commercial 96-pin-tool replicator device, used as the support to 
immobilize 96 stainless steel pins coated with PDMS hollow fiber membrane.
43
 The 
performance of the 96-pins was tested against other possible configurations (e.g. membrane, 
multi-fiber “brush”, and commercial SPME metal fiber), and the 96-pins device was found to 
be the most suitable configuration for the automated 96-well format SPME-LC system 
because of higher reproducibility and robustness. The in-house multi-fiber SPME device not 
only addressed the limitations of the expensive commercial fiber assemblies, but it also took 
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advantage of controlling the length and thickness of the extraction phase over the metal 
substrate. O'Reilly et al. reported on the evaluation of different agitation methods (such as 
sonicating, magnetic stirring, and orbital shaking), and they showed that the application of an 
orbital shaker provided more uniform agitation.
43
 Based on the results of O'Reilly’s study, 
Vuckovic et al. reported on the application of a prototype SPME autosampler named 
Concept 96 (designed by Professional Analytical System (PAS) Technology) for determining 




Meanwhile, Xie et al. reported on an automated in-tip fiber SPME approach in 96-well 
format coupled with LC–MS/MS for high-throughput clinical application.
76
 In Xie’s 
research, SPME fibers were fitted in the tips of pipets and a commercially available Tomtec 
Quadra 96-workstation was used to aspirate and dispense the sample solution and desorption 
solvent to the pipet tips. However, the in-tip fiber SPME system has limitations when applied 
to complex and viscous samples (a result of the narrow opening of the pipet tips, and 
difficulties in expelling all sample residues).  
In recent years, different geometries (rod fiber, disk, thin-film) and various coating 
chemistries have been designed and developed for the Concept 96-fiber SPME system, and 
used for the high-throughput analysis of drugs from complex biological samples (urine, 
plasma, and whole blood) with high efficiency and precision.
73, 74, 77-79
  
1.6 12BThin-film microextraction 
SPME was originally introduced in rod fiber geometry and it has been the most 
common format since its introduction. However, the main limitation of the SPME fibers is 
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their relatively low sensitivity due to the small amount of sorbent: the amount of analyte 
extracted by SPME is typically small, especially when extracting analytes with a high degree 
of matrix binding (e.g., drug-protein binding in plasma or whole blood matrixes). For a given 
application, this may result in low absolute recoveries and necessitate the use of highly 
sensitive analytical instrumentation to ensure an adequate limit of quantitation is achieved. 
As a result, during the past several years, improving the extraction capacity and consequently 
the overall method sensitivity has been one of the main focuses of SPME method 
development.  
According to the fundamental principles of SPME (Equation 1.1), the amount of 
analyte extracted by SPME is proportional to the volume of the extraction phase ( fV ). 
Therefore one approach to improve the extraction recovery is to increase the volume of the 
extraction phase. This improvement can be accomplished by either increasing the thickness 
of the stationary phase coating as is accomplished in stir-bar sorptive extraction
19, 80
 or 
increasing the surface area.
81
 The use of thicker coatings increases the extraction equilibrium 
time leading to lower sample throughputs (Equation 1.8). On the other hand, increasing the 
surface area can be achieved by increasing the diameter of the SPME fiber or using thin-film 
geometry. A large increase in the fiber diameter has the limitation of occupying a large space 
(volume) in the sample well. This space causes displacement of the sample solution and 
limits the maximum sample volume that could be placed in the wells. In contrast, the 
application of thin-film geometry addresses this limitation by occupying less space and 
facilitating the use of larger sample volumes.  
22 
In addition to the increased extractive phase volume, and consequently the improved 
sensitivity, thin-film geometry offers two other advantages over the traditional rod fiber 
geometry. First, the thinner SPME coating provides significant improvements in the 
convection and mass transfer of the analyte, which results in a faster equilibrium extraction 
time (Equation 1.8). Secondly, the application of thin-film geometry is beneficial for the pre-
equilibrium extraction as the initial rate of SPME extraction is proportional to the surface 




Equation 1.9  
In Equation 1.9, dn/dt represents the rate of extraction, A represents the surface area of 
the extraction phase, δ represents the thickness of the boundary layer, Ds represents the 
diffusion coefficient of the analyte in the sample matrix, 
0
sC represents the initial 
concentration of analyte in the sample, and t represents the extraction time. Based on 
Equation 1.9, by using very short pre-equilibrium extraction times, when the analyte uptake 
by the coating is linear at the time of extraction, thin-film SPME coating is able to extract a 
larger amount of analyte in comparison with rod fiber geometry.  
The Pawliszyn group has reported on the demonstration of the theoretical concept of 
thin-film SPME coupled with LC–MS/MS application by the immobilization of a layer of 
C18 coating on a flattened end of a stainless steel rod (Figure  1.3X (b)). This report indicates 
that an increase in the surface area of the SPME coating resulted in a significant 
improvement of the extraction rate and up to a 2-fold improvement in the analytical 










1.7 Concept 96-blade (thin-film) SPME device and 96-autosampler 
In order to overcome the limitations of the in-house multi-fiber devices (e.g. instability 
of the immobilized fibers during the agitation) and the difficulties in manually flattening the 
fibers to make thin films, the study of this thesis is focused on the application of a 
commercial 96-blade (thin-film geometry) device designed by PAS Technology. The 96-
blade SPME device is composed of eight rows of blade sets (stainless steel) where each 
blade set consists of 12 thin-film pins. The eight rows of the blade sets are held together 
using nine inter-blade holders, creating a 96-blade SPME device  (Figure  1.3X (c)) that works 
as a part of Concept 96-autosampler. The robotic Concept 96-autosampler is designed to 
directly place the 96-blade device into the 96-well plates prefilled with samples/solvents, 
enabling the performance of preconditioning, extraction, washing, and desorption steps. The 
detailed description of the Concept 96-autosampler is provided in X Chapter 2 X, Section X 2.2.4X. 
 
(a) (b) (c) 
Figure  1.3 (a) In-house 96-fiber SPME, (b) In-house 96-thin-film SPME, and (c) Concept 96-blade SPME 
device. Figures (a) and (c) are reprinted from reference 
35
 and Figure (b) is reprinted from reference 
73
 
with the permission of the publishers. 
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1.8 14BIntroduction to available SPME coatings for LC applications 
To date, the application of SPME with GC analysis is predominant over SPME-LC 
applications. One of the main reasons for this preference is the lack of automation of SPME 
in LC applications, which has been addressed in recent years. Another main reason for the 
prevalence in the use of SPME in GC applications is the limited number of available 
extractive phases suitable for use with LC applications.
82
 Currently, there are eight 
commercially available SPME coatings including PDMS, PDMS/DVB, polyacrylate, 
Carbowax-polyethylene glycol (PEG), Carbowax/templated resin (CW/TPR), CW/DVB, 
Carboxen (CAR)/ PDMS, and DVB/CAR/PDMS. These coatings are basically designed for 
GC applications and thus roughly cover the scale of polarity applied in LC analysis. In 
addition, they occasionally exhibit some limitations such as physical instability, swelling in 
organic solvents, lack of inter-lot reproducibility, and high cost (>$150 per fiber). Even 
though these fibers are reusable, because of their high cost their initial application in the 
multi-fiber design is prohibitive. Recently, the first SPME fiber probe with designated design 
for LC applications has become commercially available. This SPME fiber, which is made of 
C18-silica based stationary phase, is disposable yet still expensive (>$18 per fiber).  
During the past decades many efforts have been made toward developing and 
evaluating improved SPME-LC coatings, and many in-house-made SPME coatings have 
been discovered and tested in various applications. Wu et al. have shown a wide applicability 
for a biocompatible polypyrrole polymer coating for the extraction of several classes of 
analytes due to its inherent multi-functionality.
83-87
 Liao et al. reported on the development 
of poly (acrylic acid) coated fused silica to extract proteins.
88
 Polycrystalline graphites have 
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been used as alternative sorbents for the SPME-LC applications for the extraction of non-
ionic surfactants and various organic pollutants in water.
89-91
 Li et al. reported on the 
development of single-walled carbon nanotube SPME coatings by electrophoretic deposition 
and applied them for the determination of phenols in aqueous samples.
92
 In addition, sol-gel-
based SPME coatings have also been studied in an effort to improve the chemical and 
mechanical stability of the SPME coatings in LC application.
93-95
 The incorporation of 
different functional groups has lead to the development of various monolithic silica coatings 
96, 97
 and polymer monolithic coatings 
98, 99
 with the focus on improvements in the extraction 
of polar compounds.  
Molecularly imprinted polymer (MIP) SPME coatings have been introduced based on 
the mechanism of molecular recognition and as a selective tool for analytical recognition and 
quantitation of compounds.
100
 Furthermore, the development of biocompatible coatings 
based on restricted access materials (RAM) facilitates the extraction and enrichment of low 




Recently variations in the extractive phases for SPME-LC applications have increased 
by the development of diverse coating chemistries based on mixtures of SPE sorbents with a 
biocompatible binder.
1, 37, 73, 79, 103-106
  
1.9 15BCoating requirements for the 96-blade SPME system for the analysis of biological 
samples 
The properties of a given SPME coating depend on the extractive phase materials and 
the applied method for the deposition of the coating on the substrate. To date, several SPME 
26 
coating preparation procedures have been explored, including physical deposition, sol-gel 
technology, and electrochemical procedures. Typically, physical deposition of the coating on 
the SPME fiber and lack of chemical binding between the coating and the substrate are the 
main reasons for poor mechanical and chemical stabilities of the coatings.
107
 Chemical 
stability in contact with aqueous and organic solvents and mechanical stability are two main 
requirements for the SPME extractive phases used in LC applications. The deficiency of the 
SPME coating to meet these requirements leads to classification of the coating as 
‘disposable’. Therefore, the coatings need to be renewed prior to the next analysis: a process 
that is time-consuming and cost-prohibitive especially in the case of a multi-fiber SPME 
system.  
As a result, a proper coating deposition method should be applied to ensure the 
preparation of good quality coatings with a high degree of stability and robustness. On the 
other hand, since the 96-blade device is a commercial product, the ultimate goal is the 
industrialization of the coating preparation procedure. Therefore, the procedure of SPME 
coating preparation should be reproducible, cost-effective, and easy to automate. The 
reproducibility of the coating preparation procedure leads to high fiber-to-fiber 
reproducibility, and consequently the precision of the analytical method. Biocompatibility of 
the coating (described in detail in Chapter 3) is another important factor in the application of 
the automated 96-blade SPME system for the analysis of biological samples.  
In addition to the above-mentioned properties, extraction recovery and a relatively 
short equilibrium time are two other desired characteristics for the SPME coating, which can 
be obtained by the proper choice of extractive material and geometry of the extractive phase. 
27 
The overview of the desired coating properties for the 96-blade SPME system for the 
analysis of biological samples is available in Figure  1.4X. 
 
Figure  1.4 Desired coating properties for 96-blade SPME system for bioanalysis 
 
1.10 16BResearch objective 
The research objectives of this thesis include (i) improvement in throughput, sensitivity, and 
efficiency of the SPME method through the application of a 96-blade (thin-film) SPME 
system, (ii) development and evaluation of different coating preparation strategies, and (iii) 
coating chemistries for the automated 96-blade SPME system (with the desired properties 
discussed in Section 1.9, XFigure  1.4X), and (iv) application of the developed 96-blade SPME-
LC–MS/MS system for the analysis of low molecular weight compounds from biofluids. 
 To address the limitations of the current commercial SPME coatings (e.g., instability 
of the coating for long-term handling, limited extraction recovery for a wide range of 




















the evaluation of different coating procedures for the development of biocompatible and 
long-lasting coatings, which can be used for the analysis of a wide class of compounds from 
complex biological matrixes. Thus, X Chapter 2 X consists of a report on the application of sol-
gel technology for the preparation of highly-stable thin-film octadecyl (C18)-silica gel 
coating for the 96-blade SPME system. In Chapter 3, three different methods: dipping, brush 
painting, and spraying are evaluated for the preparation of biocompatible particle-based 96-
thin-film SPME coatings. In X Chapter 4 X the evaluation of three different biocompatible 
polymers is discussed, with the main focus to improve the biocompatibility of the SPME 
coatings for direct immersion extraction from whole blood matrix. The optimized coating 
strategy with the best biocompatible characteristic for whole blood was then used for the 
application in a novel approach named ‘Extracted Blood Spot’ (EBS) sampling. The 
evaluation of this approach was accomplished using two different analytical methods of LC–
MS/MS and direct analysis in real time (DART)-MS/MS.  
 In order to address the requirement for simultaneous analysis of compounds from 
different classes and polarities, the development and the evaluation of biocompatible 
polystyrene-divinylbenzene-polyacrylonitrile (PS-DVB-PAN) and phenylboronic acid-
polyacrylonitrile (PBA-PAN) coatings for the extraction of a wide polarity range of analytes 
from biological fluids were the focuses of the studies in X Chapter 5 X. In X Chapter 6 X the method 
development and the application of the PS-DVB-PAN 96-blade SPME-LC–MS/MS system 
for the analysis of grape, berry, and wine samples are discussed, along with a comparison of 
SPME with the solvent extraction method. Finally, X Chapter 7 X summarizes the main research 




1BThin-film octadecyl-silica gel coating for automated 96-blade SPME 
coupled with LC–MS/MS 
2.1 17BPreamble and introduction 
2.1.1 49BPreamble 
This chapter has been published as a paper: Fatemeh S. Mirnaghi, Maria Rowena N. 
Monton, Janusz Pawliszyn, Thin-Film Octadecyl-Silica Glass Coating for Automated 96-
Blade SPME Coupled with LC–MS/MS for Analysis of Benzodiazepines, J. Chromatogr. A, 
2012, 1246, 2-8. The materials of the current chapter are reprinted from this publication with 
the permission of Elsevier (Copyright Elsevier 2012). The contribution of co-author Maria 
Rowena Monton to the work described within this chapter was technical advice at the early 
stage of preparation of sol-gel coating. All of the work reported within this chapter has been 
performed solely by the author. 
 




The main reason for physical and chemical instability in most commercially available 
SPME coatings is the physical deposition of the coating on the SPME substrate which results 
in instability of the coating after several uses.
108-110
 One solution to overcome this common 
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problem is the creation of chemical binding between the sorbent and the SPME substrate. 
Over the past twenty years, the development and application of sol-gel SPME coatings has 
increased to address this issue.
109, 111-116
 The sol-gel process consists of three main steps: 
hydrolysis, condensation, and polycondensation reactions. The sol is a colloidal suspension 
which is developed through condensation reactions of the hydrolyzed products of a silicon 
alkoxide. The polycondensation of the sol promotes further cross-linking, resulting in a 
three-dimensional network, and leads to the creation of a gel. Eventually, evaporation of 
solvents in the gel during the drying step results in the final silica gel.
109, 117-119
 The sol-gel 
process has been broadly utilized for the production of different types of products including 
bulk glasses and films,
109, 117-119
 in which the latter is usually made by dipping or spinning 
methods.
120
 As many studies have reported on the development and application of sol-gel 
based SPME coatings, the chemical bond between the silica gel sorbent and the metal SPME 
substrate significantly improves the thermal and mechanical stability of the coating.
109, 111-116
 
 Organically modified silica (ORMOSIL) is an organic-inorganic hybrid material 
which is also synthesized through the sol-gel process. For the preparation of ORMOSIL, a 
second precursor containing an organic substituent is added to the sol-gel reaction, which 
leads to the fabrication of a hybrid complex. The blending of an organosilicon with an 
inorganic precursor in ORMOSIL gel facilitates the development of unique functionalities to 
the final material.
109, 117-119, 121, 122
 The properties of coatings made from ORMOSIL gel can 
be optimized through the selection of different sol-gel precursors, providing an appealing 
flexibility for analytical applications.
118, 119
  
Depending on the type of sol-gel chemistry, the stability of the sol-gel coating in 
desorption solvents can be challenging in LC applications. Up to now, many sol-gel SPME 
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coatings have been developed and applied for thermal desorption in gas chromatography 
applications, but only a few sol-gel SPME coupled with LC applications have been reported 
for the solvent desorption of compounds.
93-95, 110
  
The work completed for this chapter is focused on the development, optimization, and 
evaluation of high-quality octadecyl (C18)-silica gel coating with high chemical and physical 
stability and long-term reusability, which can be used in conjunction with an LC system. 
Referring to the required coating properties for automated 96-blade thin-film SPME systems 
(already discussed in X Chapter 1 X) and owing to the above-mentioned characteristics of sol-gel 
based coatings, the main goal of this work was the development of thin-film C18-silica gel 
coatings for the 96-blade SPME system.  
The sol-gel technique provides a chemically bonded extractive phase on the surface of 
stainless steel blades and presents a successful means of chemical immobilization for the 
SPME coating. This provides good mechanical and chemical stability and prevents 
instability and stripping of the coating in long-term use.  
 In addition, apart from the universal advantages of thin-film geometry for SPME 
coating (i.e., improvement in extraction sensitivity and rate, and shorter extraction time
35, 81
) 
the use of thin-film geometry in the sol-gel based SPME coating provides additional benefits. 
These benefits include preparation of uniform coatings, straightforward control of coating 
thickness, and minimal cracks and shrinkage during the silica gel coating preparation, which 
are the main challenges in the sol-gel process.
93 
 In this study, octadecyl (C18) was selected as the stationary phase due to its extraction 
recovery for a wide range of compounds. Several variables such as the sol-gel aging time, 
the speed of the dipping step, drying atmosphere, and drying temperature were evaluated and 
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optimized for the preparation of high-quality C18-silica gel thin-film coatings. The 
performance of the C18-silica gel 96-blade SPME system, coupled with LC–MS/MS, was 
evaluated for high-throughput analysis of benzodiazepines (diazepam, nordiazepam, 
oxazepam, and lorazepam) from phosphate-buffered saline solution (PBS) and human 
plasma. Various factors such as reusability, reproducibility, and validity of the system were 
evaluated. This study can be used as a preliminary investigation for the preparation of other 
sol-gel derived thin-film SPME coatings with diverse properties and functionalities. The 
chemical structure of the benzodiazepines under study is demonstrated in XFigure  2.1.X 
2.2 18BExperimental 
2.2.1 51BChemicals and materials 
Tetraethyl orthosilicate (TEOS), sodium chloride, potassium chloride, potassium 
phosphate monobasic, and sodium phosphate dibasic were purchased from Sigma-Aldrich 
(MO, U.S.). Acetonitrile (HPLC grade) and methanol (HPLC grade) were purchased from 
Caledon Labs (ON, Canada). Ethanol (HPLC grade) was purchased from Fisher Scientific 
(NJ, U.S.). N-Octadecyl triethoxysilane (C18-TEOS) was purchased from UCT Specialties 
LLC (PA, U.S.). Diazepam, lorazepam, oxazepam, nordiazepam, and diazepam-d5 were 
purchased from Cerilliant (TX, U.S.) as 1 mg/mL standards in methanol with the exception 
of lorazepam, which was purchased as a 1 mg/mL standard in acetonitrile. Human plasma 
was purchased from Lampire Biological Laboratories (PA, U.S.). Aluminum oxide sand 
paper (220 grit) was purchased from Benchmark (ON, Canada). Polypropylene Nunc 96-well 




Figure  2.1 Chemical structure of diazepam, nordiazepam, oxazepam, lorazepam, and diazepam-d5 
 
2.2.2 Preparation of standard solutions and samples 
Working standards were prepared monthly from stock solutions using 
acetonitrile/water (50:50 v/v) as the diluent and were stored at 4 °C. To ensure good 
instrumental performance, quality control (QC) standards were injected at the beginning, 
end, and periodically throughout the sample run. For the instrumental calibration, the 














Phosphate-buffered saline (PBS) solution was prepared by dissolving 8.0 g of sodium 
chloride, 0.2 g of potassium chloride, 0.2 g of potassium phosphate, and 1.44 g of sodium 
phosphate in 1 L of nanopure water with the pH adjusted to 7.4. The spiked PBS and plasma 
samples were prepared daily. The concentration of organic solvents in samples was always 
kept at less than 1%. After spiking the analytes in plasma, samples were incubated overnight 
to ensure drug-plasma protein binding equilibria was reached prior to extraction. 
2.2.3 53BLiquid chromatography and mass spectrometry conditions 
A Waters Symmetry Shield RP18 (Waters Associates, Inc., MA, U.S.) with 2.1 mm × 
50 mm dimensions and a 5 μm particle size was used as the chromatographic column. An 
LC-10 AD Shimadzu high-pressure liquid chromatography system (Shimadzu, Kyoto, Japan) 
was used for the separation of compounds. Chromatographic conditions used for the 
separation of benzodiazepines were previously reported by Lord et al.
123
 An API 3000 triple 
quadrupole mass spectrometer (Applied Biosystems, CA, U.S.) equipped with a 
TurboIonSpray source was used for quantitative analyses of the compounds.  
A CTC PAL autoinjector from Leap Technologies (CTC Analytics, NC, U.S.) was 
used for the injection of 20-µl sample volumes into the LC–MS/MS system. The MS/MS 
analysis was performed in positive mode under multiple reaction monitoring (MRM) 
conditions and using instrument settings described in Table  2.1X. The MS conditions were 
optimized at the following values: nebulizer gas = 12, curtain gas = 8, collision gas = 12 
(arbitrary units), ionspray temperature = 450 °C, and ionspray voltage = 5300 V. Analyst 
1.4.2 software was used for data acquisition and processing. When analyzing biological 
samples, a bypass pump and a switching valve (Waters Corporation, MA, U.S.) were used to 
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divert the flow of column effluent into the waste in the first minute of the chromatographic 
run time. 






DP  (V) FP (V) EP(V) CE (V) CXP (V) 
Diazepam 285.1 154.1 100 270 13 37 10 
Nordiazepam 271.1 140.1 90 165 15 40 11 
Oxazepam 287.1 241.1 80 180 13 31 23 
Lorazepam 321.0 275.1 90 210 9 30 20 
Diazepam-d5 290.2 198.2 80 200 11 45 40 
*DP=Declustering potential, FP=Focusing potential, EP=Entrance potential, CE=Collision energy,  
and CXP=Collision cell exit potential  
 
2.2.4 54BAutomated Concept 96-blade SPME system 
The Concept 96-blade SPME device and autosampler were provided by Professional 
Analytical System (PAS) Technology (Magdala, Germany). The thin-film blades are made 
of stainless steel (1.4310 grade) with the following dimensions: length: 50 mm, width: 2.5 
mm, depth: 0.7, and each blade set consists of 12 thin-film pins. The 96-blade SPME device 
is composed of eight rows of blade sets, holding together with the use of inter-blade holders, 
creating a 96-blade SPME system (Figure  1.3X (a)). The Concept 96-autosampler, which was 
used for this study, contains three integrated arms, three separate orbital agitators, and one 
static stage. The entire system is fully controlled by the Concept software.  
The 96-well-plates can be fitted on top of the agitators and the static stage. One robotic 
arm is designed to automatically hold, move, and place the 96-blade SPME device into the 
96-well-plates, enabling the performance of the steps of preconditioning, extraction, 
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washing, and desorption. The orbital agitators are assigned to shake the 96-well-plates at a 
specific speed controlled with Concept software. The second arm is equipped with a nitrogen 
blow-down device in order to perform solvent evaporation and analyte pre-concentration in 
cases when enhanced sensitivity is important and reconstitutions and/or pre-concentration are 
required. Furthermore, the third arm is equipped with a syringe for dispensing a specific 
volume of the solvent into the individual wells of the 96-well-plate. In addition, the initial 
prototype of the Concept 96-autosampler has the functionality to inject the samples into the 
HPLC port for on-line chromatographic separation and analysis. However, the application of 
this feature resulted in a significant reduction of the sample throughput since simultaneous 
sample preparations and injections were not feasible. Therefore, the unit was operated as an 
off-line sample preparation station for high-throughput SPME analysis, and a separate 
commercially available HPLC autosampler was used to perform LC injections from the 
multi-well plate.  
Figure  2.2X (a) demonstrates a close-up view of three optimized C18-silica gel coated 
blades, and Figure  2.2X (b) shows the Concept 96 autosampler from PAS Technology.  
2.2.5 55BPreparation of C18-silica gel solution 
The C18-silica gel was made using tetraethyl orthosilicate (TEOS) and n-octadecyl 
triethoxysilane (C18-TEOS) as precursors under hydrolytic conditions and acidic catalysis 
(hydrochloric acid (HCl)). The sol was prepared by mixing the appropriate amounts of 
reaction components (44.5: 19: 28: 8.5 % (v/v) for TEOS: C18-TEOS: ethanol: acidified 
water, 0.01% HCl) to obtain a C18-TEOS/TEOS molar ratio of 0.2.
113
 The mixture was then 
aged for 3 h at 25 °C and 1000 rpm stirring speed. After 3 h of stirring, the coating 
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preparation was performed immediately in order to prevent any viscosity changes in the sol 
and to preserve the reproducibility of the final silica gel. The bare silica gel was prepared in 
absence of C18-TEOS in the sol mixture (63.5: 28: 8.5 % (v/v) for TEOS: ethanol: acidified 
water, 0.01% HCl), and all subsequent steps of the coating preparation followed the same 






Figure  2.2 (a) Close-up view of three optimized C18-silica gel coated blades (b) The Concept 96-
autosampler and its labeled components: A, C, and, D are orbital agitators for extraction, desorption, 
and conditioning, respectively. B is the wash station. E is the 96-blade device. F is the nitrogen 
evaporation device. G is the syringe arm. 
 
2.2.6 56BPreparation of C18-silica gel 96-blade SPME coating 
In order to obtain effective immobilization and chemical binding of the silica gel 
coating to the SPME stainless steel substrate, the surface of the thin-film stainless steel 
blades needed to be treated prior to the coating immobilization. First, the steel blades were 
polished with sand paper and cleaned by sonicating in acetone for 10 min. Then, the stainless 
steel blades were oxidized through 1 h of sonication in concentrated hydrochloric acid. In the 
next step the steel blades were immediately washed with plenty of water, rinsed with 
nanopure water, and dried in an oven for 1 h at 150 °C. After cooling to room temperature, 
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the dipping method was used to coat 2 cm of the length of the blades using the prepared sol. 
For the coating preparation, the blades were immersed in the dipping solution and were 
withdrawn vertically at a 90° angle.  
In order to attain the proper film thickness without any shrinkage or cracking, the 
speed of the coating withdrawal was optimized to 1 mm/s. The prepared coatings were then 
immediately dried for 1 h at room temperature in a desiccator under running nitrogen. Then, 
the coatings were dried in an oven using a temperature gradient starting at 40 °C (kept for 1 
h) and increased at a rate of 0.5 °C/min to 150 °C (for 5 h). After cooling the coatings to 
room temperature and before initial use, the C18-silica gel thin-film coatings were 
preconditioned overnight in methanol/water (1:1 v/v) prior to the first use. 
2.2.7 57BAutomated 96-blade SPME procedure 
Prior to each extraction, a 30 min preconditioning of the C18-silica gel coating in 
methanol/water 1:1 v/v (with agitation) was required. After preconditioning, a precisely 
controlled volume (1.5 mL) of the sample was used for 40 min equilibrium extraction at an 
agitation speed of 1000 rpm (2.5 mm amplitude). In order to remove the attached salts, 
proteins, and biological particulates onto the coating surface, a 15 s static washing step in 
water was performed after extraction from human plasma. Then, desorption of analytes was 
performed in 1.5 mL of acetonitrile/water 1:1 v/v solvent (spiked with 10 ppb diazepam-d5 
as an internal standard) for 40 min at an agitation speed of 1200 rpm (1 mm amplitude). The 
carryover was evaluated by performing a second desorption using fresh portions of 
acetonitrile/water 1:1 v/v solvent. Finally, the 96-well plate containing the final extract was 
transferred to the LC–MS/MS system for separation and quantitation. Each step 
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(preconditioning, extraction, washing, and desorption) was performed automatically using 
the Concept autosampler and software with pre-set time and agitation speeds.  
2.2.8 58BData analysis and calculations 
The isotopic label calibration was drawn by plotting the peak area ratio of the analyte 
to internal standard versus analyte concentration. The unknown sample concentrations were 
calculated from the equation y = mx + b, as determined by the standard line. In order to 
ensure the accuracy of low concentration standards, 1/y linear weighted regression was used 
for the calibration. Percent absolute recovery or extraction recovery was calculated by a ratio 
of the amount (ng) of analyte extracted by the SPME coating versus the total amount (ng) of 
analyte originally present in the spiked sample, multiplied by 100. Percent carryover was 
determined by dividing the ng extracted from the second desorption with the total ng 
extracted from the first and second desorptions, multiplied by 100.  
2.3 19BResults and discussion 
2.3.1 59BSol-gel reaction 
The sol-gel is a process in which a solution or sol goes through a sol-gel transition. As 
a specific example of the silica sol-gel process, an alkoxysilane (TEOS and C18-TEOS in 
this study), undergoes hydrolysis, condensation, and polycondensation reactions in the 
presence of ethanol and water, and under acidic or basic conditions (acidic conditions in this 
study). Finally, sol-gel polymerization yields a network of Si-O-Si chemical linkage and the 
gel is processed by drying. Hydrolysis and condensation reactions of most metal alkoxides 
have an extremely fast rate and can be carried out without a catalyst, but the reactions of 
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alkoxysilanes proceed more slowly, requiring the addition of either an acidic or basic 
catalyst.
117




Figure  2.3 Schematic illustration of the sol-gel process. Figure reproduced from reference with the 





2.3.2 Binding the silica gel coating to the metal substrate 
Binding the C18-silica gel coating to the stainless steel substrates involves the creation 
of a -M-O-Si- chemical bond between the oxidized metal substrate and the silicon oxide in 
the coating film.
124
 The schematic illustration of the chemical binding of silica gel coating to 
the metal substrate is shown in XFigure  2.4 
 
Figure  2.4 Schematic illustration of the chemical binding of the silica gel coating to the metal substrate. 




2.3.3 61BCracking and shrinkage 
As reported in many studies, one of the most challenging issues in the preparation of 
sol-gels is the creation of undesirable shrinkage and cracking, which are driven through 
capillary forces and originate from solvent evaporation during the drying of the gel.
93, 118
 As 
XFigure  2.5X shows, the preparation of a thin-film silica gel coating without the optimization of 
the parameters is not exceptional and it also results in shrinkage and cracks on the coating. 
Since the main goal of this study is the development of a high quality C18-silica gel thin-film 
SPME coating with improved stability and reusability, it is vital to overcome the challenging 
limitations of the cracks and shrinkage in the thin-film silica gel coating. The results of this 
study show that shrinkage and cracking of sol-gel thin-film are controllable through the 
optimization of the thickness of thin-film coating and drying conditions. 
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Figure  2.5 Typical cracks and shrinkage in thin-film silica gel coating without the optimization of the 
thickness of thin-film coating and drying conditions 
 
2.3.4 62BThe critical thickness of the silica gel thin-film 
The critical thickness is ~1 µm for inorganic sol-gels and as high as 10 µm for 
ORMOSIL gels. The problem of shrinkage and cracking is more significant for sol-gel films 
thicker than the critical thickness. Usually, the organic-inorganic hybrid films (ORMOSIL) 
lead to less shrinkage and lower rigidity of the film as compared to inorganic sol-gels. This 
result is achieved because of the presence of organic materials in the organic-inorganic 
hybrid gel that provide stress relaxation through plastic deformation.
109, 110, 124
 Because the 
ORMOSIL gel has been used as an SPME coating in this work, it is critical that the thickness 
of the coating be maintained as low as 10 µm to obtain structural integrity and high-quality 
thin-film silica gel without shrinkage or cracking. Even though the application of a very thin 
SPME coating may result in a low extraction volume (Vf) and, consequently, leads to lower 
extraction recovery (Equation 1.1), it is preferable to obtain high-quality thin coatings with a 
lower extraction recovery rather than low-quality thick coatings with a larger extraction 
recovery.  
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The thickness of sol-gel thin-film is controlled via two main factors: the viscosity of 
the sol-gel solution and the withdrawal speed of the dipping step in the coating preparation 
procedure.
93, 124
 The coating thickness increases with the withdrawal speed and viscosity at 
approximately ηv
2/3
, where η represents the viscosity of the solution and v represents the 
withdrawal speed.
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 The results show that the viscosity of the C18-silica gel itself is a 
function of the sol-gel composition (C18-TEOS/TEOS ratio) and the aging time of the sol, 
which are individually described in the following sections. 
2.3.5 63BOptimization of C18-TEOS/TEOS ratio 
 The ratio of C18-TEOS/TEOS is one of the contributing factors to the viscosity of the 
sol, and consequently the thickness of the silica gel coating. Three different ratios of C18-
TEOS/TEOS (i.e., 0.2, 0.3, and 0.5) were evaluated for the preparation of C18-silica gel 
coating. As expected, the results showed that the sols made with C18-TEOS/TEOS ratios of 
0.3 and 0.5 were more viscous and resulted in thicker gels that led to considerable cracking 
and shrinkage of the coating. In contrast, sols made with a C18-TEOS/TEOS ratio of 0.2 
resulted in optimal viscosities to produce a coating with thickness lower than the critical 
thickness and a final silica gel free from cracks and shrinkage. Therefore, the C18-
TEOS/TEOS ratio of 0.2 was considered the optimum ratio for sol-gel coating preparation in 
this study. 
2.3.6 64BOptimization of sol-gel aging time 
Sol-gel aging time is another contributing factor to the viscosity of the sol and 
thickness of the silica gel coating and plays an important role in the characteristics and the 
quality of the final product. Insufficient aging times cause inadequate polycondensation of 
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the sol which adversely influences the coating properties. On the other hand, long aging 
times result in a greater extent of polycondensation and cross-linking of the sol, which 
finally ends up with the transition to a rigid gel. As the viscosity of the sol exceeds a critical 
limit, it leads to the coatings which are thicker than the critical thickness and cause cracks 
and shrinkages. So, it is very important that the aging time be properly optimized.  
The results show that for the preparation of the C18-silica gel a minimum of 3 h aging 
time is required for sufficient polycondensation of the sol, and aging times longer than 6 h 
result in a cross-linked gel which is too viscous to be used for coating preparation. Therefore, 
three aging times of 3, 4, and 4.5 h were evaluated. The aging time of 3 h produced the most 
high-quality coating with no evidence of shrinkage. In contrast, aging times of 4 and 4.5 h 
resulted in coatings which exceeded the critical thickness with apparent cracks and shrinkage 
on the surface. Therefore, 3 h was used as the optimum aging time for the rest of the study.  
2.3.7 65BOptimization of withdrawal conditions 
The speed of withdrawal of the substrate from the solution during the dip-coating 
procedure is another significant factor that affects the thickness of the coating. In this work, a 
range of withdrawal speeds (0.5–10 mm/s) was studied, the results of which indicate that the 
speed of the withdrawal is very critical to the quality of the coating. A withdrawal speed of 
>1 mm/s results in a much thicker coating with surface cracks and shrinkage, but withdrawal 
speeds of ≤1 mm/s resulted in higher quality coatings free of cracks or shrinkage. The 
withdrawal speed of 1 mm/s was optimum both in terms of coating quality and extraction 
recovery (thicker than those made with speeds of <1 mm/s) and was used for the remainder 
of the study.  
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In addition, the angle of the withdrawal can affect the thickness of the coating. In order 
to achieve an even layer of thickness on both sides of the thin-film substrate, the substrate is 
dipped into the solution and is drawn up vertically at 90°.
124
 Any variance from 90° may 
cause variation in thickness of the coating from one side of the substrate to the other.  
2.3.8 66BOptimization of drying conditions 
The origin of the shrinkage and cracking comes from the drying process. Therefore, 
one of the solutions to prevent this limitation and to obtain a high-quality silica gel thin-film 
is to optimize the drying conditions. According to the literature, the formation of cracks is 
more likely to occur when the silica gel is completely dried at room temperature or when the 
temperature is lower than at which the bonds between the thin-film gel and the substrate are 
formed.
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 However, the results of this thesis show that the immediate and complete drying 
of the coatings at high temperatures can also cause cracks and shrinkage.  
In this work various drying conditions were evaluated and the best quality silica gel 
films were obtained when the coating was immediately dried for 1 h under running nitrogen 
flow at room temperature and then transferred to an oven for complete drying. It is assumed 
that drying of the sol-gel coating in a neutral atmosphere at room temperature prevents 
boiling of the ethanol and water present in the gel (which usually occurs at high 
temperatures): this method minimizes the formation of the fractures and cracking in the 
coatings. Next, a temperature gradient was used for complete drying of the silica gel thin-
film SPME coating (started at 40 °C, maintained for 1 h, then increased to 150 °C at a rate of 
0.5 °C/min, and kept for 5 h).  
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2.3.9 67BEvaluation of surface topography and thickness of the coating  
The surface topography and the thickness of the optimized C18-silica thin-film sol-gel 
coating was evaluated using scanning electron microscopy (SEM). Prior to taking the SEM 
images, a 10 nm layer of gold was deposited on the surface of the coating. The SEM images 
were obtained using LEO 1530 field emission SEM (Carl Zeiss NTS GmbH, Germany). As 
shown in Figure  2.6X (a) the SEM images indicate that the flow of nitrogen over the surface of 
the coating during the initial drying step creates a rough and wrinkled coating surface, 
resulting in an improved surface area of the coating. The average thickness of the optimized 




Figure  2.6 SEM images of the C18-silica gel thin-film. (a) Surface morphology of the optimized C18-silica 
gel thin-film (dried at room temperature under N2 followed by complete drying under a temperature 
gradient in an oven) using 923 × magnification. (b) Estimation of the coating thickness of the optimized 
C18-silica gel thin-film using 736 × magnification. 
 
2.3.10 6O ptimization of the C18-silica gel 96-blade SPME system 
The automated optimization of all SPME steps, (i.e., preconditioning, extraction, 
washing, and desorption) was performed using the Concept autosampler. The optimization of 
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the SPME conditions was performed using the optimized C18-silica gel thin-film coating 
(C18-TEOS/TEOS = 0.2, aging time = 3 h, withdrawal speed = 1 mm/s, and drying 1 h under 
nitrogen at 25 °C followed by a gradient temperature:  40-150 °C).  
Preconditioning: Prior to each extraction, the C18-silica gel coatings were 
preconditioned in methanol/water 50:50 (v/v) to properly activate (swell) the silica gel 
coatings and to achieve the efficient partitioning of the analytes into the extractive phase. 
 Extraction: In order to evaluate and monitor the extraction recovery of the coating and 
to obtain the maximum sensitivity of the system, all experiments were performed at 
equilibrium extraction. The evaluation of extraction time profiles of the benzodiazepines 
under study was performed in PBS and human plasma matrixes, and no significant difference 
was observed between the two profiles for all four analytes. Using the C18-silica gel 96-
blade SPME system, a 40 min extraction time was required to reach equilibrium for all four 
compounds and applied for the rest of the study. However, this time of analysis can be 
significantly decreased using pre-equilibrium extraction: owing to the computer-controlled 
timing and high precision of the automated 96-blade SPME system, pre-equilibrium 
extraction can be precisely performed without any loss of accuracy. The extraction time 
profile for all four benzodiazepines from PBS is illustrated in XFigure  2.7X.  
A 1.5 mL volume of the sample was used for the extraction and this volume was 
carefully controlled throughout the study. The agitation speed was optimized based on the 
highest applicable speed resulting in optimum extraction recovery without a chance for 
spilling or cross contamination of the samples. Using the agitator with the amplitude of 2.5 
mm for extraction, the optimal agitation speed was 1000 rpm. 
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Wash: After extraction and before transferring the blades to the desorption solvent, a 
fast wash step in water is required to remove loosely attached particles and salts from the 
coating surface. For this study a 15 s wash step (immersion of the blades in 1.5 mL of 
nanopure water pre-filled in the wells of a 96-well plate) was optimized to obtain efficient 
rinsing of the coating with a minimal loss of analytes. The possibility of the analytes’ loss 
during the wash step was evaluated by analyzing the wash solution and the amount was 
determined to be <1% for all four benzodiazepines.  
 
 
Figure  2.7 Extraction time profile for the extraction of benzodiazepines from PBS (pH = 7.4) using the 
C18-silica gel 96-blade SPME system. The extraction of 50 ng/mL benzodiazepines, extraction speed = 
1000 rpm, desorption time = 40 min, and desorption speed = 1200 rpm. 
 
Desorption: Desorption conditions including desorption solvent, time, speed, and 
volume was precisely optimized. The desorption solvent was selected to be compatible with 
the composition of the mobile phase in order to achieve proper chromatographic peak shape. 






































50:50 (v/v), and acetonitrile/water 80:20 (v/v) were used for solvent optimization. The 
results showed that acetonitrile/water 50:50 (v/v) resulted in the best recovery and lowest 
carryover. The evaluation of desorption time and speed demonstrated that a minimum of 40 
min desorption time and 1200 rpm (1 mm amplitude) agitation speed provided the best 
recovery and minimal carryover (< 1% for all four benzodiazepines). A desorption time of 
longer than 40 min did not provide any improvement in the amount of recovery. A minimum 
of 1.5 mL of desorption solvent was required to cover the coating for efficient recovery. 
Using an agitator with 1 mm amplitude, the agitation speeds larger than 1200 rpm caused 
spilling and cross contamination of the samples. A speed of 1200 rpm was chosen to achieve 
the highest level of efficiency.  
In order to remove the trace of analytes remaining from the previous extraction and to 
prepare the coating for the next use, a second 30 min desorption step, called a “carryover” 
was used prior to the next extraction. The efficacy of the 30 min carryover step for cleaning 
the trace analytes (< 1%) was evaluated by analysis of the third desorption. No trace amounts 
of analytes were detected for the third desorption, indicating that a second 30 min desorption 
was sufficient to clean the coating. In order to compensate for any possible variation in the 
injection volume, and the ionization and detection of the analytes, 10 ng/mL of diazepam-d5 
was added as an internal standard to all the samples and the desorption solvents.  
2.3.11 69BEvaluation of the extraction recovery of C18-silica gel 96-blade SPME coating 
The absolute recoveries for the extraction of diazepam, nordiazepam, oxazepam, and 
lorazepam from PBS and human plasma matrixes are shown in XTable  2.2X. The results indicate 
that the C18-silica gel coating appears to have higher selectivity for non-polar compounds 
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(i.e., diazepam with log of octanol-water partition coefficient (log P) = 2.8 and nordiazepam 
with log P = 2.7) rather than more polar ones. However, by selecting the proper precursors in 
the sol-gel reaction, the optimized coating preparation procedure can also be used to prepare 
other types of thin-film silica gel coatings for the extraction of more hydrophilic compounds. 
Since there is a high binding affinity between benzodiazepines and plasma proteins,
127
 when 
extracting from plasma only a small concentration of analyte remains unbound (free) to be 
extracted with SPME coating.
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 Therefore, a significant difference in the amount of absolute 
recoveries from PBS and human plasma can be observed. 
Table  2.2  Percent of absolute recovery for the extraction of selected benzodiazepines from PBS and 
human plasma using the C18-silica gel 96-blade SPME-LC–MS/MS system. 
Analytes PBS Human plasma 
Diazepam 83 ± 3.5 2.5 ± 0.20 
Nordiazepam 48 ± 1.5 1.5  ± 0.15 
Oxazepam 11 ± 1.2 0.55 ± 0.05 
Lorazepam 11 ± 1.1 1.7± 0.18 
 
The extraction volume (Vf), distribution constant (Kfs), and fiber constant (Kfs.Vf) of the 
thin-film C18-silica gel 96-blade SPME coating for extracting benzodiazepines from PBS is 
illustrated in XTable  2.3X. The volume of the thin-film blade coatings was determined based on 
the width (w = 2.5 mm) and depth (d = 0.7 mm) of the blade substrates and the length (l = 




Vf = 2[lb (w+2b)] + 2[lb (d+2b)] + [b (d+2b) (w+2b)] Equation 2 .1                   
Through reducing the volume of desorption solvent and/or the evaporation of the final 
extract, further concentration of analytes in the final extract can be obtained. 
Table  2.3 Evaluation of thin-film C18-silica gel coating parameters when extracting 100 ng/mL 
benzodiazepines spiked in 1.5 mL PBS. 
2.3.12 Evaluation of non-specific extraction of silica gel coating 
The non-specific extraction of sol-gel coating was studied through evaluating the 
extraction recovery for a bare silica gel coating prepared in the absence of the extractive 
precursor (C18-TEOS). The results demonstrate that the amount of non-specific extraction 
was <0.05% for all four benzodiazepines. 
2.3.13 71BEvaluation of the stability and reusability of the C18-silica gel 96-blade SPME 
coating 
The chemical and physical stability and reusability of the C18-silica gel 96-blade 
SPME coating were evaluated. For evaluating the chemical stability, three sets of coatings 
were soaked in pure ethanol, methanol, and acetonitrile overnight, and their physical 
appearance and extraction recovery were compared before and after exposure to the solvents. 
The results of the evaluation showed no difference in the coating properties before and after 
long-term organic solvent exposure, indicating the high chemical stability of the C18-silica 
 Diazepam Nordiazepam Oxazepam Lorazepam 
%Absolute recovery 83 48 11 11 


















Fiber constant (Kfs.Vf), mL 7.32 1.38 0.18 0.18 
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gel 96-blade SPME coating. For testing the physical stability, reproducibility, and reusability 
of the system, a set of C18-silica gel coatings were used for 100 sequential extractions from 
PBS. The coatings displayed reproducible extraction recovery for at least 100 uses in PBS 
(3% RSD for diazepam and 11% RSD for oxazepam for n = 13 experiments and n = 12 
coatings) with no changes in physical appearance, indicating high physical and chemical 
stability, reproducibility, and reusability of the C18-silica gel coatings. XFigure  2.8X (a) 
illustrates the evaluation of the extraction recovery and reproducibility of the coating for 100 
times extraction from PBS.  
It is assumed that the high chemical and mechanical stability of C18-silica gel thin-film 
coating is due to the chemical -M-O-Si- bond between the metal substrate and the sol-gel 
coating. The reusability of the coating was also evaluated for human plasma matrix, and the 
results (XFigure  2.8X (b)) showed good physical stability and reproducible recovery for at least 
20 extractions (8% RSD for diazepam and 11% RSD for oxazepam for n = 5 experiments 
and n = 12 coatings). After twenty extractions the coating was still presenting reproducible 
extraction recovery; however, due to the complexity of the biological matrix in human 
plasma some physical changes were observed on the surface of the coating.  
It is assumed that the observed physical changes are possibly due to the adsorption of 
plasma proteins to the untreated silanol sites on the C18-silica gel coating, especially because 
extraction and desorption are performed at neutral pH. In future studies the long-term 
biocompatibility of the C18-silica gel coating in a biological matrix such as human plasma 
might be improved by end-capping the silanol groups.  
The results show that the washing step after extraction is a critical factor in preserving 
the stability of the coating in the human plasma matrix. As a preliminary assessment, the 
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stability of the C18-silica gel coating in a whole blood matrix was also evaluated for three 
trials, and no red blood cell (RBC) attachment was observed. Since most particle-based 
SPME coatings suffer from a lack of biocompatibility and reusability in whole blood due to 







Figure  2.8 Reusability of the C18-silica 96-blade SPME system for equilibrium extraction of (a) 50 























































2.3.14 Inter- and intra-blade reproducibility of the C18-silica gel 96-blade SPME 
coatings 
The inter-blade relative standard deviation (RSD) of the coating was investigated to 
evaluate the reproducibility of the dipping process and to study the variations between the 
extraction recoveries of different coated blades. In addition, in order to inspect the 
reproducibility of the extraction recovery of the individual C18-silica gel 96-blade SPME 
coatings and the entire SPME-LC–MS/MS method, the intra-blade standard deviation was 
tested.  The results of the evaluation of inter-blade and intra-blade relative standard deviation 
of the system for the extraction of benzodiazepines from PBS and human plasma are 
reported in XTable  2.4X. The reproducibility of the system can be further improved through the 
automation of the dip-coating process. 
 
Table  2.4 Inter- and intra-blade reproducibility of C18-silica gel 96-blade SPME coating for three 
extractions and n = 12 (50 ng/mL of benzodiazepines for PBS extraction and 300 ng/mL of 
benzodiazepines for human plasma extraction). 
Extraction matrix Diazepam Nordiazepam Oxazepam Lorazepam  
PBS inter-blade RSD (%)   3.8 5.6 7.4 8.5  
PBS intra-blade RSD (%) 3.5 5.3 9.1 7.2  
Plasma inter-blade RSD (%)  8.8 9.8 9.7 10.6  
Plasma intra-blade RSD (%) 8.3 9.1 13.0 12.2  
 
2.3.15 Limits of detection and quantitation 
For the entire study of this thesis, the limit of detection (LOD) was calculated based on 
3×S/N (signal to noise), and the limit of quantitation (LOQ) was calculated based on 
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10×S/N. The signal to noise ratio was determined manually on chromatogram printout and 
was confirmed based on four replicated analyses at the LOD and LOQ levels. The LOD of 
C18-silica 96-blade SPME-LC–MS/MS for the extraction of all four benzodiazepines from 
human plasma was estimated to be in the range of 0.4–0.7 ng/mL, and the LOQ was in the 
range of 1.5–2.5 ng/mL. The lowest and highest LOD and LOQ were obtained for the 
analysis of diazepam and oxazepam, respectively. The method displayed a good linear 
response with a linear regression coefficient in the rage of 0.987-0.996 for all four 
compounds.  
2.4 Conclusions and future directions 
The incorporation of thin-film geometry and the optimized conditions for the 
preparation of sol-gel coatings has facilitated effective control of the coating thickness and 
minimized the occurrence of cracks and fractures during the drying process. As a result, a 
sol-gel extractive phase is obtained with high physical and chemical stability and improved 
reusability; these are the most important properties of the sol-gel as it relates to SPME-LC 
applications. High chemical stability of the C18-silica gel 96-blade SPME coating 
overcomes the challenge of stabilizing the sol-gel coating in desorption solvents, and 
facilitates new applications for the sol-gel based SPME-LC system for the extraction of non-
volatile and semi-volatile compounds. The C18-silica gel 96-blade SPME system allows for 
simultaneous analysis of up to 96 samples, automatically.  
The high-throughput format is time efficient, requiring approximately 1.5 min analysis 
time per sample. Taking advantage of the good precision of the automated system, this 
analysis time can be reduced even further via pre-equilibrium extraction. The open-bed C18-
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silica gel 96-blade SPME system can be applied for the analysis of complex matrixes 
containing particulate matters (i.e., biological tissue, food homogenates, and suspensions) 
without any need for sample pre-treatment. The proposed system has the potential to be 
applied to high-throughput analysis in different areas of science including biological, 
pharmaceutical, environmental, food, and clinical studies.  
The optimization of C18-silica gel SPME coating provides valuable insights into the 
critical aspects of fabricating high-quality sol-gel-based coatings in thin-film format. The 
incorporation of optimized parameters for the preparation of high quality silica gel coating 
facilitates the preparation of other sol-gel-derived coatings with different properties (using 
different types of precursors). Future applications of this study include the preparation of sol-
gel coatings containing entrapped biomolecules to be used for diverse applications such as 
sample preparation (as outlined in the present work), or for solid-phase assays such as drug-
protein binding studies (using protein-doped thin-films). 
2.5 21BAddendum 




2BOptimization of the coating procedure for high-throughput 96-blade solid 
phase microextraction system coupled with LC–MS/MS 
3.1 22BPreamble and introduction 
3.1.1 74BPreamble 
This chapter has been published as a paper: Fatemeh S. Mirnaghi, Yong Chen, Leonard 
M. Sidisky, Janusz Pawliszyn, Optimization of the Coating Procedure for High-Throughput 
96-Blade Solid Phase Microextraction System Coupled with LC–MS/MS for Analysis of 
Complex Samples, Anal. Chem. 2011, 83, 6018-6025. The materials of the current chapter 
are reprinted from this publication with the permission of the American Chemical Society 
(Copyright 2011 American Chemical Society). The contributions of Yong Chen and Leonard 
M. Sidisky were the preparation of three sets of coatings which were used in one part of this 
study for evaluation of the coating preparation procedure.  
 
I, Yong Chen, authorize Fatemeh Mirnaghi to use the material for her thesis. 
   
I, Leonard M. Sidisky, authorize Fatemeh Mirnaghi to use the material for her thesis.  
 
3.1.2 75BIntroduction 
During the last two decades, the high selectivity and sensitivity of LC–MS/MS 
compared to other techniques has led to its widespread application in the quantitative 
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determination of drugs and metabolites in different biological samples.
128-131
 However, the 
direct introduction of samples to the LC–MS/MS without sample pre-treatment is very 
challenging and can result in critical limitations (Section X 1.1X, X Chapter 1 X). The necessity of 
the application of sample preparation techniques prior to LC–MS/MS analysis has been 
addressed through the introduction of different methods. However, in spite of the application 
of sample preparation techniques, a reliable and accurate determination of analytes in very 
complex matrixes, such as plasma and whole blood, is still challenging. Many reports have 
indicated that the matrix effect phenomenon (ion suppression or enhancement) is more likely 
to be observed with the application of less selective sample preparation techniques.
132-135
 As 
a result, the choice of an appropriate sample preparation technique is critical for the effective 
sample clean-up and isolation of analytes from complex matrixes.  
SPME is an equilibrium-based sample preparation technique. The clean-up in SPME-
LC is performed by selective extraction of analytes that have a high affinity toward the 
extractive phase, followed by liquid desorption of extracted analytes in a desorption solvent. 
Theoretically, SPME can provide cleaner sample extracts than PPT and LLE and equal or 
better sample clean-up than that obtained by SPE. This superiority is a result of the use of a 
small volume of sorbent while the absolute amounts of analytes of interest and potential 
interferences extracted by SPME are much smaller and depend on the magnitude of their 
distribution constant. In fiber/thin-film geometry of SPME, the sample is exposed to an 
open-bed coating, addressing the limitations of clogging and/or contamination of the 
extractive phase that is common in conventional packed-bed systems.  
However, in open-bed extractive phases the adhesion of macromolecules such as 
particulate and proteins to the coating surface can become problematic. The adsorbed 
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macromolecules can act as a diffusion barrier, which influences the kinetics of extraction and 
affects the amount of analytes extracted by the coating.
79
 In addition, it may affect the 
recovery of the coating for the subsequent extractions and could limit the reusability of the 
coating. One of the solutions to dealing with the issues involved in open-bed extractive 
phases is the application of biocompatible coatings. The application of biocompatible 
coatings can help to minimize the attachment of the macromolecules on the surface of open-
bed SPME coatings and to preserve the efficiency of the coating.  
In SPME, ‘biocompatibility’ can be understood to mean two different terms: (i) 
prevention of adverse and/or toxic reactions in the living system (which is relevant for in 
vivo applications), and (ii) reduction of the adhesion of biological molecules such as proteins 
or blood cells to the surface of the coating (applicable in both in vivo and in vitro 
applications).
79
 Application of biocompatible coatings can preserve the efficiency of the 
coating via minimizing the attachment of macromolecules on the surface of the SPME 
coating. To date, several studies have been reported on the development and evaluation of 
biocompatible SPME coatings for in vivo and in vitro applications using biocompatible 
polymers. The development of biocompatible SPME coatings can be obtained via the 




 and the 
coatings based on restricted access materials
101, 102
) or modification of the conventional 
SPME coatings with biocompatible polymers such as polyacrylonitrile
104
 and poly(ethylene 
glycol)
139
. The former type benefits from the development of an unlimited number of 
biocompatible coatings via the modification of available SPME extractive phases with 
biocompatible polymers.  
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The choice of a proper biocompatible polymer for the development of a stable and 
long-lasting SPME coating can be challenging. Polyacrylonitrile (PAN) is a biocompatible 
polymer that is used extensively in biomedical studies such as dialysis and ultrafiltration and 
has shown good biocompatible properties in different applications.
140, 141 
Most importantly, 
in addition to its biocompatible characteristics, PAN can act as a chemically and 
mechanically stable glue. These properties make PAN a perfect choice for use as a binder for 
the immobilization of particles and a biocompatible phase for minimizing the adhesion of 
macromolecules on the surface.  
A previous study demonstrated the application of PAN as a biocompatible binder for 
the preparation of SPME coatings via a dipping method, and has proved the biocompatibility 
of the coatings by X-ray photoelectron spectroscopy.
104
 Since the main goal of this thesis is 
the preparation of the coating with biocompatibility, high stability, and log-term reusability 
for the automated 96-blade SPME system, PAN was chosen as the binder for immobilizing 
the stationary phase on the substrate. The C18 silica-based stationary phase was chosen for 
the extraction phase because of its capability and applicability for efficient extraction of a 
large variety of analytes. The main focus of the work described in this chapter is the 
evaluation of different coating preparation procedures in order to achieve an optimum 
coating strategy for the 96-blade SPME system. Three different methods, namely dipping, 
brush painting, and spraying were evaluated, and the spraying method was established as 
optimum in terms of stability and reusability.  
The performance of the coating prepared with the optimized preparation method 
(spraying) was evaluated for high-throughput analysis of benzodiazepines (diazepam, 
lorazepam, oxazepam, nordiazepam) from phosphate-buffered saline solution (PBS) and 
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human plasma. Reusability, reproducibility, pH stability, and reliability of the C18-PAN 96-
blade SPME system were evaluated. The structures of the analytes under study are shown in 
XFigure  2.1X. 
3.2 23BExperimental 
3.2.1 76BChemicals and materials 
Polyacrylonitrile, trichloroacetic acid, sodium hydroxide, and a flask-type sprayer were 
purchased from Sigma-Aldrich (MO, U.S.). N, N-Dimethylformamide (DMF) was purchased 
from Caledon Labs (ON, Canada). Discovery silica-based-C18 particles (5 µm) were 
obtained from Supelco (PA, U.S.). The remainder of the materials was purchased from the 
same sources reported in X Chapter 2 X (Section X 2.2.1X).  
3.2.2 77BPreparation of standard solutions and samples 
The information for this section was described in X Chapter 2X (Section X 2.2.2X).  
3.2.3 78BCoating procedures for the preparation of C18-PAN 96-blade SPME coating 
Surface treatment of the stainless steel blade was performed through sonication of 
individual sets of blades with concentrated hydrochloric acid for about 60 min. The blades 
were then washed thoroughly and rinsed with nanopure water. Then, they were dried at 150 
°C for 30 min, and finally cooled to room temperature. The blades were coated using three 
different methods: spraying, dipping, and brush painting. In all three cases the C18 particles 
were immobilized on the surface of the stainless steel blades using biocompatible PAN glue. 
Since a previous study showed that 10% w/w PAN in DMF resulted in optimum properties 
of the required glue,
104
 the same combination was used for the preparation of PAN glue. 
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Then, the PAN-DMF mixture was heated in the oven at 90 °C for 60 min until a yellowish 
clear solution was obtained (PAN does not dissolve in DMF at room temperature). The 
mixture was then cooled to room temperature and C18 particles were added (20% of the total 
volume). All three coatings were prepared using the same slurry of the C18-PAN mixture.  
For the spraying method, a flask type sprayer (250 mL Erlenmeyer flask with a sprayer 
head) was used for spraying the slurry on the thin-film stainless steel surface. After 
transferring the mixture into the flask-type sprayer, the source of nitrogen gas was connected 
to the sprayer head to provide the required pressure for spraying. Then, the coating 
preparation was performed by spraying very thin layers of C18-PAN slurry on the first 2 cm 
of the length of the blades. After each layer, the coatings were immediately cured in the oven 
at 180 °C for 2 min, and then cooled to room temperature.  
For the dipping method, the first 2 cm of the length of the blades were dipped into the 
C18-PAN coating slurry and were then slowly withdrawn. Next, the coatings were dried 
immediately at 180 °C for 2 min.  
A painting brush was used to prepare the coatings with the brush painting method:  thin 
layers of the coating slurry was spread onto the first 2 cm of the length of the blades using a 
fine brush with a width approximately equal to the width of the blades; the coating on the 
blades was dried under the same conditions as the other two coatings.  
For all three types, the sequential steps of the coating and thermal drying were repeated 
for 10 layers in order to fully cover the blade surface and to obtain proper thickness of the 
C18-PAN coatings. 
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3.2.4 79BAutomated Concept 96-blade SPME system 
The Concept 96-blade SPME device and autosampler were both obtained from PAS 
Technology (Magdala, Germany). A detailed description of the Concept 96-blade SPME 
device and autosampler was provided in X Chapter 2 X (Section X 2.2.4X). XFigure  3.1X demonstrates 
the C18-PAN coated 96-blade SPME device. 
 
Figure  3.1 C18-PAN coated 96-blade SPME device. 
 
3.2.5 80BAutomated SPME procedure for high-throughput analysis 
The Concept software was adjusted to automatically perform sequential steps of 
preconditioning, extraction, washing, and desorption with the preset times and agitation 
speeds. Prior to extraction, preconditioning of the C18-PAN coating was performed via 30 
min agitation in methanol/water 50:50 (v/v). 
The extraction was performed from 1 mL of the spiked samples placed in each well of 
the 96-well plate with a 1000 rpm agitation speed (2.5 mm amplitude). The time of 
extraction was set for 1 h in order to achieve equilibrium extraction for all four analytes. 
After extraction from the plasma, the coating was washed for 15 s (static) to remove salts, 
macromolecules, and proteins from the coating surface. The extracted analytes were then 
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desorbed in 1 mL of acetonitrile/water 50:50 (v/v) spiked with 10 ppb diazepam-d5 (as an 
internal standard) for 40 min and with a 1200 rpm agitation speed (1 mm amplitude). Finally, 
the 96-well plate containing the final extract was directly transferred into the LC–MS/MS 
autoinjector for analysis. The evaluation of the extraction recovery, reusability, 
reproducibility, and pH stability were performed at the equilibrium extraction following the 
same SPME procedure described in this section. 
3.2.6 81BLC–MS/MS conditions 
The LC–MS/MS conditions for this study are identical to those described in Chapter 2 
(Section X 2.2.3X). A typical SPME-LC–MS/MS chromatographic data set for equilibrium 
extraction of benzodiazepines from human plasma is illustrated in XFigure  3.2X.  
3.2.7 82BCalibration and calculations 
Internal standard calibration was used to compensate for any possible variation during 
the desorption step and the LC–MS/MS injection and run. It should be noted that the internal 
standard was purposely added during the desorption step rather than the extraction step in 
order to verify and monitor any variation in the coating extraction recovery during the 
coating reproducibility and reusability test. Therefore, a 10 ng/mL diazepam-d5 was used as 
an internal standard for all the standards and desorption solvents for the entire study. The 
unknown sample concentrations were calculated from the equation of isotopic label 
calibration, and a 1/y linear weighted regression method was used for the calibration to 
ensure the accuracy of low concentration standards. The methods for calculation of the 
percent absolute recovery and carryover were reported in X Chapter 2 X (Section X 2.2.8X) 
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Figure  3.2 Examples‎of‎XIC‎chromatograms‎(321.0‎→ 275.1,‎285.1‎→‎154.1,‎271.1‎→‎140.1,‎290.2‎→‎
198.2,‎and‎287.1‎→‎241.1‎respectively)‎for SPME-LC–MS/MS analysis of 100 ng/mL of benzodiazepines 
from human plasma. 
 
3.3 24BResults and discussion 
3.3.1 83BOptimization of the coating preparation procedure 
In order to achieve the most stable and reproducible procedure for making C18-PAN 
96-blade coatings, three different methods of coating preparation were studied. In this part of 
the experiment, three different sets of blades were prepared by Supelco using dipping, brush 
painting, and spraying methods. The blades were then tested by the author at the University 
of Waterloo for sequential extractions from spiked PBS samples and were evaluated based 
66 
on their physical stability, extraction recovery, and reproducible extraction recovery. The 
results of the evaluation of all three sets of coatings for long-term extraction of diazepam 
from PBS are demonstrated in XTable  3.1X. These results indicate that the coatings prepared by 
dipping and brush painting resulted in poor stability in long-term usage; in 70 trials most of 
the coatings prepared by dipping and brush painting peeled off from the substrate surface, 
resulting in loss of recovery. In contrast, the spraying method resulted in the production of 
significantly more stable and robust coatings without any loss of recovery or any changes in 
physical condition. The reason for improved stability of the sprayed C18-PAN coating is 
because of the effective deposition of the multi thin-layers of small particles of the coating 
slurry on the blades. The etching step provides a rough surface on the substrate and improves 
the available surface area on the metal substrate. The spraying method spreads fine particles 
of the coating slurry on the pores of the roughened surface of the blades with high pressure. 
Repeating the spraying procedure for several layers, followed by thermal drying at high 
temperatures after each layer, provides a strong attachment of the coating to the stainless 
steel substrate. This strong connection prevents detachment of the coating from the surface in 
long-term use. Therefore, the spraying method was selected as the optimal method for the 
preparation of the C18-PAN coating and was used for the entire study.  
The optimized thickness of the sprayed C18-PAN coating was obtained over 10 layers 
of spraying (60 µm) which resulted in optimum robustness and stability of the coating. The 
study showed that much thinner coatings resulted in lower physical stability, and 
consequently less reusability.  
In another part of this study, an evaluation was performed for studying the efficiency 
of pre-treatment (acid etching) of the stainless steel blades on physical stability and 
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robustness of the coating. Two sets of pre-treated and untreated blades were coated with the 
spraying method and used for the sequential extractions of diazepam from PBS for more than 
140 usages. The untreated blade set showed stripping and detachment of the coating from the 
surface after several extractions; however, the pre-treated blades demonstrated very stable 
properties and no changes in the physical condition of the coatings (for up to 140 
extractions). The stability of the pre-treated sets is a result of the pre-treatment process of the 
stainless steel substrate with highly concentrated acid, which provides oxidation of the metal 
blades and promotes chemical adhesion of the C18-PAN coating on the surface of thin-film 
stainless steel substrate. 
Table  3.1 Comparison of different methods of coating preparation for C18-PAN 96-blade SPME coatings 
when extracting 50 ng/mL diazepam from PBS. 
 
3.3.2 84BCharacterization and scanning electron microscopy of the sprayed C18-PAN 
coating  
The octadecyl-silica (C18) 5 μm particles are made of octadecyl as the bonded phase 
and silica as the platform. These spherical particles have a pore size and surface area of 
around 180 Å and 200 m
2
/g, respectively. The process of spraying and thermal drying 
(evaporation of DMF solvent at high temperatures) results in the creation of a highly porous 
Coatings 
Average absolute 
recovery for n=12 
after 15 extractions 
Average absolute 
recovery for n=12 
after 35 extractions 
Average absolute 
recovery for n=12 after 
70 extractions 
Physical stability after 
70 extractions (n=12) 
Spraying 97% (RSD=5%) 






77% (RSD=46%) 32% (RSD=147%) 
Weak 
 
Dipping 55% (RSD=80%) 




C18-PAN surface. The porosity of the structure is a critical factor influencing the efficiency 
of the adsorption process because the porous structure significantly increases the effective 
surface area of the coating; therefore higher extraction recovery can be expected.
83
  
The topography of the coating surface was studied with scanning electron microscopy 
(SEM) using the same instrument and procedure reported in X Chapter 2 X (Section X 2.3.9 X). As 
shown in SEM micrographs in XFigure  3.3X, the surface of the coating looks uniform and dense 
with a porous structure. The SEM was also used to study the average thickness of the coating 




Figure  3.3 SEM images of the C18-PAN SPME prepared using the spraying method. (a) Surface 
morphology using 3500 × magnification, and (b) estimation of the coating thickness using 80 × 
magnification.  
 
3.3.3 85BOptimization of the automated 96-blade SPME system 
Preconditioning: The results of the evaluations indicate that the preconditioning step has a 
significant influence on the extraction recovery of the C18-PAN coating. Preconditioning 
aids in activating the C18-PAN coatings for the extraction. In order to achieve the efficient 
partitioning of the analytes into the extractive phase, prior to each extraction, the coatings 
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were preconditioned in methanol/water 50:50 (v/v) and prevented from drying until the time 
of extraction.  
Extraction: Practically, equilibrium time is achieved when no additional increase in the 
amount of extracted analyte is obtained by increasing the time of extraction.
35
 Therefore, the 
amount of analyte extracted at equilibrium time achieves the maximum method of sensitivity 
and demonstrates the extraction recovery of the coating. The evaluation of the extraction 
time profiles of the analytes under study in PBS and human plasma matrixes showed no 
significant differences between the two profiles. The equilibrium time for all four 
benzodiazepines was estimated at about 60 min. Therefore, 60 min equilibrium extraction 
was used for the entire study (this time of analysis, however, can be significantly shortened 
using pre-equilibrium extraction). The extraction time profile for the extraction of 
benzodiazepines from PBS is illustrated in XFigure  3.5 X.  
A 1 mL volume of the sample was used as the extraction volume, and it was precisely 
controlled through the study. The optimization of the agitation speed was performed based 
on the highest applicable speed, which resulted in the greatest recovery without the chance of 
spilling and cross contamination of the sample. The optimal speed was 1000 rpm using an 
agitator with 2.5 mm amplitude. 
Wash: When extracting from human plasma, a fast wash step should be employed 
between the extraction and desorption steps in order to minimize the transfer of any adsorbed 
salts and proteins onto the coating surface to the desorption solvent. The solvent and time for 
the wash step should be optimized to achieve efficient rinsing of the coating and minimal 
loss of the analytes. In the current study, a 15 s wash in purified water (no agitation) was 
effective for removing any attached proteins and particles from the surface with minimum 
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loss. In order to study the possibility of analyte loss, the wash solution was directly injected 
into the LC–MS/MS system. The amount of loss during the 15 s washing step for all four 
benzodiazepines was determined to be about 1-1.5%. In order to prevent the injection of the 
particulates and proteins from the wash solution into the LC–MS/MS system, it is strongly 
recommended that the pre-column and post-column filters are incorporated, and a bypass 
switching valve is used to divert the first 1.0 min of chromatographic run time to the waste. 
 
 
Figure  3.4 Extraction time profile for the extraction of benzodiazepines from PBS using the C18-PAN 96-
blade SPME system. Extraction time profiles were constructed using 50 ng/mL of benzodiazepines in 
PBS, pH = 7.4 (1000 rpm extraction agitation speed, 40 min desorption time, 1200 rpm desorption 
agitation speed, and n = 12). 
 
 Desorption and carryover: The optimization of the desorption conditions (solvent, 
time, volume and speed) was performed to obtain efficient desorption of the analytes from 
the coating and to minimize any remaining trace of the analytes on the coating. Three 
desorption solvents (methanol/water 50:50, acetonitrile/water 50:50, and acetonitrile/water 






























the desorption efficiency of both compositions of acetonitrile/water (50:50 and 80:20 v/v) 
resulted in significantly improved absolute recovery and lower carryover (74-97% absolute 
recovery and 1-1.5% carryover) when compared to that of methanol/water 50:50 v/v (45-
60% absolute recovery and 2-5% carryover). In spite of the similarity of desorption 
efficiency for both acetonitrile/water compositions, the composition of acetonitrile/water 
50:50 (v/v) was selected as the optimal desorption solvent for the following three reasons: (i) 
it minimizes the consumption of organic solvent (a greener method), (ii) it decreases the 
possibility of solvent evaporation during the desorption step, and (iii) it obtains the most 
compatibility with the composition of the LC–MS/MS mobile phase (preventing tailing and 
bad peak shape).  
The comparison of the absolute recovery of the three desorption solvents for 
equilibrium extraction is demonstrated in XFigure  3.6X. Furthermore, the optimal desorption 
volume was found to be 1 mL to ensure the entire length of the coating is covered with the 
solvent and to prevent spilling/cross contamination. Desorption profile studies showed that a 
minimum of 40 min desorption time and a 1200 rpm agitation speed (1 mm amplitude) is 
required to obtain the most efficient desorption of the analytes and the lowest carryover.  
To study the amount of analytes carried over from the previous analysis, a second 
desorption step was performed for 30 min in acetonitrile/water 50:50 (v/v) and analyzed 
using the LC–MS/MS system. The analysis of the second desorption solution showed < 2% 
carryover for all four analytes; a desorption efficiency of >95% is acceptable for quantitative 
analysis. In the case of reusable application of the coatings, such as in the current study, any 
remaining trace of the analytes in the coating must be removed prior to the next extraction 
using a second desorption step. Ideally, the preconditioning procedure can be used to remove 
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the carryover from the previous extraction; but, in the current study, the preconditioning 
solvent is methanol/water 50:50 (v/v), and it does not completely remove the remaining trace 
of the analytes from the previous extraction. Therefore, after the main desorption step, a 30 
min second desorption (carryover) step is always required to entirely eliminate the trace 
amounts of analytes. In order to optimize the carry over step, a third desorption step was also 
performed and analyzed: no remaining traces of analytes were detected. Therefore, a 30 min 
second desorption was found to be effective to clean any trace of the analytes. 
 
Figure  3.5 C18-PAN 96-blade desorption solvent optimization using 1 mL desorption solvents, when 
extracting 50 ng/mL benzodiazepines from PBS (60 min extraction time, 40 min desorption time, 1200 
rpm desorption agitation speed, and n = 12). 
 
3.3.4 86BEfficiency of C18-PAN 96-blade SPME coating 
SPME is basically a non-exhaustive sample preparation technique that functions based 
on the partitioning of analytes between the sample and the extractive phase. The small 
amount of extraction recovery and low sensitivity of the traditional geometries of SPME are 
considered to be limiting factors of SPME (as a result of the small volume of the extractive 

































geometry, when extraction has reached the equilibrium, the sprayed C18-PAN 96-blade 
coating could provide almost exhaustive extraction in the case of diazepam and >74% 
absolute recovery for the extraction of nordiazepam, oxazepam, and lorazepam from PBS.  
Table  3.2X demonstrates the absolute recoveries of the analytes under study for the 
extraction from PBS and plasma using the C18-PAN 96-blade SPME system. The 
differences in the amount of absolute recovery of the analytes for the extraction from PBS 




Table  3.2 Percent of absolute recovery for the extraction of selected benzodiazepines from PBS 
and human plasma using a sprayed C18-PAN 96-blade SPME-LC–MS/MS system (the 
average for n = 6 and five experiments). 
 
3.3.5 87BComparison of recovery of C18-PAN blades with that of C18-PAN rod fibers 
As part of this thesis, the recovery of the sprayed C18-PAN thin-film 96-blade system 
was compared with that of the C18-PAN rod fiber, a study previously published by the 
Pawliszyn research group.
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 In the previous work, the 1.5 cm length of the stainless steel rod 
fibers (254 µm wire diameter) were coated with C18-PAN slurry using the dipping method, 
and a thickness of 60 µm was achieved. Table  3.3 X compares the surface area, extraction 
volume (Vf), distribution constant (Kfs), fiber constant (Kfs.Vf), and extraction recoveries of 
Analytes PBS  Human plasma 
Diazepam 96.7 ± 5.3 4.5± 0.40 
Nordiazepam 82.3 ± 4.0 4.6  ± 0.30 
Oxazepam 74.3 ± 4.6 4.0 ± 0.30 
Lorazepam 74.8 ± 4.3 10.0 ± 0.50 
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the sprayed C18-PAN thin-film blades with those of dipped C18-PAN rod fibers for the 
equilibrium extraction of nordiazepam and diazepam from PBS. The coating volume of the 
thin-film and the distribution constants were calculated based on Equations 2.1 and 1.1, 
respectively. For the rod fiber coatings, the volume of the coating can be determined from 
the coating length (l) and thickness (b), and the radius of the support wire (r) using Equation 
3.1: 




] Equation 3.1 
The thin-film geometry of the 96-blade resulted in a 9.4-fold increase in the volume of 
the coating when compared to rod fibers (XTable  3.3X). For the extraction of nordiazepam, the 





). The absolute recovery for the dipped fibers was determined as 23% versus 82% 
for the sprayed blades. Since for both systems the volume of the sample, initial concentration 
of the analytes in the sample, and coating thickness were the same, the 3.6-fold increase in 
the extraction recovery of nordiazepam corresponds to the effect of increasing the volume in 
the blade system (Equation 1.1).  
For the extraction of diazepam, in addition to the 9.4-fold increase in the volume of the 
coating, the application of the sprayed blade system resulted in a 3.4-fold enhancement in the 
distribution constant. Therefore, the maximum improvement in the extraction recovery was 
obtained (40% recovery for the dipped fibers versus exhaustive recovery for the sprayed 
blades). It should be noted that, due to of the large extraction phase to sample volume ratio, 
KfsVf in the denominator of the Equation 1.1 could not be neglected; therefore, the amount of 




Table  3.3 Comparison of the sprayed C18-PAN 96-blade with dipped C18-PAN rod fibers
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(Equilibrium extraction from PBS) 
 
3.3.6 Reusability and robustness of the C18-PAN 96-blade SPME coating 
The robustness and reusability of the sprayed C18-PAN 96-blade SPME coating was 
evaluated using two sets of coated blades (n = 12) for 140 independent extractions from 
spiked PBS and plasma (XFigure  3.7X). The coatings showed good physical stability and 
reproducible recovery for at least 140 extractions from PBS (RSD = 3–5% for all four 
benzodiazepines for n = 17 experiments and n = 12 coatings) and 70 extractions from human 
plasma (RSD = 7–10% for all four benzodiazepines for n = 13 experiments and n = 12 
coatings). Even though the complex biological matrix of plasma caused a drop in the 
extraction recovery after the 70
th
 extraction, the amount of extraction recovery was still 
reproducible from the 70
th
 to the 140
th
 extractions (RSD = 10-14% for all four 
benzodiazepines for n = 12 experiments and n = 12 coatings). Therefore, if a proper 
Analyte Nordiazepam   Diazepam 
Parameters 
Sprayed C18-PAN 
96-blade (2 cm) 
Dipped C18-PAN 
rod fibers (1.5 cm) 
Sprayed C18-PAN 
96-blade (2 cm) 
Dipped C18-PAN 



































4.50 0.49  
32.50
 
 1.01  
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calibration technique is employed, the coatings could also be reused at least 140 times in 
plasma. The above-mentioned reusability test for plasma extraction was re-confirmed by 





Figure  3.6 Reproducibility and reusability of the C18-PAN 96-blade SPME system for equilibrium 
extraction of (a) 50 ng/mL of benzodiazepines from PBS (n = 12)  and (b) 100 ng/mL of benzodiazepines 
from human plasma (n = 12).  
 
The chemical stability of the sprayed C18-PAN coating was also studied by soaking 
three sets of coatings (n = 5) overnight in pure acetonitrile, methanol, and DMF. The 
efficiency of these coatings was compared to another untreated set of coatings as reference. 






















































coatings in contact with solvents did not show any differences when compared to those in the 
reference set, indicating the high chemical stability of the sprayed C18-PAN coating.  
3.3.7 89BIntra- and Inter-blade reproducibility of the C18-PAN 96-blade SPME system 
The reproducibility of the coating preparation procedure and variations in the 
extraction recovery of the spray-coated blades were studied by evaluating inter-blade RSD 
for the recovery of n = 96 manually-made C18-PAN coatings. Through an evaluation of 
intra-blade variations of the coatings, the repeatability of the extraction recovery of the 
individual coatings and reproducibility of the optimized SPME-LC–MS/MS method were 
studied. XTable  3.4X illustrates the results of inter- and intra-blade RSD of the coatings when 
extracting benzodiazepines from PBS and plasma. The spraying procedure in this study was 
performed manually: it is expected that the inter-fiber reproducibility of the system can be 
significantly improved through the automation of the coating procedure.  
 
Table  3.4 Inter- and intra-blade reproducibility of the C18-PAN 96-blade SPME system 
when extracting benzodiazepines from PBS and plasma (n = 96 and three extractions). 
Extraction matrix PBS Plasma 
Inter-blade RSD (%) 5-7 9-11 
Intra-blade RSD (%) 5-8 8-9 
 
3.3.8 Evaluation of pH stability 
The pH stability of the C18-PAN 96-blade SPME coating was evaluated in the pH 
range of 1-12. The study of the pH stability was performed by evaluating the physical 
appearance and extraction recovery of n = 3 C18-PAN coatings which were used for 10 
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sequential extractions in PBS, adjusted to a specific pH. The results of the evaluation 
indicate that C18-PAN coating preserves physical and chemical stability and reproducible 
extraction efficiencies in the pH range of 2-10. However, for extractions outside this range of 
pH, the harsh chemical effect of highly acidic and basic conditions results in a significant 
reduction of the coating thickness after several extractions, and consequently a  considerable 
loss of extraction recovery. 
3.3.9 91BEvaluation of LOD, LOQ, and linearity 
The methods for determining the LOD and LOQ were reported in X‎Chapter 2 X (Section 
X‎2.2.8X). The LOD was in the range of 0.1-0.3 ng/mL for all four benzodiazepines when 
extracting from human plasma. The limit of quantitation was obtained in the range 0.5-1 
ng/mL for the extraction of all four analytes from human plasma. The highest and lowest 
LOD and LOQ were obtained for lorazepam and diazepam, respectively. The method 
demonstrated good linearity in the concentration range of 0.5-500 ng/mL for all four 
analytes. The linear regression coefficients of the constructed calibration curves for the 
extraction of all four benzodiazepines from human plasma ranged between 0.985-0.993. 
3.3.10 92BSensitivity improvement via drug-protein binding disruption 
As discussed in X Chapter 1 X, the amount of analyte extracted by SPME is influenced by 
the sample binding matrix. As a result, when extracting from complex biological samples 
(e.g., plasma or whole blood) the amount of recovery corresponds to the free concentration 
of the analyte in plasma. This amount of recovery can be increased through precipitation of 
the binding matrix (e.g., plasma proteins), and consequently disruption of ligand-receptor 
binding prior to SPME analysis. This method provides an enhancement in the free portion of 
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analytes in the sample matrix, and consequently an improvement in the sensitivity of the 
assay. 
Many studies have reported on different approaches for the precipitation of plasma 
proteins.
9, 144, 145
 The most common method includes the addition of an organic solvent to the 
plasma sample. This method suffers from dilution of the sample by adding a substantial 




In order to study the applicable methods for drug-plasma binding disruption with minimal 
dilution, several approaches (e.g., heating, freezing and thawing, and acid precipitation) were 
explored in this thesis. Among the tested methods, acid treatment resulted in the successful 
precipitation of the proteins and provided the best recovery. Typically, the available methods 
of acid precipitation in the literature include a considerable volume of the acid (and base for 
neutralization), which dilute the sample.
144
 In this study the method of acid precipitation was 
optimized with minimum dilution (<5%). 
This evaluation showed that 30 µL of saturated trichloroacetic acid solution in water (4 
g/mL) is adequate for complete plasma protein precipitation (PPT) in 1 mL of plasma. The 
procedure for acid precipitation is optimized as follows: After the addition of the acid, the 
sample is immediately vortexed (1200 rpm speed, 30 s). The mixture is then kept in ice for 5 
min. After allowing the mixture to warm to room temperature, it is centrifuged at 4000 rpm 
for 25 min. The supernatant is then separated and neutralized to pH 7.4 with 10 µL of 10 M 
NaOH.  
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The final product was used for SPME extraction, followed by LC–MS/MS analysis. 
The evaluation of the percent recovery was performed using pre-spiked and post-spiked 
plasma samples (spiked before and after protein precipitation, respectively). The results for 
the SPME-LC–MS/MS analysis of pre- and post-spiked protein precipitated plasma samples 
are demonstrated in XTable  3.5 X.  
The results indicate that there is some loss of analyte for the pre-spiked samples during 
the acid treatment, which is a common phenomenon in acid protein precipitation methods.
146
 
This loss can be attributed to incomplete disturbing of the analyte-protein bindings before 
precipitation. It was reported that this issue can be resolved through another acidification 




But, in the case of this study, the addition of another acidification step provides a 
greater degree of dilution, which is not optimal for the proposed system. As a result, as long 
as it is experimentally proven that the amount of recovery is reproducible (XTable  3.5 X), the 
current optimized method with minimum dilution can be used for disturbing the analyte-
protein binding and improving the free concentration of analytes in the sample.  
With a maximum dilution of 4 % (including acid and base addition), a 55% recovery 
was achieved for the SPME extraction of diazepam for a pre-spiked plasma compared to 
83% for a post-spiked plasma sample. The comparison of the recovery for the pre-spiked 
protein-precipitated sample with that of untreated plasma (4.5%, Table  3.2X) exhibits a 12-
fold increase in the sensitivity of the SPME for the extraction of diazepam from plasma. 
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Table  3.5 SPME extraction recovery and reproducibility for the extraction of diazepam from 
protein precipitated plasma.  
*Plasma protein precipitation 
3.4 25BConclusions and future directions 
The automated C18-PAN 96-blade SPME system allows for the high-throughput 
simultaneous sample preparation of 96 samples in a total of 160 min which corresponds  to 
<1.7 min per sample. This length of analysis is based on the time required for equilibrium 
extraction, and it can be further decreased via pre-equilibrium extraction without loss of 
precision (using an automated system). In addition to the improved stability and reusability 
of the analysis of biological samples, the C18-PAN coating resulted in significant 
improvements in the extraction recovery of oxazepam and lorazepam when compared to the 
C18-silica gel coating. On the other hand, the time of equilibrium extraction was longer for 
the C18-PAN coating, which can be attributed to the differences in the properties of the two 
extractive phases including the thickness of the coatings (60 versus 10 µm). 
The thin-film geometry of the blades resulted in a significant enhancement in the 
absolute extraction recovery of the system and provided low levels of detection and 
quantitation. The proposed C18-PAN 96-blade SPME system has the potential to be 
employed for high-throughput analysis in a wide variety of research areas such as food, 
clinical, biological, pharmaceutical and environmental sciences, and metabolomics studies.  






Post-spiked acid PPT*  83   7 9 
Pre-spiked acid PPT  55  9 12 
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A reported example for the clinical application of the automated C18-PAN 96-blade 
SPME system is its utilization for high-throughput therapeutical monitoring of tranexamic 
acid concentration in human plasma in patients undergoing cardiopulmonary bypass 
surgery.
147
 Furthermore, determination of selected pharmaceutical residues in wastewater 
and in vivo determination of selected pharmaceuticals in fish muscle are the two 
pharmaceutical and environmental applications for the developed C18-PAN SPME coating 
that have been recently reported by the Pawliszyn research group.
148, 149
  
The next steps of study for the reported work in this chapter are the modification and 
evaluation of the system for direct extraction from whole blood matrix, and the development 
of other types of extractive phases capable of extracting different classes of compounds in a 
wide range of polarity (which are discussed in X Chapters 4 X and 5X, respectively).  
3.5 26BAddendum 
The text of this chapter was rewritten in comparison to the published research article. 
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Chapter 4  
3BReusable SPME coating for direct immersion whole blood analysis and 
extracted blood spot sampling coupled with LC–MS/MS and DART–
MS/MS    
4.1 27BPreamble and introduction 
4.1.1 93BPreamble 
This chapter has been published as a paper: Fatemeh S. Mirnaghi, Janusz Pawliszyn, 
Reusable SPME Coating for Direct Immersion Whole Blood Analysis and Extracted Blood 
Spot Sampling Coupled with Liquid Chromatography−Tandem Mass Spectrometry and 
Direct Analysis in Real Time−Tandem Mass Spectrometry, Anal. Chem. 2012, 84, 8301–
8309. The materials of the current chapter are reprinted from this publication with the 




Packed-bed extractive phases usually suffer from clogging and contamination of the 
system in contact with complex biological matrixes. The open-bed extractive phase in SPME 
addresses this issue and facilitates the direct handing of complex matrixes. However, there is 
a possibility of the adhesion of macromolecules onto the outer surface of the SPME coating, 
which can be resolved via the application of biocompatible coatings. 
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These biocompatible coatings preserve the efficiency of the SPME coating for long-
term exposure to complex biofluids by reducing the attachment of macromolecules and 
particulate matters onto the surface.  
As described in X Chapter 3 X, many contemporary studies have investigated the 
development and evaluation of biocompatible SPME coatings.
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 When dealing with whole 
blood matrix, the adsorption of protein and adhesion of blood cells on the surface of the 
SPME coating are two different issues that must be resolved using biocompatible coatings. 
Not all biocompatible coatings that minimize protein adsorption are also capable of the 
effective prevention of blood cell attachment; most available lab-made or commercial 
biocompatible SPME coatings lack reusability in whole blood (despite their compatibility 
with plasma matrix). This lack of reusability is due to irreversible attachments of blood cells 
to the coating surface, which affects the kinetics of the extraction and results in a loss of 
coating recovery after several uses in whole blood. While many studies have reported on the 
development of biocompatible coatings for long-term use in the human plasma matrix,
74, 104, 
139
 no study thus far has addressed the development of the biocompatible coatings for ‘long-
term reusability’ in whole blood matrix.  
In Chapter 3 the development and optimization of the thin-film C18-PAN coating for 
the extraction from human plasma was discussed, demonstrating the coating’s high degree of 
reusability for direct extractions from human plasma. The evaluation of this coating for 
several extractions from whole blood, however, showed irreversible red blood cell 
attachment on the coating surface and loss of extraction recovery. The current chapter, 
therefore, discusses some modifications to the C18-PAN coating in order to improve the 
biocompatibility with whole blood in long-term use.  
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The surface chemistry and topography of the coating are important parameters that 
influence the intensity of the protein adsorption and interaction of blood cells on the coating 
surface.
150
 Fabrication of a hydrophilic polymer layer on the surface of the extractive phase 
is one common solution for minimizing the adsorption of blood cells. Theoretically, the polar 
polymer layer acts as a barrier on the surface via the formation of a hydration layer with the 
available water molecules in the matrix. This layer protects the coating surface against the 
interactions with the blood cells and proteins.
151
  
This chapter is focused on the modification of the thin-film C18-PAN coating using 
two different polymers: polyacrylonitrile (PAN),
104
 and 2-methacryloyloxy ethyl 
phosphorylcholine (MPC)
152-155
. Polyacrylonitrile polymer is one of the most common and 
widely-used biocompatible polymers. The application of PAN for the development of 
biocompatible surfaces has already been reported in many studies, indicating the significant 
effect of PAN on reducing the interaction of matrix components with the exposing 
surface.
140, 156-158
 Moreover, MPC has the same structure as the phosphatidylcholine polar 
group that forms the cell membrane; it can therefore form a membrane structure with anti-
thrombus properties which controls the adhesiveness of blood platelets to the surface. The 
structures of PAN and MCP are shown in XFigure  4.1X. 
For the purpose of this study, a new washing strategy after extraction was employed in 
order to improve the reusability of the modified coatings in whole blood. The modified 
coatings were evaluated in terms of the extent of blood cell attachment, reproducible 
extraction recovery, and reusability for direct immersion whole blood analysis in long-term 
usage.  
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This chapter also includes a discussion of the employment of the optimal modified 
C18-PAN for the evaluation and optimization of extracted blood spot sampling coupled with 
LC–MS/MS and direct analysis in real time (DART)–MS/MS. For the entire study, diazepam 
and diazepam-d5 were used as the model analyte and isotopic-labeled analogue, respectively. 
 
4.1.2.1. Introduction to extracted blood spot (EBS) sampling 
Since the introduction of dried blood spot sampling (DBS) in the 1960s, DBS has been 
commonly used for the population screening of newborns, and many applications have been 
reported for the qualitative and quantitative screening of metabolic disorders.
159, 160
 Over the 
years, this technique has been successfully applied for the screening of individuals for 
clinical purposes and detecting numerous biological markers in epidemiological studies.
161-
163




DBS offers a number of advantages over conventional whole blood, plasma or serum 
sample collections, including: (i) being a less invasive sampling method, (ii) requiring 
smaller blood volumes (reducing the use of animals and cost of analysis), (iii) offering easier 
storage and shipment to laboratories with no requirement for freezers and dry ice (cost 
efficient), and (iv) minimizing the risk of biohazard infection.
159, 164
 However, the application 
of DBS (filter paper deposition) has some disadvantages, including: (i) possible hematocrit 
and chromatographic effect (uneven distribution of the analyte and variation in assay result 
when punching the blood spot), (ii) error and/or contamination due to punching device, (iii) 
instability of some compounds on filter paper, and (iv) analyte signal 
suppression/enhancement due to the blood and filter paper matrixes. 
165-168 
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In order to overcome the above mentioned limitations, this work for the first time 
introduces the ‘Extracted Blood Spot’ (EBS) approach. EBS includes the utilization of a 
biocompatible SPME coating (instead of filter paper/card in DBS) for spot sampling of blood 
or other biofluids. With the EBS approach, a small volume of the blood sample is deposited 
on a customized SPME coating. In a short sampling time (based on the kinetics of the 
extraction), analytes are selectively extracted into the coating. Then, in a short time interval, 
before the blood spot dries on the coating, a fast wash step rinses the blood matrix from the 
coating surface. In next step, the analytes can be immediately desorbed or the coating can be 
stored and transported to a laboratory for analysis.  
EBS integrates all four steps of sampling, extraction, analyte pre-concentration, and 
sample clean-up in one single step and offers the following advantages over the conventional 
DBS technique: (i) extraction and preservation of the analytes against possible variation 
(e.g., oxidation), (ii) prevention of the adverse ion suppression/enhancement caused by filter 
paper and blood matrixes (the blood spot is rinsed and removed in the wash step), (iii) no 
limitation with filter paper punching, hematocrit and chromatographic effect, (iv) a simple 
sample preparation step with fewer experimental steps, and (v) automation and high-
throughput. 
 
4.1.2.2. Introduction to direct analysis in real time (DART) 
Direct analysis in real time (DART) is a fast method of analysis which provides the 
immediate analysis and screening of samples without the need for sample pre-treatment.
169-
171
 The DART ionization source facilitates the desorption of analytes directly from the 
sample substrate placed in the open atmosphere between the exit of the source and the inlet 
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of a mass spectrometer. The DART source works via the direction of a heated gas flow 
(containing metastable–electronic or vibronic excited-state–atoms of helium and nitrogen) to 
the sample. This step results in the heating of the sample, and desorbing the molecules of 
interest into the gas state where ionization occurs.
171
  
The major limitation of DART is the possibility of the matrix effect, which may 
happen in the absence of sample pretreatment, though the introduction of complex samples 
containing numerous interferences to the system.
172, 173
 This limitation impacts sensitivity, 
accuracy, and precision and makes qualitative and quantitative analysis difficult.
172
 
Therefore, in order to obtain accuracy and reliability in a short analysis time, an appropriate 
sample preparation method that features efficient and fast sample clean-up is required. For 
the first time, in this study, the SPME coating is utilized for the extracted blood spot 
sampling coupled with DART–MS/MS. The application of the modified biocompatible 
SPME coating for EBS sampling provides efficient and fast sample clean-up, isolation, and 
pre-concentration of compounds from complex matrixes prior to DART.  
4.2 Experimental 
4.2.1 95BChemicals and materials 
Stainless steel (1.4310 grade) thin-film substrates were obtained from PAS 
Technology. The 74×74 stainless steel meshes were obtained from IonSense Inc. MPC 
(Lipidure
®-
CM) was purchased from NOF Corporation (Japan). Discovery silica-based-C18 
particles (5 µm) were obtained from Supelco (PA. U.S.). The remainder of the materials 




                                             n=3 and m=7 
(a) 
   
(b) 
Figure  4.1 Structure of (a) 2-methacryloyloxy ethyl phosphorylcholine (MPC), and (b) polyacrylonitrile  
 
4.2.2 96BPreparation of standard solutions and buffers 
The information for this section was described in X Chapter 2 X (Section 2.2.2 X), with the 
exception of using human whole blood instead of human plasma. 
4.2.3 97BPreparation of modified biocompatible C18-PAN SPME thin-film coatings 
C18-PAN SPME coatings were prepared with the spraying method following the same 
formula and procedure reported in X Chapter 3 X (Section X 3.2.3X). C18-PAN coatings were then 
modified using two different polymers as described below. For all the modifications, the 
dipping method was used for covering the original C18-PAN, since it provides more uniform 
and reproducible coverage compared to spraying and brush painting methods.  
MPC-modified C18-PAN: An MPC solution was prepared by dissolving MPC particles 
in ethanol (5% w/v). The C18-PAN coatings were dipped in the MPC solution for 60 s, 
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followed by drying at 50 °C for 4 h. The coating and drying steps were repeated three times 
to obtain full coverage on the surface.  
PAN-over C18-PAN: PAN glue was prepared with the same procedure described in 
X Chapter 3 X (Section X 3.2.3X). Different approaches were tried and evaluated for the preparation 
of the modified PAN-over C18-PAN coating, including: (i) dipping the C18-PAN coatings 
(n = 6) in PAN glue for 20 s, and drying at 180 °C for 2 min, (ii) dipping two sets of C18-
PAN coatings (n = 6 each) in PAN glue for 20 and 60 s, followed by drying at 70 °C for 4 h, 
and (iii) preparation of two sets of C18-PAN coatings (n = 6 for each set) in different 
thicknesses (10 s dipping for thin and 60 s dipping for thick cover), followed by drying under 
an ultraviolet (UV) lamp light [emitting UVA (320-400 nm) and UVB (280-320 nm) 
regions] for 30 min on each side.  
4.2.4 98BLC–MS/MS conditions 
The LC–MS/MS conditions were identical to those of explained in Section X 2.2.3X 
(X Chapter 2 X). The summary of MS/MS parameters for diazepam and diazepam-d5 is provided 
in Table  2.1X. 
4.2.5 99BAutomated 96-blade (thin-film) SPME system 
This study utilizes the Concept 96- blade (thin-film) SPME device and 96-autosampler. 
The detailed description of the original system is provided in X Chapter 2 X (Section X 2.2.4X). 
However, in this study the static wash station of the original Concept 96-autosampler was 
modified to an agitating wash station, and an updated version of agitator was used for the 
desorption. XFigure  4.2X illustrates a picture of the modified Concept 96-autosampler including 
four orbital agitators. 
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Figure  4.2 The modified Concept 96-autosampler including the following labels: a: 96-thin-film SPME 
device, b, c, d, and e: orbital agitators for extraction, desorption, wash, and conditioning, respectively. f: 
syringe arm, and g: nitrogen evaporation device 
 
4.2.6 100BAutomated SPME-LC–MS/MS procedure for direct immersion blood analysis 
The spiked whole blood samples were incubated to reach equilibrium between the drug 
and the blood binding matrix. Each step (preconditioning, extraction, wash and desorption) 
was carried out automatically with a preset time and speed. Prior to extraction, the modified 
C18-PAN coatings were preconditioned while being agitated in methanol/water 50:50, v/v 
(30 min). Equilibrium extraction (60 min) was performed from 1 mL of spiked whole blood 
or PBS (pH = 7.4) at a speed of 1,000 rpm and with 2.5 mm amplitude. After being extracted 
from the blood, the coatings were rinsed for 20 s in nanopure water along with agitation. 
Desorption was performed in 1 mL of acetonitrile/water 50:50 (v/v) for 40 min (1500 rpm, 1 
mm amplitude). Prior to the next extraction, the carryover of analyte on the coating was 
cleaned using a 30 min second desorption in 1 mL of acetonitrile/water 1:1, v/v (1500 rpm, 1 
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mm amplitude). The above-mentioned procedure was performed for the evaluation of all the 
types of modified C18-PAN coatings. 
4.2.7 101BThe procedure for extracted blood spot sampling coupled with LC–MS/MS  
The optimized UV-dried thin PAN-over C18-PAN coating was utilized for the 
extracted blood spot experiment. Five µL of the spiked whole blood was spread on the PAN-
over C18-PAN coatings using a micropipette. Then, the blood spots were left for 2 min to 
enable the extraction of the analytes by the coating. The blades were then immediately 
assembled into the 96-blade holders and mounted on the 96-autosampler to be washed for 20 
s in nanopure water while agitating. This washing step helped to clean the attached blood 
cells from the surface before they dried on the coating. Next, the coatings were desorbed in 1 
mL of acetonitrile/water 1:1 (v/v) for 40 min (1500 rpm speed, 1 mm amplitude). The 
analysis of the samples was carried out using the same LC–MS/MS conditions described for 
the direct immersion whole blood analysis (Section X 4.1.4X). If any transportation was 
necessary, the coatings could also be frozen and stored for a later desorption and analysis. A 
second desorption in 1 mL of acetonitrile/water 1:1 v/v (30 min, 1500 rpm, 1 mm amplitude) 
was performed to clean the carryover from the previous desorption prior to reusing the 
coatings. 
4.2.8 102BCoating preparation for the EBS-DART system 
The preparation of the coating for the EBS-DART system was completed in two main 
steps. Initially, the 74×74 stainless steel bare meshes were coated with a layer of C18-PAN 
using the brush painting method. The C18-PAN slurry was prepared following the same 
procedure described in X Chapter 3 X (Section X 3.2.3X). The stainless steel bare meshes were 
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prepared to have dimensions of approximately 1.2 × 15 cm, which fit into the DART 
transmission module. Then, using a painting brush with the approximate width of the mesh, a 
thin layer of the coating slurry was spread on the surface of the mesh. Next, the meshes were 
dried in the oven (180 °C) for 2 min.  In next step, a layer of PAN was placed on top of the 
coatings using the brush painting method, followed by drying each side under UV light for 
30 min. XFigure  4.3X (a and b) compares the bare stainless steel mesh versus PAN-over C18-
PAN coated mesh. 
4.2.9 103BEBS-DART–MS/MS conditions 
A DART-Standardized Voltage and Pressure (DART-SVP) model ion source 
(IonSense, Inc., Saugus, MA) was coupled with an Applied Biosystems API 4000 triple 
quadrupole mass spectrometer via a Vapur interface (IonSense, Inc.). The Vapur interface is 
necessary for (i) the efficient collecting of the desorption gas, and (ii) the transfer of the gas 
to the atmospheric-pressure interface inlet of a mass spectrometer. The utilization of the 
Vapur interface improves the sensitivity and reproducibility of the analysis.   
The DART-SVP was fitted with a single dimensional motorized linear rail and was 
controlled through the DART-SVP web-based software for the automatic introduction of the 
samples to the source. DART software was set to control the gas selection, ionization 
polarity mode, contact closure to the mass spectrometer, rail speed for sample introduction, 
and the gas heater temperature for the analytes’ desorption.  
The optimization of the parameters and analysis of the samples were performed by 
spotting the samples on the PAN-over C18-PAN coated mesh (in case of EBS-DART–
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MS/MS analysis) and  bare mesh (in case of DART–MS/MS analysis); the meshes were held 







Figure  4.3 Pictures of (a) stainless steel bare mesh, (b) PAN-over C18-PAN coated mesh, (c) transmission 
module, and (d) DART–MS/MS. 
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The transmission module includes a series of 10 holes with a 7 mm diameter (placed 
every 14 mm) which sandwiches and holds the meshes so that samples can be pipetted 
(XFigure  4.3X (c)).
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The linear rail is capable of moving the module through the gap between 
the DART source and the ceramic transfer tube of the Vapur interface where the ionization 
takes place (XFigure  4.3X (d)). In this study, 5 μL aliquots of the sample were deposited on the 
meshes (bare and coated) using a micropipette.  
In the case of the coated meshes, the blood spots were left on the meshes for 5 min to 
allow for the extraction of the analytes. Then, they were immediately rinsed for 5 s with 
nanopure water. Then, coated meshes containing extracted analytes were fully dried (using a 
blow drier) before being introduced to the DART source for analysis. In the case of the bare 
meshes, the blood spots were left to completely dry (following the routine procedures), prior 
to the time of analysis.  
The DART parameters for the analysis of diazepam are optimized in the following 
conditions: source gases = helium and nitrogen, source gases pressure = 80 psi, desorption 
temperature = 250 ºC, discharge needle voltage = 3000 V, grid voltage = 350 V, sampling 
time = 30 s, gap time = 5 s, the distance between the DART gun and ceramic transfer tube of 
the Vapur interface = 11 mm, transmission module sampling speed = 0.2 mm/s. The MS/MS 
analysis in API 4000 mass spectrometer was performed in positive mode under multiple 
reaction monitoring (MRM) conditions at 285.1 → 154.1 and 290.2 → 198.2 for diazepam 
and diazepam-d5, respectively. Collision gas was optimized at 12 (arbitrary units). 
Declustering potential, entrance potential, collision energy, and collision cell exit potential 
were set at 75, 15, 40, and 15 V for diazepam, and 100, 15, 50, and 17 V for diazepam-d5, 
respectively. 
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4.2.10 104BData analysis and calculations 
The methods for calculating the percent absolute recovery and carryover are reported 
in X Chapter 2X (Section X 2.2.8X). A 1/y linear weighted regression method was used for drawing 
the calibration curves. The absolute matrix effect was calculated based on the ratio of the 
peak area of the blank blood extract spiked with the known concentration of the analyte to 
the peak area obtained from the standard solution of the analyte with the same concentration, 
multiplied by 100. Matrix effects larger than 120% and smaller than 80% represent 
significant ionization enhancement and suppression for a given analyte, respectively.
7, 175
 
The methods for determining the LOD and LOQ were already reported in X‎Chapter 2 X (Section 
X‎2.2.8X). 
4.3 29BResults and discussion 
4.3.1 105BCoating topography and blood biocompatibility 
XFigure  4.4X shows the scanning electron microscopy (SEM) micrographs of the original 
and all the modified C18-PAN coatings (details for SEM instrument and procedure were 
reported in X Chapter 2 X, Section X 2.3.9X). 
In the original C18-PAN coating, the amount of stationary phase particles is much 
higher than the PAN content, with PAN mainly acting as a porous glue to bind the stationary 
phase particles together. Thus, there is no coverage layer of polar PAN preventing the blood 
cells from attaching to the coating surface (XFigure  4.4X (a)). The addition of another 
biocompatible layer on the top surface of the coating is therefore required in order to 
improve the blood biocompatibility. This additional biocompatible layer acts as a protective 
layer on the coating’s outer surface and minimizes the adsorption of blood cells on the 
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surface. The SEM micrograph of the UV-dried PAN-over modification (XFigure  4.4X (b)) 
indicates that it properly provides the required protective layer on the C18-PAN coating 
surface. In contrast, this chapter’s studies indicate the weaker biocompatible characteristics 
of MPC-modified C18-PAN coatings. This weaker biocompatibility can be explained by the 
lack of a uniform full-coverage protective layer on the surface to protect the coatings against 
interactions with blood cells (XFigure  4.4X (d)).  
The main characteristic of the polyacrylonitrile [poly(vinyl cyanide)] as a 
biocompatible polymer is the presence of strongly polar nitrile groups. The cyano functional 
groups (C ≡ N) in polyacrylonitrile interact with water molecules contained in blood via 
hydrogen bonding, and form a hydration layer that inhibits the interaction of the blood cells 
and proteins with the coating surface.
176 
4.3.2 106BApplication of direct blood analysis for the evaluation of modified biocompatible 
C18-PAN SPME coatings  
Evaluation of the modified C18-PAN coatings made with all the types of modifications 
showed that UV-dried thin PAN-over C18-PAN provided the best results in terms of 
biocompatibility and reusability (at least 30 reproducible extractions from whole blood). A 
detailed description of the evaluation and performance of all the modifications are described 
in the following section: 
MPC-modified C18-PAN: The evaluation of thin-film MPC-modified C18-PAN 




      




Figure  4.4 Scanning electron microscopy (SEM) micrographs of (a) original C18-PAN, (b) UV-dried thin 
PAN-over C18-PAN, (c) UV-dried thick PAN-over C18-PAN, and (d) MPC-modified C18-PAN thin-film 
SPME coating. 
 
This coating demonstrated improved reusability for at least 20 direct blood analyses 
with negligible blood cell attachment and no change in the extraction recovery of the coating 
(RSD= 11%). After the 20
th
 extraction, some localized attachment of the blood cells started 
appearing, mainly in the tip areas of a number of thin-film coatings (4 out of 12). The 
absolute recoveries for 20 extractions are shown in XFigure  4.5X.  




Figure  4.5 Direct immersion SPME-LC–MS/MS analysis using UV-dried thin PAN-over C18-PAN and 
MPC-modified C18-PAN for the extraction of 100 ng/mL of diazepam from whole blood, n = 6 
(quantitation based on external calibration). 
 
 
PAN-over C18-PAN: Three different drying strategies were tested for the preparation 
of the modified PAN-over C18-PAN coating. Among all methods, drying with UV light had 
the best results and the UV-dried thin PAN-over C18-PAN showed the best performance in 
terms of blood compatibility. The performance of all the PAN-over coatings under different 
drying conditions is compared as follows: 
a) Drying at 180 °C: although this modification decreased the amount of interactions 
of the blood cells with the coating surface, it resulted in localized red blood cell attachments 
in some small holes on the surface. The creation of small holes on the surface of the coatings 
is likely due to the vigorous evaporation of the solvents while drying at high temperatures. 
 b) Drying at 70°C: two sets of coatings (20 s and 60 s dipping in PAN) were dried 
using this method. However, both sets presented improved prevention of the blood cells’ 
attachment on the surface of the coatings up to 16 extractions, this drying strategy resulted in 





























c) Drying under UV light: This drying method was used to address the limitation of 
unwanted coating changes from high-temperature drying. UV light was used for curing two 
sets of thin and thick PAN-over coatings (20 s and 60 s dipping in PAN) for 30 min on each 
side. For both sets of coatings (n = 6 for each), the improvement of biocompatibility with 
whole blood was significant. However, the thinner PAN layer provided much better coating 
recovery and quality. As shown in XFigure  4.5X, the thin PAN-over C18-PAN coating resulted 
in reproducible efficiencies (RSD = 12%) for at least 30 extractions from whole blood 
without any blood cell attachment.  
In addition, the thinner modified coating provided higher extraction recovery. The 
extraction recovery of the thin UV dried PAN-over C18-PAN coating (95 ± 5% for the 
extraction of diazepam from PBS) is comparable to the original C18-PAN; however, the 
thicker modification provided a decrease in extraction recovery when they are compared for 
equilibrium extraction in PBS (80 ± 7%). The coating recoveries of the original and all the 
modified C18-PAN coatings are reported in XFigure  4.6X. It seems that the thin PAN layer acts 
as a porous bag which holds the C18-PAN coating (XFigure  4.4X (a and b)) without changing 
the extraction recovery of the original coating. However, it is assumed that the thicker PAN 
layer changes the efficiency of the original coating by blocking the available surface pores 
on the coating (XFigure  4.4X (c)). This thick layer can act as a barrier for the analytes and 




Figure  4.6 The comparison of the extraction efficiencies of the original and modified C18-PAN coatings 
for equilibrium extraction of 100 ng/mL diazepam from phosphate buffered saline (pH = 7.4), n = 6.  
 
4.3.3 107BOptimization of SPME parameters for the UV-dried thin PAN-over C18-PAN 
SPME coating for direct immersion whole blood analysis 
The optimized SPME parameters of the PAN-over C18-PAN coating were comparable 
to that of the original C18-PAN coating for the extraction of diazepam (with the exception of 
the wash step). A detailed description of the SPME parameter for C18-PAN coating can be 
found in X Chapter 3 X (Section X 3.3.3X). In summary, 30 min preconditioning (methanol/water 1:1 
v/v), 60 min equilibrium extraction (comparable for PBS and whole blood), and 40 min 
desorption (acetonitrile/water 1:1 v/v) were found to be as the optimal SPME parameters for 
the extraction of diazepam from whole blood. A 30 min second desorption was needed to 
clean the trace residual in the coating from the previous desorption (< 2% carryover). 
The optimization of the wash step showed that the application of the agitation during 
wash is vital for the removal of adsorbed blood cells on the surface. A 20 s wash step in 
nanopure water along with agitation was enough to clean the proteins and blood cells from 
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the surface of the coating. A shorter wash step resulted in some red blood cell attachments. 
In addition, a longer wash step was not optimal, since it provides a higher chance of analyte 
loss. The possibility of the loss of analyte during the 20 s wash was evaluated through the 
direct injection of the wash solution into the LC–MS/MS system. The amount of absolute 
loss of diazepam during the 20 s wash step (with agitation) was 0.3% (RSD = 13%, n = 6).  
4.3.4 108BReproducibility and validation for direct immersion whole blood analysis coupled 
with LC–MS/MS 
Evaluation of the absolute matrix effect was performed by comparing the blank blood 
extract spiked with the 50 ng/mL of diazepam with the same concentration of the standard 
solution. The reproducibility of the coating preparation step and repeatability of the 
extraction recovery in long-term use were studied through inter- and intra-blade RSD, using 
two different calibration methods (isotope dilution and external calibration methods). Table 
 4.1X reports on the absolute recovery and matrix effect, inter- and intra-day reproducibility, 
LOD, LOQ, and linearity for direct immersion whole blood analysis of diazepam 
(equilibrium extraction). 
 




Inter-day (RSD %) 
isotope dilution/ 
external calibration 















4.8* 4/12* 1/10* 0.2 0.5 105 0.996 
* n = 4 for 100 ng/mL diazepam in whole blood 
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Extracted Blood Spot Sampling (EBS) 
4.3.5 109BOptimization of EBS parameters for LC–MS/MS analysis 
By applying the current blade geometry for the preparation of the coating, a blood spot 
volume as low as 3 up to 20 µL can be used for EBS sampling. However, through the 
application of other geometries with higher surface areas, the available surface area of the 
coating can be improved and a larger sample volume can be used. A 5 µL sampling volume 
was used to evaluate the limit of quantitation of the method for small volumes of the sample. 
After the deposition of the blood spot on the surface of the coating, the blood and the coating 
needed to be in contact for a period of time to allow for the extraction of compounds by the 
coating. It is important that this period – referred to as the “extraction time” – be optimized. 
 Since the coating is designed to be reusable, the extraction time should be short 
enough to prevent the complete drying of the proteins and blood cells on the coating and 
long enough to get a reproducible amount of extraction recovery. The results of the studies 
on the extraction time show that a 2 min extraction addresses both above-mentioned issues. 
The wash, desorption, and carry over steps for the extracted blood spot sampling were 
similar to those of the direct immersion procedure (20 s wash along with 40 min desorption 
in acetonitrile/water 1:1 v/v and 30 min second desorption to clean < 2 % carryover).  
4.3.6 110BQuantitation, reproducibility, and validation for EBS-LC–MS/MS 
Taking advantage of the concept of microextraction, EBS can benefit from having a 
short pre-equilibrium extraction time and, consequently, achieves a small but reproducible 
amount of extraction recovery. It is highly recommended that a proper quantitative 
calibration method is applied for the EBS-LC–MS/MS analysis in order to obtain reliable 
104 
and precise quantitative results. Matrix-matched external calibration and isotope dilution are 
the proposed quantitation methods to be used for the EBS-LC–MS/MS analysis. The 
reproducibility of the assay was compared using both quantitative methods. As expected, the 
isotope dilution calibration resulted in large improvements in reproducibility. Therefore, the 
isotope dilution method was used as the quantitation technique for this study in order to 
compensate for any possible variation in the sampling time in the pre-equilibrium extraction 
method, and to achieve higher precision.  
The recovery of diazepam for tested spiking levels of 0.5 and 50 µg/mL were found to 
be 97 % (±2) and 102 % (±3) when matrix-matched isotope dilution was used for 
quantitation of n = 4 samples. XTable  4.2X reports on absolute recovery and matrix effect, 
reproducibility, LOD, LOQ, and linearity of EBS-LC–MS/MS analysis for a 5 µL volume of 
blood and 2 min extraction time. The limits of detection and quantitation can be obtained 
through the application of a larger volume of the sample. 
 
Table 4.2 Recovery, reproducibility, and validation for the extracted blood spot-LC–MS/MS 




Inter-day (RSD %) 
isotope dilution/ 
external calibration 















(5 µL, 2min) 
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Direct Analysis in Real Time (DART) 
4.3.7 111BMechanism of desorption and ionization in DART 
As briefly explained in the “Introduction” section of this chapter, the desorption of 
analytes from the coating and their ionization are made by directing a flow of heated gases 
containing metastable species into the sample.
169
  
As inert gases flow through the DART chamber, an electrical discharge creates plasma 
that contains ions, electrons, and excited neutral atoms and molecules. Electrostatic lenses 
remove the charged particles (ions and electrons) from the gas stream, carrying metastable 
species. The gas temperature is increased through a heater coil as it travels toward the exit 
orifice of the source. The heated gas (containing neutral but highly energetic atoms and 
molecules) exits the source heading toward the sample, which is placed along the path 
between the DART insulator cap and MS inlet, for thermal desorption and ionization.  
Even though the DART ionization mechanism is not fully characterized, it is assumed 
that the ionization in the positive mode is initially performed by the reaction of gas 
metastables with some ambient atmospheric species such as water to form reactive 
protonated clusters. Then, the formation of [M+H]
+
 ions is achieved by subsequent proton 
transfer from these species to the analyte’s molecule (M).
169, 171, 172
 
4.3.8 112BOptimization of the coating preparation for EBS-DART–MS/MS 
Typically, stainless steel meshes are used as the substrate for the deposition of samples 
in the DART-SVP system. These meshes are used because the substrate needs enough paths 
to facilitate transmission of the heated desorption gas through the sample to allow for the 
efficient desorption and ionization the target analytes. When combining EBS with DART, it 
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is preferable to prepare the coating on similar stainless steel meshes for the same reason. The 
coated mesh should be very thin in order to prevent complete blocking of the mesh holes 
with the coating. In addition, the method of coating preparation should be reproducible.  
In this study, thin layers of the UV-dried PAN-over C18-PAN extractive phase was 
coated on the stainless steel meshes using three different methods of coating preparation 
(dipping, brush painting, and spraying). Brush painting was found to be the most applicable 
and reproducible method for the preparation of EBS-DART systems. In order to guarantee 
the easy transmission of desorption gas through the coating, 10 tiny holes were made on the 
spotting area of the coated meshes using a very small needle. The patterns of the holes for all 
the coatings were kept similar for the entire study. 
4.3.9 113BOptimization of EBS sampling for DART–MS/MS 
As previously discussed, it is crucial to optimize the extraction time for EBS in order 
to prevent the complete drying of the blood cells on the coating and to obtain reproducible 
recovery. The results show that an extraction time longer than 5 min results in difficulties in 
washing the blood from the surface of the coated mesh. Since the maximum extraction time 
was preferable in order to obtain higher sensitivity (without the risk of blood cell 
attachment), 5 min was used as an optimal extraction time for the entire EBS-DART–
MS/MS study. After a 5 min extraction, the application of a pressured stream of water (using 
a wash bottle) for 5 s was found sufficient to wash the blood from the surface of the PAN-
over C18-PAN coated meshes. Then, in order to prevent any variation in analysis, the coated 
meshes should be fully dried before being introduced to the DART source. Higher RSD 
values were obtained for the samples which were not fully dried. 
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 For the drying step, four different methods were evaluated: (i) 30 min drying at room 
temperature, (ii) drying with KimWipe paper tissue through gentle wiping to absorb water, 
and drying with (iii) hot or (iv) cold air using a blow dryer (3 min). The evaluation of the 
drying approaches demonstrated that all four methods of drying were comparable in terms of 
extraction recovery and reproducibility for the analysis of diazepam; however, the last three 
methods were much faster.  
The short 30 s sampling (desorption and ionization) time in DART does not result in 
complete desorption of the analytes from the coating. Therefore, in cases when the coated 
meshes are reused for the analysis, the coatings can be vortexed in acetonitrile/water 1:1 
(v/v) for 40 min and allowed to dry thoroughly before usage, or longer exposure time in 
DART can be used to achieve complete desorption of the analytes from the coating.  
4.3.10 114BOptimization of the desorption/ionization gas temperature in DART–MS/MS 
Desorption/ionization of gas temperature is one of the key parameters that influence 
the result of DART–MS analysis. In order to obtain the most efficient thermal desorption of 
the diazepam, a wide range of temperature (150–400 °C) was tested, and the result were 
evaluated in terms of signal intensity and reproducibility. The optimal temperature was 
found at 250 °C; it provided the highest peak intensity and lowest RSD for the desorption 
and ionization of diazepam. The lack of efficiency for higher temperatures is a result of the 
instability of the C18 particles and polyacrylonitrile at the temperatures >250 °C. 
4.3.11 115BDART–MS/MS sample presentation speed 
Sample presentation speed or the speed that the sample is pushed through the 
desorption/ionization region has a significant effect on the process of the desorption and 
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ionization of analytes in DART. In order to evaluate the optimum sampling speed, a range of 
speeds (0.2 to 1 mm/s) was tested. The results showed that a sample presentation speed of 
0.2 mm/s (minimum available speed) provided the highest signal intensity and 
reproducibility for diazepam. A slower sampling speed allows the sample spots to remain in 
the heated ionization region longer, resulting in more efficient desorption and ionization. 
4.3.12 116BQuantitation and validation of EBS-DART–MS/MS 
Matrix-matched external calibration is usually used for the quantification of analytes in 
DART–MS analysis; however, depending on the analyte of interest and the matrix under 
study, many studies have reported on the limitations of ambient MS analysis in DART due to 
the relatively high RSD for replicated DART–MS measurements.
172, 177
  
In contrast, isotopic-labeled internal standards can significantly improve 
reproducibility by compensating for the signal fluctuation and unavoidable matrix effects 
that usually occur with ambient ionization techniques.
172, 177
 Therefore, matrix-matched 
isotope dilution was employed for quantitation of EBS-LC–MS/MS analysis in this study, 
and calibration curves were plotted daily. The isotope dilution calibration for diazepam in 
whole blood for EBS-DART–MS/MS system is illustrated in XFigure  4.7X. 
In this part of the study, the recovery, limits of detection and quantitation, and linearity 
of the EBS-DART–MS/MS (coated mesh) sampling was compared with regular DART–




Figure  4.7 Isotope dilution calibration for diazepam in whole blood (diazepam-d5 as internal standard) 
using EBS-DART–MS/MS (UV-dried PAN-over C18-PAN coated mesh). 
 
Table  4.3 Recovery and validation for EBS-DART–MS/MS and DART–MS/MS. 
 UV dried PAN-over C18-PAN Bare mesh 
Recovery * (%) 
(2 µg/mL spiking level) 
96 108 
Recovery * (%) 
(50 µg/mL spiking level) 
102 93 
LOD (µg/mL) 0.3 0.3 
LOQ (µg/mL) 1 1 
Linearity (R²) 0.9965 0.9981 
Linearity (µg/mL) 1-200 1-50 
* Recoveries were calculated based on isotope dilution matrix-matched calibration when extracting 
 
5 µL of  5 µg/mL diazepam in whole blood (n = 4). 
 
Recoveries were calculated based on the matrix-matched isotope dilution calibration. 
EBS-DART sample preparation (coated mesh) provided an improvement in the linear range 
y = 0.1836x 










































when compared to the bare mesh. It should be noted that the reported LOD and LOQ values 
are based on 5 µL of blood sample and considering >95% diazepam-plasma protein binding. 
4.3.13 117BReproducibility of EBS-DART–MS/MS  
The evaluation of inter- and intra-day reproducibility in three different matrixes 
(acetonitrile/water 50:50 (v/v), PBS, and blood) was performed for bare and C18-PAN 
coated mesh using external calibration and isotope dilution (XTable  4.4X). The results of the 
analysis for both bare and coated meshes and using all three matrixes reveal that the 
normalization of the analyte’s response using isotope dilution calibration provides a 
significant improvement in quality and reproducibility of the data.  
Table  4.4 Reproducibility for DART–MS/MS and EBS-DART–MS/MS. 
Isotope dilution/external calibration reproducibility (RSD, %).  
 Bare mesh PAN-over C18-PAN coated mesh 
Matrix 
 




4/24 3/21 3/20 3/22 
PBS buffer 5/30 4/33 4/25 3/30 
Whole blood 4/40 5/35 3/21 2/20 
* 5 µL of 5 µg/mL diazepam (and diazepam-d5 in case of isotope dilution) in whole blood. 
 
The relatively high RSD for the external calibration (which is corrected by isotope 
dilution calibration) could be explained by the following reasons: (i) variations in position of 
the mesh in the transmission survey, (ii) random distribution of the sample spot on mesh, (iii) 
variation of the thickness of the coated meshes, and (iv) the possibility of leaky Vapur 
interface on MS. However, even when external calibration is used, the reproducibility of the 
assay is improved using the coated mesh in comparison to the bare mesh. 
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4.3.14 118BEvaluation of matrix interferences in EBS-DART–MS/MS 
Matrix effects (ion suppression/enhancement) provided by interfering matrix components 
can lead to significant errors in the quantification of the analytes, and can influence detection 
capability, precision, and accuracy of the method.  
The main goal for the integration of EBS with DART is to minimize the matrix effect 
by cleaning up the sample and normalizing the matrix. For the purpose of evaluating matrix 
effects, the total ion chromatogram for the analysis of 5 µL blood spot samples (10 ppm 
diazepam) on PAN-over C18-PAN coated mesh was compared with that of bare mesh. As 
shown in XFigure  4.8X (a), in the absence of EBS sampling, the existence of matrix inferences 
resulted in a significant suppression of the diazepam’s signal (m/z = 285.1). In contrast, the 
selective extraction of analyte and the wash of the blood spot in EBS sampling resulted in the 
elimination of ion suppressing components, and a much cleaner mass spectra was obtained 
(XFigure  4.8X (b)).  
As another part of study, matrix-matched external calibration curves of DART–
MS/MS (bare mesh) and EBS-DART–MS/MS (coated mesh) in whole blood was compared 
in their overlapped linear range (1–50 µg/mL). As shown in XFigure  4.9X, a significant shift in 
the matrix-matched external calibration curve of the bare mesh was observed, when it is 
compared with that of coated mesh. This observation can be explained by the adverse matrix 
effect on the ionization of analytes on the bare mesh or the possible pre-concentration of 








Figure  4.8 Evaluation of matrix interferences for blood analysis. Full scan Q1 mass spectra for (a) 
DART–MS using bare mesh, and (b) EBS-DART–MS using PAN-over C18-PAN coated mesh (2 min 






Figure  4.9 Comparison of diazepam matrix-matched external calibration curve for DART–MS/MS 
(using bare mesh) with that of EBS-DART–MS/MS (using PAN-over C18-PAN coated mesh) for 5 µL of 
blood spot. 
 
4.4 30BConclusions and future directions 
This optimized biocompatible coating has the potential to be applied for the analysis of 
other complex biological matrixes such as tissue and food samples. As a future approach, the 
biocompatible PAN-over C18-PAN SPME offers the chance for reliable at vivo (instant 
sampling of biofluids in field at the time they leave the living system) and in vivo 
applications (using other geometries of coating), through minimizing the risk of cell 
coagulation on the surface and adverse and toxic reactions in the living system.  
EBS benefits from the advantages of DBS and presents solutions for the limitations of 
DBS. In this work, EBS-LC–MS/MS integrates sampling and sample preparation into a 
single step. In addition, the application of an automated high-throughput system aided the 
preparation of 96 EBS samples in approximately 42 min, corresponding to < 0.5 min per 
sample.  
y = 22507x 
R² = 0.9987 
y = 16251x 
























EBS-DART–MS/MS is a novel approach which improves the reliability of DART by 
cleaning up the interfering matrix without requiring time-consuming sample treatment. 
DART–MS/MS is a very fast analysis method with no need for any chromatographic 
separation, and it can achieve high reliability through being combined with EBS sampling, 
without sacrificing time. The application of the high-throughput automated transmission 
survey in this study resulted in a total of 14 min for the EBS-DART–MS/MS analysis of 10 
samples (5 min extraction, 3 min blow drying, and 6 min mass spectrometry), which 
corresponds to 1.4 min per sample. This analysis time can be reduced by the application of 
EBS-DART in 96-format.  
The reported range for the therapeutic and toxic concentrations of diazepam in the 
literature differ based on different individual patient conditions, various dose intakes in 
different treatment, and the plasma/whole blood distribution ratio of the analyte.
178-181
 The 
average ranges for the therapeutic and toxic concentrations of diazepam in whole blood are 




For a 5 µL blood spot in EBS-LC–MS/MS 
and EBS-DART–MS/MS studies, a LOQ of 0.2 and 1 µg/mL were obtained, respectively. 
These limits of quantitation can match the entire toxic concentration range of diazepam and 
medium-to-high levels for the therapeutic concentrations range. However, the enhancement 
of sensitivity can be achieved via an increase of the sample volume (from 5 µL up to 50-100 
µL for instance) and/or by increasing the available free concentration of the analyte in the 
matrix (such as the disruption of drug-protein binding which was discussed in X Chapter 3 X, 
Section X 3.3.5X).  
The application of the thin-film coating with a higher surface area can facilitate the 
enhancement of the volume of the blood spot in EBS sampling. Therefore, for future studies, 
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square thin-film geometry (length: 10 mm, width: 10 mm, thickness: 0.8 mm) with a 2-fold 
increase in surface area is proposed by the author as an alternative to the current geometry 
(XFigure  4.10X). The proposed geometry will facilitate an even distribution of blood spot with 
larger volumes and individual applications of EBS coatings (instead of blade rows). In 
addition, it will provide a faster extraction rate, higher recovery, and improved LOD in a 
limited extraction time.  
  
  (a) (b) 
Figure  4.10 (a) Current geometry, and (b) newly proposed geometry for the extracted blood spot 
sampling using UV-dried thin PAN-over C18-PAN thin-film coating. 
 
The application of the EBS-DART–MS/MS is very valuable for analyzing short-lived 
metabolites and unstable compounds, and it is beneficial for monitoring and determining 
unstable metabolites for on-site clinical and biological analysis. The application of the 
presented EBS-DART–MS/MS system was recently reported in the Pawliszyn research 
group for the analysis of cocaine and methadone in urine samples.
183
 As a future approach, 
further investigations are required for the application of the EBS methodology for the 
analysis of other classes of compounds with different polarities and characteristics.  
116 
4.5 31BAddendum 
The text of this chapter was rewritten in comparison to the published research article. 
The author thanks IonSense Inc. and VBM Consulting Ltd. for their collaboration and the 




 4BDevelopment of coatings for the automated 96-blade SPME system, 
capable of extracting a wide polarity range of analytes from biofluids 
5.1 32BPreamble and introduction 
5.1.1 119BPreamble 
This chapter has been published as a paper: Fatemeh S. Mirnaghi, Janusz Pawliszyn, 
Development of Coatings for Automated 96-Blade Solid Phase Microextraction-Liquid 
Chromatography–Tandem Mass Spectrometry System, Capable of Extracting a Wide 
Polarity Range of Analytes from Biological Fluids, J. Chromatogr. A, 2012, 1261, 91-98. 
The materials of the current chapter are reprinted from this publication with the permission 
of Elsevier (Copyright Elsevier 2012). 
5.1.2 120BIntroduction 
Since the introduction of SPME in 1990,
31
 this technology has been expanding to 
different areas such as clinical, biological, pharmaceutical, food, environmental and 
metabolomics studies.
1, 32, 34, 38, 41, 147, 184
 The successful and reliable utilization of SPME 
technique for different applications relies on addressing the requirements for each individual 
study, including the construction of new SPME devices, the development of high-throughput 
automated SPME systems, and the discovery of new stationary phases. Some studies require 
the analysis of compounds from different classes and with various physiochemical properties 
(e.g., metabolomics studies). This requirement can be addressed through (i) the development 
of different chemistries of SPME extractive phases for individual polar or non-polar groups 
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of compounds, or (ii) the development of proper SPME coatings to enable parallel 
extractions of compounds in a wide range of polarity. The latter category takes advantage of 
the simultaneous extraction of analytes with different properties and hydrophobicity in a 
single experiment. This advantage is valuable when it is not feasible to design two separate 
experiments for the extraction of polar and non-polar analytes (i.e., the amount of sample is 
too small and/or the metabolites are not stable). The simultaneous extraction of analytes 
results in significant time saving as well as improvements in the accuracy of the data by 
avoiding the possible variations in different experimental conditions. 
 
 Most commercially available SPME coatings exhibit limited efficiency toward the 
extraction of a wide range of polarity. In addition, they suffer from the lack of chemical and 
physical stability, long-term reusability,
110
 and biocompatibility (the fouling of the extraction 
phase upon exposure to biological samples).
79
 As reported in X Chapters 2X and X 3X, so far C18-
silica gel and C18-PAN are the only developed extractive phases for the 96-blade SPME 
system. As expected from their C18- functional group, they are mainly capable of the 
extraction of non-polar and mid-polarity compounds, and are limited in their ability to 
extract highly polar analytes. 
Therefore, the main focus of this chapter is the development and evaluation of 
alternative coatings for the 96-blade SPME system capable of the simultaneous extraction of 
both hydrophilic and hydrophobic compounds in a single experiment. Modified polystyrene-
divinylbenzene copolymer with a weak anion exchanger (PS-DVB) and phenylboronic acid 
(PBA) are two candidate stationary phases which can address the discussed requirements. 
The combination of the reversed phase mechanism of PS-DVB and ion exchange interactions 
119 
of copolymerized weak anion exchanger groups provides a unique extraction recovery for 
this mixed-mode sorbent for a wide range of compounds.
185, 186
  
In addition, PBA contains different functional groups which are involved in multiple 
interaction mechanisms with compounds, and provides the efficient extraction of different 
classes of analytes.
187-189
 A previous study of the Pawliszyn group reported on the successful 
application of these two extractive phases for the efficient extraction of 36 metabolites with a 
wide range of polarity.
105
 However, in the previous work the stability, reusability, and 
biocompatibility of the coatings were not the main focus. The coatings were prepared in 
single rod fiber geometry, and commercial glue was used for the immobilization of particles 
on the substrate. The current study consists of the development of PS-DVB and PBA 
stationary phases for the 96-blade SPME system with four main improvements upon the 
previous work: (i) high stability and reusability, (ii) improved biocompatibility, (iii) thin-film 
geometry and correspondingly increased sensitivity, and (iv) the application of an automated 
high-throughput 96-format SPME system, with the main focus on its ability to extract 
analytes in a wide range of polarity.  
In order to achieve the required biocompatibility and stability properties, PAN was 
used as the biocompatible binder for the immobilization of the particles on the coatings. The 
efficiency of the PS-DVB-PAN and PBA-PAN 96-blade SPME systems were evaluated for 
the LC–MS/MS analysis of diazepam, oxazepam, caffeine, riboflavin, and sucrose with a 
wide range of polarity (log P = 2.8 to -3.7)
190
 from PBS and human plasma. Extraction 
recovery, reusability, reproducibility, absolute matrix effect, and the validity of the system 
were evaluated and/or optimized for both proposed coatings. The structures of diazepam and 
120 
oxazepam are shown in XFigure  2.1X, and the structure of caffeine, riboflavin, and sucrose are 
shown in XFigure  5.1X. 
 




Figure  5.1 Chemical structure of caffeine, riboflavin and sucrose. 
 
5.2 33BExperimental 
5.2.1 121BChemicals and materials 
Caffeine, riboflavin, sucrose, and acetic acid were purchased from Sigma-Aldrich 
(MO, U.S.). Easy modified polystyrene-divinylbenzene (Macherey-Nagel) particles were 
purchased from VWR International (Mississauga, Canada). Phenylboronic acid particles 
Sucrose 
 
Caffeine                                                            Riboflavin 
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were purchased from Varian Inc. (CA, U.S.). The remainders of the materials were 
purchased from the same sources reported in X Chapters 2X andX 3X (Sections X 2.2.1X and X 3.2.1X). 
A concentration of 1 mg/mL of analytes was purchased or prepared as the stock 
solution. The working standards were prepared daily (due to the instability of sucrose) from 
stock solutions using acetonitrile/water (1:1 v/v) as the diluents, and all stocks and working 
standards were stored at 4 °C in a refrigerator. Other information regarding the preparation 
of standard solutions and samples was provided in Section X 2.2.2 (Chapter 2)X. 
5.2.2 122BAutomated Concept 96-Blade SPME system 
This study used the Concept 96-blade SPME system along with the original 
configuration of Concept 96-autosampler described in X Chapter 2 X (Section X 2.2.4X). 
5.2.3 123BPreparation of PS-DVB-PAN and PBA-PAN coatings 
In X Chapter 3 X it was reported that the spraying method resulted in the highest levels of 
stability and reusability among other tested methods (spraying, dipping, and brush painting). 
As a result, the spraying method (reported in Section X 3.2.3, Chapter 3 X) was chosen as the 
optimal method of coating preparation. In this chapter, the same formula and procedure was 
followed for the preparation of the coatings except that the spraying and drying steps were 
repeated 15 times in order to uniformly cover the surface of the substrates (due to the larger 
particle size). Finally, in order to improve the biocompatibility of the coatings and to 
minimize the attachment of the plasma proteins on the surface, a very thin layer of PAN glue 
was sprayed on the surface of the final coatings.  
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5.2.4 124BLiquid chromatography and mass spectrometry conditions 
The liquid chromatography and mass spectrometry instrumentations used in the 
experiments of this chapter were the same as those reported in X Chapter 2 X (Section X 2.2.3 X). A 
reverse phase pentafluorophenyl column (Supelco Discovery HSF5 column, 2.1 × 150 mm, 
and 3 μm particles) with gradient elution of mobile phases A (water/acetic acid 99.9/0.1, v/v) 
and B (acetonitrile/acetic acid 99.9/0.1, v/v) were used for the chromatographic separation of 
the analytes under study. The gradient elution program was optimized as follows: it started at 
10% B and kept for 2 min (0.01–2.00 min), then, sharply raised to 90% B and kept for 3 min 
(2.01–5.00 min). After 5 min, the gradient was sharply changed to 10% B where it remained 
for another 5 min (5.01-10.00 min). The following were optimized as mass spectrometry 
parameters: ionspray temperature = 450 °C, ionspray voltage = 5300 V, nebulizer gas = 8, 
curtain gas = 6, and collision gas = 12 (arbitrary units). A summary of other MS/MS 
parameters is provided in XTable  5.1X. A typical SPME-LC–MS/MS chromatographic peak for 
all the analytes under study is provided in XFigure  5.2X. 
Table  5.1 Summary of MS/MS parameters 
 
* DP = Declustering potential, FP = Focusing potential, EP = Entrance potential, CE = Collision energy,  
and CXP = Collision cell exit potential.  
 
Analytes Q1(mass amu) Q3(mass amu) DP (V)* FP (V)* EP (V)* CE (V)* CXP (V)* 
Diazepam 















Riboflavin 377.3 243.2 120 290 8 33 20 
Caffeine 194.9 138.2 65 270 12 27 11 
Sucrose 365.1
§




Figure  5.2 Typical SPME-LC–MS/MS chromatographic data of the model analytes 
 
5.2.1 125BOptimized procedure for the automated 96-blade SPME analysis 
Prior to extraction, the PBA-PAN coatings were conditioned for 30 min in 
methanol/water 1:1 v/v (along with agitation). The preconditioning step was not found 
necessary for the PS-DVB-PAN coating. Equilibrium extraction was performed for 60 and 
120 min from 1 mL of spiked samples for the PS-DVB-PAN and PBA-PAN coatings, 
respectively (1000 rpm and 2.5 mm amplitude). A 10 s wash in nanopure water was carried 
out for both coatings after extraction from human plasma. The optimized desorption 
conditions for PS-DVB-PAN and PBA-PAN coatings were found to be 40 and 60 min 
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(respectively), using 1 mL of acetonitrile/water 1:1 (v/v) and 1200 rpm speed (1 mm 
amplitude). For both coatings, a 40 min second extraction was used to clean the residual 
trace of analytes from the coatings. 
5.3 34BResults and discussion 
5.3.1 126BCharacterization and scanning electron microscopy of the coatings  
XFigure  5.3X (a) demonstrates the chemical structure of modified polystyrene-
divinylbenzene (PS-DVB) copolymer with an unknown weak anion exchanger (WAX). 
According to the manufacturer, it has a particle size of 80 µm, a specific surface area of 650 
–700 m
2
/g, and a pore size of 50 Å. The modified PS-DVB copolymer with WAX exhibits 
more polar properties than conventional PS-DVB polymers because of its bifunctional 
characteristic as a mixed mode sorbent.
185, 186
  
As shown in XFigure  5.3 X (b), the PBA coating consists of phenylboronic acid covalently 
linked to a silica gel surface. This silica-based extractive phase consists of irregularly shaped 
acid-washed silica with a particle size of 40 µm, a mean porosity of 60 Å and a specific 
surface area of 500 m
2
/g.  
Due to the multiple functional groups in the PBA coating, different types of 
interactions and extraction mechanisms, depending on the nature of the analyte and the pH of 
the sample matrix, are involved. Boronic group functionality facilitates the covalent bonds of 
the phenylboronic acid with cis-diol containing compounds. However, for those analytes 
lacking cis-diol groups the extraction is performed via secondary interaction mechanisms, 
including hydrogen bonding interactions (with hydroxyl groups in neutral and anionic 
forms), ionic interactions (in case of the formation of the boronate form in alkaline 
125 
conditions), charge transfer (anionic boronate functionality), and van der Waals and pi-pi 
interactions (with phenyl and propyl groups). The exhibition of the anticipated secondary 
interactions is demonstrated in Figure  5.4X. The capability of PBA to covalently bond with 
cis-diol containing compounds provides the opportunity for the efficient extraction of 
compounds that are not easily extracted by other sorbents via a universal extraction 






Figure  5.3 Structure of (a) polar modified polystyrene-divinylbenzene copolymer with an unknown weak 
anion exchanger, and (b) phenylboronic acid sorbent consisting of phenylboronic acid covalently linked 
to a silica gel surface. 
 
Scanning electron microscopy (SEM) was used for the evaluation of the topography of 
the coatings’ surface using the same instrument and procedure reported in X Chapter 2 X (Section 
X 2.3.9X). The results of scanning electron microscopy of the coatings are shown in XFigure  5.5X. 
The thickness of the PS-DVB-PAN and PBA-PAN coatings were estimated to be 
approximately 230 and 185 µm, respectively. 
126 
 




Figure  5.5 SEM images of (a) PS-DVB-PAN‎SPME‎coating‎(80‎μm‎particles)‎using‎416 × magnification, 
and (b) PBA-PAN‎SPME‎coating‎(40‎μm‎particles)‎using‎837 × magnification. 
5.3.2 127BDevelopment of the automated 96-blade SPME method 
Preconditioning: The effect of preconditioning on the extraction recovery of the 
coatings was evaluated through the extraction recovery and reproducibility of the system 
with and without a preconditioning step (30 min agitation in methanol/water 1:1 v/v). The 
evaluation showed no considerable difference in the extraction efficiencies of PS-DVB-PAN 
coatings in both conditions. In contrast, the preconditioning of silica-based PBA-PAN thin-
film coating resulted in very significant improvements in the extraction recovery. A 30 
127 
minute preconditioning step, with agitation, was found optimal for the preparation of PBA-
PAN coating prior to the extraction.  
Extraction: The extraction time profiles demonstrated showed that 60 and 120 min 
extractions are required for equilibrium extraction of all five analytes when extracting with 
PS-DVB-PAN and PBA-PAN coatings, respectively ( XFigure  5.6X). The evaluation of the 
extraction time profiles for extraction from human plasma compared to that of PBS showed 
no significant difference. The extraction was performed from 1 mL of spiked PBS or human 
plasma, and this volume was controlled precisely through the entire study. The extraction 
agitation speed was set to 1,000 rpm (2.5 mm amplitude), as the maximum available speed 
without spilling the sample.  
Wash: A 10 s static wash step in nanopure water after extraction from human plasma 
was optimized as the minimum washing time with no protein attachment and the least 
amount of loss of analytes for the PS-DVB-PAN and PBA-PAN coatings. The evaluation of 
loss of analytes during the 10 s washing step showed that the amount of loss was in the range 
of 0.2 - 1.5% for all five compounds for both coatings. 
Desorption: The desorption solvent was optimized via the evaluation of three different 
solvents (acetonitrile/water 50:50, methanol/water 50:50, and acetonitrile/water 80:20 v/v).  
For both PS-DVB-PAN and PBA-PAN coatings, acetonitrile/water 50:50 v/v was the 
optimal desorption solvent (it had the best recovery and lowest carryover) for all five 
analytes (XFigure  5.7X). Minimum desorption times of 40 and 60 min were found to be optimal 
for the efficient desorption of all five analytes, with the lowest carryover from PS-DVB-PAN 






Figure  5.6 Extraction time profile of 100 ng/mL diazepam, oxazepam, caffeine, and riboflavin, 
and 300 ng/mL sucrose spiked in PBS, pH = 7.4 for (a) PS-DVB-PAN (n = 6) and (b) PBA-
PAN coatings (n = 6). 
 
In order to obtain a full coverage of the coatings and efficient desorption without the 
risk of spilling/cross contamination, 1 mL of the desorption solvent and 1200 rpm agitation 
speed (1 mm amplitude) was optimized. For the PBA-PAN coating, the effect of pH on the 
desorption of the compounds containing cis-diol functional groups (disruption of the 
covalent bindings with the boronic group) were evaluated through the comparison of 
desorption in acidic and neutral conditions. The comparison of the efficiency of the acidic 



































































acetonitrile/water 50:50 (v/v) showed no significant differences for the desorption of the 





Figure  5.7 Desorption solvent optimization using optimal SPME conditions for the extraction of 100 
ng/mL diazepam, oxazepam, caffeine, and riboflavin, and 300 ng/mL sucrose spiked in PBS (pH = 7.4)  






















































Carryover: For both coatings, a second 40 min desorption step in fresh 
acetonitrile/water 50:50 (v/v) was found optimal to remove any remaining traces of the 
analytes from the previous desorption. The results of the analysis of the second desorption 
(demonstrating the amount of carryover after the first desorption) for the PS-DVB-PAN and 
PBA-PAN coatings are shown in XTable  5.2X. Desorption efficiencies of ≥ 95% are suitable for 
the quantitative analysis. The evaluation of the third desorption step (40 min) resulted in no 
detectable signal, indicating that a second 40 min desorption was enough for removing the 
trace of analytes from the coatings. 
 
Table  5.2 Percent carryover for PS-DVB- PAN and PBA-PAN SPME coatings for the equilibrium 
the extraction of 100 ng/mL diazepam, oxazepam, caffeine, and riboflavin, and 300 ng/mL sucrose 
spiked in PBS, pH = 7.4 (n = 6). 
Analyte 
PS-DVB-PAN 
% Carry over 
PBA-PAN 
% Carry over 
Diazepam 3.1 ± 0.2 2.1 ± 0.2 
Oxazepam 2.8 ± 0.15 1.5 ± 0.2 
Caffeine 1.5 ± 0.05 0.5 ± 0.1 
Riboflavin 2.0± 0.08 0.7 ± 0.1 
Sucrose ND ND 
ND = Not Detected 
 
5.3.3 128BEfficiency of PS-DVB-PAN and PBA-PAN 96-blade SPME coatings 
XTable  5.3X demonstrates the extraction recovery of the PS-DVB-PAN and PBA-PAN 
coatings for the extraction of the compounds under study from PBS (pH = 7.4) and human 
plasma. Taking advantage of bifunctional properties and thin-film geometry, the PS-DVB-
PAN 96-blade SPME coating provided exhaustive extraction recovery for non-polar and 
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polar compounds (diazepam: log P = 2.82, oxazepam: log P = 2.24, and caffeine: log P = –
0.07), and >70% recovery for more polar compounds such as riboflavin with log P = –1.9. In 
addition, the coating demonstrated successful extraction (3.5%) for sucrose (log P = –3.7), 
which could not easily be extracted using pre-existing 96-blade SPME coatings. As shown in 
XTable  5.3X, PBA-PAN coating was also able to extract both types of polar and non-polar 
compounds with good efficiencies (4–74% absolute recovery). It is noteworthy that SPME is 
an equilibrium-based and non-exhaustive sample preparation technique. Consequently, the 
demonstration of exhaustive or high extraction recovery for this wide range of polarity of 
compounds is a remarkable benefit, obtained from the improved efficiency of the system 
(thin-film geometry and stationary phases). This improved efficiency cannot be easily 
achieved with conventional existing SPME systems. In addition, the ~4% recovery for the 
extraction of very polar sucrose from an aqueous sample is valuable, since the previous study 
(rod fiber geometries) showed an extraction recovery of <0.8% using similar stationary 
phases and almost no recovery using the other types of extractive phases.
105
 
 In SPME, the degree of enrichment of the compounds in the coating can be shown 
through the evaluation of coating constant: the coating constant for all five compounds when 
using thin-film PS-DVB-PAN and PBA-PAN coatings for the extraction from PBS are 
reported in XTable  5.3X. Because of the restriction for the volume of the sample/solvent in well 
plates, a volume of 1 mL was used for both the extraction sample and the desorption solvent. 
However, further pre-concentration of the analytes can be obtained through the evaporation 
of the final extracts.  
For the PBS-PAN coating, the effect of pH on the extraction recovery of the 
compounds containing cis-diol group (sucrose and riboflavin) were studied at alkaline pH 
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(i.e., pH = 8.5). For this part of the experiment, except for the regular preconditioning step in 
methanol/water 50:50 (v/v), the coating was preconditioned for 30 min in phosphate buffer 
(pH = 10) to obtain the reactive boronate form (i.e., B(OH)3). Then, the extraction was 
performed for 120 min in phosphate buffer (pH = 8.5), followed by a 60 min desorption in 
99% acetonitrile/water 50:50 (v/v) + 1% acetic acid (to ensure disruption of the covalently 
bounded cis-diol groups to the coating). The evaluation showed no significant difference in 
the amount of recoveries for the extraction from alkaline pH in comparison with 
physiological pH, as it has been shown for sucrose in the previous study.
105
  
The differences in the absolute recoveries of some analytes between the extraction 





Table  5.3  Absolute recovery and coating constant for PS-DVB-PAN and PBA-PAN 96-blade SPME 
coatings for equilibrium extraction (100 ng/mL diazepam, oxazepam, caffeine and riboflavin, and 300 
ng/mL sucrose spiked in PBS (pH = 7.4), and 300 ng/mL of all five compounds spiked in human 
plasma, n=6 and four experiments). 
 PS-DVB-PAN PBA-PAN  















Diazepam 2.82 3.4 98.1 ± 4.2 5.3 ± 0.6 5.16E+4 74.1 ± 5.5 1.5 ± 0.2 2.87E+3 
Oxazepam 2.24 12.4 97.4 ± 3.3 6.7 ± 0.5 3.75E+4 50.1 ± 2.3 1.8 ± 0.2 1.01E+3 
Caffeine -0.07 10.4 98.9 ± 5.4 30.2 ± 2.1 8.99E+4 33.7± 2.7 15.1 ± 1.5 5.09E+2 
Riboflavin -1.46 10.2 71.4 ± 2.9 42.6 ± 3.3 2.50E+3 44.6 ± 3.9 19.5 ± 1.8 8.06E+2 
Sucrose -3.70 12.6 3.5± 0.3   3.6± 0.4   3.63E+1 4.0 ± 0.4   3.8 ± 0.5     4.17E+1 
 
* Syracuse Research Corporation PhysProp Database 
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5.3.4 129BThe 96-blade SPME system and the extraction from human plasma matrix 
Understanding the drug-protein interactions is essential in basic life sciences since 
protein binding plays an important role in intermolecular interactions in living organisms. 
Only free concentration of the drug can transfer through membranes, induce therapeutic 
response, or be metabolized and eliminated from the body. Therefore, in order to understand 
the drug distribution and pharmacological activity of the pharmaceuticals, determining the 
free and bound concentration of drugs in a living system is crucial.
191, 192
 
Human plasma consists of different transport proteins. Albumin is the most abundant 
protein that plays a transportation role in the circulatory system. It includes three 
homologous domains (I-III), each divided into two sub-domains (A and B). The principle 
regions of the ligand binding for this protein are located in the hydrophobic cavities in sub-
domain IIA and IIIA, which have similar chemistry.
193
 In addition to these two sub-domains 
(considered as high affinity binding sites), albumin has a number of lower affinity binding 
sites. Furthermore, there are nonspecific interactions between the ligands and the polypeptide 
chain of the protein.
194, 195
 Depending on the type, characteristic, and extent of the ligand, it 
can be bound to the protein molecule at various binding sites. Consequently, multiple ligand-
protein equilibria are established.  
When dealing with SPME systems with negligible depletion (usually considered as 
<5% extraction recovery),
196
 the amount of analyte extracted by SPME coating is 
proportional to the initial free concentration of the ligand (analyte) in the plasma matrix 





Figure  5.8 Schematic illustration of ligand-protein binding and ligand-SPME coating equilibria. Figure 
reproduced from the reference with the permission of the publisher.
192 
 
However, in the SPME systems with significant depletion where free molecules of the 
analyte of interest (ligand) are considerably removed from the system, the free (unbound) 
concentration of the ligand in the extraction matrix drops. As a result, the system may 
attempt to re-establish the disturbed equilibrium by dissociating a portion of the ligand 
molecules from the ligand-protein complex to compensate for the change in equilibrium. 
In this case, a fraction of the dissociated analyte may be extracted with the SPME 
coating (depending on the presented SPME and the ligand-binding conditions), consequently 
increasing the amount extracted by SPME coating. The feasibility and degree of the 
occurrence of the changes in ligand-protein equilibria depend on a variety of factors, 
including: (i) the number and extent of available low- and high-affinity binding sites for the 
specific analyte, (ii) ligand-protein binding constants for each site, (iii) the ligand to protein 
concentration ratio, (iv) kinetics of ligand-protein binding, (v) distribution constant of ligand 
for specific SPME coating, and (vi) kinetics of SPME equilibrium extraction. Among these 
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parameters, the number and degree of affinity for different binding sites and their binding 
constants toward the ligand are very important.  
The detailed principle and equations for the calculation of free, total, and percent 
ligand-protein binding for the SPME systems with negligible and significant depletion have 
been extensively reported in literature.
1, 143, 146, 191, 192, 197, 198
 In this thesis, one of the analytes 
under study was selected as an example for studying the experimental results of protein 
binding in case of a significant depletion in the 96-blade SPME system. For instance, in the 
case of the PS-DVB-PAN coating, when extracting diazepam from human plasma the 
percent plasma protein binding (PPB) is calculated as 95 % using XEquation  5.1,X
104
 when the 
slope for plasma and PBS calibration curves were determined as 5.1 and 97.9, respectively. 
The calibration curves were constructed based on the optimized SPME conditions for the 




PPB  Equation ‎5.1 
 
The % PPB for the extraction of diazepam is reported in the range of 96-98 % in the 
litreature.
127
 This minor difference can be explained as follows: According to the reported 
studies, human serum albumin contains several binding sites with different affinities for most 
benzodiazepines, such as diazepam, resulting in multiple ligand-protein equilibria.
192, 199
 In 





are orders of magnitude larger than those of the low affinity binding sites (k2= 
3.31×10
4
 and k3 = 8.10×10
3
 for diazepam). When dealing with SPME systems with 
significant depletion, the change of the free concentration in the first place influences the 
ligand binding in its low affinity binding sites because of their smaller binding constants. 
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Therefore, by removing the ligand molecules from the system in such cases, the ratio of the 
bounded ligand to the free concentration does not change considerably (XFigure  5.9 X) and, 
consequently, the amount of diazepam extracted by SPME coating does not change 
significantly. Figure  5.9X shows the schematic of a typical Scatchard plot (the ratio of the 
concentration of bound Hligand H to unbound ligand (B/LF) versus the bound ligand 
concentration (B)) for the drugs with multiple binding sites. 
This condition can be explained for any other SPME extractive phase that provides 
significant depletion of the analyte with multiple ligand-receptor equilibria. 
 
 
Figure  5.9 The schematic of a typical Scatchard plot for ligands with multiple protein binding sites. 
 
5.3.5 130BRobustness and reusability of PS-DVB-PAN and PBA-PAN coatings 
The evaluation of the robustness and reusability of the developed SPME systems was 
performed by monitoring the extraction recovery and physical stability of the coatings over 
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one hundred uses for extraction from PBS and human plasma. The results showed that both 
PS-DVB-PAN and PBA-PAN coatings presented high physical and chemical stability and 
reproducible extraction efficiencies in PBS and plasma matrixes in long-term use. The 
assessment of the reproducibility of the extraction recovery was carried out for the sequential 
extraction of diazepam and riboflavin from PBS and human plasma for 100 times ( XFigure 
 5.10X). The PS-DVB-PAN coating provided 4 and 5% RSD (n = 6 coatings and n = 18 
experiments), and PBA-PAN coating presented 5 and 7% RSD (n = 6 coatings and n = 10 
experiments) for the extractions of diazepam and riboflavin from PBS, respectively. The 
evaluation of the reusability and reproducibility of the coatings for the extraction from 
human plasma also showed that the extraction efficiencies of the coatings remained stable 
for more than 100 extractions. For n = 6 coatings, PS-DVB-PAN coating resulted in 11 and 
6% RSD, and PBA-PAN coating provided 10 and 9% RSD for sequential extractions of 
diazepam and riboflavin from human plasma, respectively (n = 10 experiments).  
The chemical stability of the coatings was also assessed by soaking the coatings in 
different organic solvents (acetonitrile, methanol, ethanol, and DMF) overnight. No changes 
in the physical properties and extraction recoveries of the coatings were observed after long-
term exposure to the tested organic solvents.  
5.3.6 131BReproducibility of the PS-DVB-PAN and PBA-PAN 96-blade SPME-LC–MS/MS 
systems 
The reproducibility of the coating preparation method was studied via the evaluation of 
inter-blade RSD. Furthermore, the intra-blade RSD of the coatings was used to test the 
repeatability of the performance of individual coatings in the SPME-LC–MS/MS method. 
138 
The results of the assessment of inter- and intra-blade RSDs of the PS-DVB-PAN and PBA-
PAN 96-blade SPME coatings are summarized in XTable  5.4X. Further improvements in inter-






Figure  5.10 Reusability of PS-DVB-PAN  and PBA-PAN thin-film SPME coatings (n = 6) for 100 times 
extraction using optimal SPME-LC–MS/MS conditions for (a) 100 ng/mL diazepam, oxazepam, caffeine 
and riboflavin, and 300 ng/mL sucrose spiked in PBS (pH =7.4) and (b) 300 ng/mL of all five compounds 
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5.3.7 132BEvaluation of matrix effects 
The details of the procedure for the calculation of the absolute matrix effect was 
provided in X Chapter 4 (Section  4.2.10)X. In this study, the blank plasma extract was spiked 
with 50 ng/mL of analyte and the peak areas were compared to those of pure standards at the 
same concentration. XFigure  5.11X demonstrates the evaluation of the absolute matrix effect for 
both coatings and all five compounds. 
 
Table  5.4 Inter-blade and intra-blade reproducibility of PS-DVB-PAN and PBA-PAN 96-blade SPME 
systems for the equilibrium extraction of 100 ng/mL diazepam, oxazepam, caffeine and riboflavin, and 
300 ng/mL sucrose spiked in PBS (pH = 7.4) for n = 6 coatings 
Coating PS-DVB-PAN PBA-PAN 
Reproducibility % Inter-blade RSD % Intra-blade RSD % Inter-blade RSD % Intra-blade RSD 
Matrix  PBS Plasma PBS Plasma PBS Plasma PBS Plasma 
Diazepam 4.4 8.2 4.3 10.6 6.4 10.1 6.9 11.7 
Oxazepam 4.6 9.3 4.5 8.7 5.6 9.5 5.2 10.6 
Caffeine 5.3 8.4 5.4 6.7 7.2 8.7 8.1 9.9 
Riboflavin 5.4 6.2 4.8 6.9 8.6 9.7 7.7 9.2 
Sucrose 8.3 10.3 8.5 12.0 9.8 13.2 10.2 14.1 
 
No significant matrix effects were determined using PS-DVB-PAN and PBA-PAN 
coatings, indicating the effectiveness of the selective extraction mechanism and the 
biocompatibility of the PS-DVB-PAN and PBA-PAN coatings. The biocompatibility of the 
coating prevented fouling of the coating by the adsorption of salts, proteins, and other 
macromolecules during extraction from biological samples. Consequently, the chance of ion 
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suppression/enhancement of the analytes with the matrix interferences is decreased. The 
efficiency of the wash step after extraction is another important factor in the successful 




Figure  5.11 Absolute matrix effect for PS-DVB-PAN and PBA-PAN coatings (n = 4). 
 
5.3.8 133BLimits of detection and quantitation 
The evaluation of the LOD and LOQ for the PS-DVB-PAN and PBA-PAN 96-blade 
SPME-LC–MS/MS systems for the extraction from human plasma is shown in XTable  5.5X. 
The methods for determining the LOD and LOQ were reported in X‎Chapter 2 X (Section X‎2.2.8X). 
Oxazepam and sucrose provided the lowest and highest LOD and LOQ values for both 
coatings, respectively. The low signal intensity for the sucrose was due to very low mass 


























5.4 35BConclusions and future directions 
The 96-blade SPME system provides high-throughput simultaneous analysis of up to 
96 samples in a total of 100 and 210 min for the PS-DVB-PAN and PBA-PAN coatings, 
which corresponds to approximately 1 and 2.2 min per sample, respectively. However, these 
lengths of analysis can be significantly decreased using pre-equilibrium extraction. 
Furthermore, the 100 x reusability of the developed coatings reduces their cost down to a few 
cents per coating. 
 
Table  5.5 Limits of detection and quantitation for PS-DVB-PAN and PBA-PAN 96-blade SPME-LC–
MS/MS analysis of all five compounds from human plasma. 
Coating PS-DVB-PAN     PBA-PAN 
Analyte LOD (ng/mL) LOQ (ng/mL) LOD (ng/mL) LOQ (ng/mL) 
Diazepam 0.3 1.0 0.4 1.5 
Oxazepam 0.1 0.5 0.2 1.0 
Caffeine 0.3 1.0 1.0 3.0 
Riboflavin 0.5 1.5 1.0 3.0 
Sucrose 25 100 25 100 
 
The PS-DVB-PAN and PBA-PAN 96-blade SPME systems demonstrated the 
successful extraction of a variety of compounds from a single complex sample with a high 
degree of efficiency and reproducibility. The sensitivity and the extraction recovery for the 
samples containing binding matrix (such as plasma) can be significantly increased through 
disrupting the drug-protein binding, without the need for any additional complicated sample 
pre-treatment step (X Chapter 3, Section  3.3.10X).  
These systems have the potential to be used in various areas of science including 
biological, clinical, pharmaceutical, food, and metabolomics studies for the high-throughput 
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analysis of various exo- and endogenous analytes with different polarities. Currently the PS-
DVB-PAN 96-blade SPME system is being used for the high-throughput sample preparation 
of biological samples for the global analysis of metabolites with a wide range of polarity 
(manuscripts under preparation). The application of the PS-DVB-PAN 96-blade SPME 
system for determining phenolic compounds from grape, berry, and wine samples is 
discussed in X Chapter 6 X. The application of the PBA-PAN 96-blade SPME system for the 
extraction of proteins from biological samples is being investigated by the Pawliszyn 
research group.  
 
5.5 36BAddendum 
The text of this chapter was rewritten in comparison to the published research article. 
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Chapter 6  
5BAutomated determination of phenolic compounds in grape, berry, and 
wine samples using 96-blade solid phase microextraction system 
6.1 37BPreamble and introduction 
6.1.1 134BPreamble 
This chapter has been accepted for publication in the Journal of Chromatography A as 
a paper entitled: F. S. Mirnaghi, F. Mousavi
 
, S. M. Rocha, J. Pawliszyn, Automated 
Determination of Phenolic Compounds in Grape, Berry, and Wine Samples Using 96-Blade 
Solid Phase Microextraction System Coupled with Liquid Chromatography-Tandem Mass 
Spectrometry (2012). 
The contributions of co-author Fatemeh Mousavi involved assistance in the analysis of 
the grape, berry, and wine samples. In addition, the contribution of Dr. Sílvia M. Rocha 
involved the provision of the wine and the dried berry and grape samples from Portugal. 
 
I, Fatemeh Mousavi, authorize Fatemeh Mirnaghi to use the material for her thesis. 
 
I, Sílvia M. Rocha, authorize Fatemeh Mirnaghi to use the material for her thesis. 
 
6.1.2 135BIntroduction 
Since food samples contain complex non-homogeneous mixture of a range of chemical 
substances, the isolation and determination of analytes of interest in food matrixes is 
144 
challenging. Even with the introduction of advanced techniques of separation and 
identification during the past several decades, it is rarely possible to analyze food samples 
without sample preparation. The sample preparation procedures often take up two thirds of 
the total analysis time, and significantly contribute to the total cost of analysis.
42
 An 
inappropriate method of sample preparation may provide significant analytical errors, which 
could result in unreliable quantitative data.
200
 Traditional sample preparation methods for 
food analysis are time-consuming and lack efficiency.
201-204
 Liquid-liquid extraction (LLE) 
exhibits a lack of sample throughput and automation, large volumes of organic solvent 
consumption, the possibility of loss of analyte during extraction, and a high degree of matrix 
effect (LC–MS applications). Solid phase extraction (SPE) may cause clogging in the packed 
bed stationary phase when dealing with complex matrixes containing macromolecules and 




Growing emphases on improved food safety and the quality of the nutrient content of 
food crops demand more rapid and automated procedures to address the increase in the 
number of samples to be tested. This demand necessitates the utilization of proper sample 
preparation techniques which offer fast, solventless, inexpensive, and easy-to-automate 
procedures. In addition, the challenge for the analysis of complex food samples containing 
particulate matters increases the need for systematic sample preparation strategies with 
minimum sample preparation steps, reproducible recovery, high accuracy, and minimal loss 
of analytes. 
SPME is a fast sample preparation technique with minimal consumption of organic 
solvents. The biocompatible open-bed stationary phases in SPME provide direct handling of 
145 
complex matrixes without the need for sample pre-treatment. In addition, it resolves the 
limitation of clogging the extractive phase with particulate matters (common in pack-bed 
systems) and the attachment of macromolecules on the surface of the coating. As a result, the 
chance of co-extraction of undesired interferences, and consequently the possibility of the 
matrix effect is reduced. This is a very important feature in LC–MS food analysis, since the 
co-elution of complex matrix interferences with the analyte of interest may result in 
suppression/enhancement of the analyte’s signal, and consequently cause significant errors in 
quantitative data.
205, 206
 Furthermore, the automated 96-blade SPME system facilitates the 
simultaneous preparation of up to 96 samples, and results in significant time savings and 
improved precision.  
Chapter 6 of this thesis reports, for the first time, on the application of an automated 
SPME-LC–MS/MS system for food analysis. Grape, berry, and wine samples were selected 
as food matrixes, and phenolic compounds were chosen as analytes of interests due to their 
importance in food analysis. 
Phenolic compounds are secondary plant metabolites that are categorized in two large 
groups of flavonoid compounds (flavanones, flavonols, flavanols, and anthocyanins) and 
non-flavonoid compounds (acids, hydroxycinnamates, and stilbenes), based on their carbon 
skeleton.
201, 207, 208
 These compounds are synthesized by grapes and a large number of other 
plants (e.g., vegetables, fruits) during normal growth and as a defense reaction to situations 
of stress (e.g., microbial infections and UV irradiation).
201, 202, 209-211
 Phenolic compounds 





Numerous studies have reported on the beneficial effects of phenolic compounds 
which are associated with human health (e.g., anti-oxidant, anti-inflammatory, anti-cancer, 
anti-microbial, and anti-aging properties).
212-216
 The flavonoids and stilbenes groups are the 
main contributors to the anti-oxidant activities of the phenolic compounds due to their ability 
to block free radical reactions by the quick donation of a hydrogen atom to lipid radicals.
212, 
217, 218 
These groups help restrain platelet aggregation and low-density lipoprotein (LDL) 
oxidation,
202, 219-222
 provide anti-aging properties,
223, 224





 and brain dysfunction
229, 230
). As a result of 
the anti-oxidant activity of the phenolics, many studies have confirmed that the regular 




In this thesis, the 96-blade SPME-LC–MS/MS system was used for determining 
naringenin and taxifolin (flavanone), trans-resveratrol (stilbene), quercetin-3-D-glactoside 
and rutin hydrate (flavonols), catechin hydrate and epicatechin (flavanol) and caffeic acid 
(phenolic acid) from Portuguese grape, berry, and wine samples. The chemical structure of 
the model analytes are demonstrated in XFigure  6.1X. The classified categories and log P of the 
analytes under study are shown in XTable  6.1X. 
In order to obtain reliable analytical data, standard addition calibration was used as the 
quantitation method for determining unknown phenolic compounds from grape, berry, and 
wine samples. Furthermore, the results of SPME analysis and its efficiency in reducing the 
matrix effects were compared with solvent extraction. 
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6.2 38BExperimental 
6.2.1 136BChemicals and materials 
L-(+)-Tartaric acid, potassium-L-tartarate monobasic, rutin hydrate, quercetin-3-D-
glactoside, naringenin, taxifolin, trans-resveratrol, (+) catechin hydrate, (–)-epicatechin, and 
caffeic acid were purchased from Sigma-Aldrich (MO, U.S.). The remainder of the materials 
were purchased from the same sources reported in X Chapters 2X, X3X and 5 (Sections X 2.2.1 X, X 3.2.1X, 
and 5.2.1). 
6.2.2 Preparation of working standards and buffers 
Stock solutions were prepared daily at a concentration of 1 mg/mL of analytes in 
methanol and kept at –30 ⁰C. Working standards were also prepared daily from these stock 
solutions using acetonitrile/water (50:50 v/v) as diluents. Tartaric buffers were made of 
proper molar ratios of potassium tartarate monobasic and tartaric acid in 1L of water and the 
pH of the buffers were adjusted accordingly (pH= 2.5 and 3.7). Synthetic wine was prepared 
as 85% tartaric buffer and 15% ethanol (v/v).
233
 The concentration of organic solvents in 
buffers and spiked real samples was always kept at less than 1%. After spiking the analytes 
in grape, berry, and wine matrixes, samples were incubated for 1 h (2400 rpm agitation) to 
allow for establishing the equilibrium of phenolic compounds with the binding matrix prior 
to extraction. 
6.2.3 138BGrape, berry, and wine samples: origin and preparation 
Sercial white and Tinta Negra red grapes were chosen from the V. vinifera L variety, 




 Sercial and Tinta Negra grapes are used to produce the world-famous Madeira 
wine. Tinta Negra, the main variety of grape cultivated in the Madeira Island (around 90%), 
was studied in terms of its phenolic compounds in both whole grape and skin. The vérasion 
Sercial white grape and maturity Tinta Negra red grape were harvested in the early ripening 
stage (0 days) and late ripening stage (42 days), respectively. 
In addition, elderberry from the Sambucus Nigra L variety was considered for the 
analysis of phenolic compounds in this study. A 5-year-old sweet Madeira wine (Tinta Negra 
mole) was also selected for evaluation of phenolics in wine.  
After being picked up, the grapes and berries were immediately transported to the 
laboratory and refrigerated at 4 ºC. For the preparation of grape skin, the Tinta Negra red 
grapes were pealed and the skin was manually separated from the pulp. All berry, grape, and 
skin samples were then freeze-dried using a VirTis bench top K freeze dryer (SP Industries, 
NY, U.S.), packed into vacuum bags, and kept under desiccators until the time of analysis. 
At the time of analysis, a blender machine was use to grind the freeze-dried samples. Then, 
aliquots of samples were weighed precisely, dissolved in optimized volumes of nanopure 
water, and mixed properly to be ready for the analysis.  
It should be noted that the volumes of dilution for each sample were optimized based 
on a pre-test analysis to estimate the approximate concentration of the analytes in the 
samples; accordingly, different dilution volumes were precisely adjusted for the final 
analyses of different analytes to prevent exceeding the linear concentration range of the 
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 Figure  6.1 Chemical structure of the phenolic compounds under study. 
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Twenty-five, 24, 16, and 12 mLs of nanopure water were used to dissolve each gram of 
red grape, white grape, elderberry, and red grape skin, respectively. The exceptions were the 
analysis of catechin and epicatechin in elderberry, white and red grapes, quercetin-3-D-
glactoside and rutin in white grape, and quercetin-3-D-glactoside and rutin in elderberry in 
which further dilution of the samples were required in order to fit in the linear range of the 
coating. The pH of Sercial white grapes (vérasion) was estimated at around 2.5 while the pH 
of elderberry, Tinta Negra whole grapes and skin, and wine were in the range of 3.5–4. 
6.2.4 139BPreparation of the coating for the 96-blade SPME system  
The process for the preparation of C18-PAN and, PS-DVB-PAN and PBA-PAN 
coatings have been discussed in X Chapter 3 X and 5X, respectively. Mixed-mode (C18+ strong 
cation exchanger, benzenesulfonic acid) and diol-based coated blades were obtained from 
Supelco (PA, U.S.). 
6.2.5 140BLiquid chromatography and mass spectrometry conditions 
Liquid chromatography and mass spectrometry instrumentations were the same as 
those reported in X Chapter 2 X (Section X 2.2.3X).  
 The MS/MS analysis was performed in negative mode under multiple reaction 
monitoring (MRM) conditions. The ionization source parameters were optimized as follows: 
nebulizer gas = –14, curtain gas = –6, collision gas = 12, spray ionization voltage = –4500 V 
and temperature = 400 °C. A summary of other MS/MS parameters is provided in XTable  6.1 X. 
A Gemini NX C18 column (3 × 250 mm and 3 μm particles, Phenomenex) was used 
for the chromatographic separation of compounds. A gradient elution using mobile phase A 
(99.9% water + 0.1% acetic acid, v/v) and B (99.9% methanol + 0.1 % acetic acid, v/v), and 
151 
a flow rate of 0.2 mL/min was used for the separation. The program of chromatographic 
gradient elution is shown in XTable  6.2X. 
Table  6.1 Classified category, log P, and optimized mass spectrometry conditions for the phenolic 






















Rutin hydrate -0.90 609.2 300.2 -100 -300 -10 -15 -53 
Quercetin-3-D-
glactoside 
-0.92 463.2 300.2 -90 -280 -10 -15 -40 
Flavanones 
Naringenin 2.63 271.2 151.2 -120 -300 -8 -10 -25 
Taxifolin 1.82 303.2 125.2 -100 -250 -15 -20 -30 
Stilbenes trans-Resveratrol 3.14 227.1 185.2 -100 -280 -15 -10 -25 
Flavanols 
Catechin hydrate 0.61 289.2 245.2 -100 -320 -15 -15 -20 
(-)-Epicatechin 0.61 289.2 245.2 -90 -300 -9 -15 -26 
Phenolic 
acids 
Caffeic acid 1.42 179.0 135.2 -105 -200 -8 -10 -25 
DP=Declustering potential, FP=Focusing potential, EP=Entrance potential, CE=Collision energy,  
and CXP=Collision cell exit potential. 
* Online chemical information resource: Hwww.chemspider.com 
 
Table  6.2 Chromatographic gradient elution program. 








6.2.6 141BAutomated Concept 96-blade SPME system 
The 96-blade system along with the modified configuration of the Concept 96 
autosampler (Chapter 4X,  Section  4.2.5) was used for this study. 
6.2.7 142BAutomated SPME procedure for high-throughput analysis 
For all experiments in this study, the extraction time was set at equilibrium for 2 h 
(1000 rpm agitation speed,  2.5 mm amplitude), and the volume of the sample was precisely 
controlled at 1 mL. A 20 s wash step after extraction from grape, berry, and wine samples 
was used to remove the macromolecules from the surface of the coating. The desorption 
conditions was optimized for 90 min in 1.5 mL of  acetonitrile/water 1:1 (v/v) with a speed 
of 1500 rpm (1 mm amplitude agitator). When needed, the final extracts were diluted to fit in 
the linear response of the MS detector, and transferred to the autoinjector for LC–MS/MS 
analysis.  
6.2.8 143BProcedure of solvent extraction for berry, grape and skin samples 
Aliquots of the elderberry, grape, and skin samples were precisely weighed and 
transferred to proper containers. The extraction was performed by sonicating the individual 
samples with a methanol/water/formic acid 70:30:1 (v/v/v) solvent at 10 °C for 20 min using 
10 times the volume of the sample weight. Extracted samples were then centrifuged for 20 
min at 5 °C (14000 rpm), and supernatants were filtered via 0.45 µm syringe filters.234 
6.2.9 144BProcedure of solvent extraction for wine  
The solvent extraction for wine was performed with the addition of 5 mL of 
methanol/formic acid 99:1 (v/v/v) per mL of wine. The procedures for other steps of solvent 
153 
extraction (including sonication, centrifugation, and filtration) were similar to those of berry, 
grape, and skin samples. 
6.3 39BResults and discussion 
6.3.1 145BOptimization of chromatographic conditions 
The choice of the chromatographic separation phase and the mobile phase was 
important in order to obtain good separation of phenolic compounds. Epicatechin and 
catechin are geometric isomers (cis and trans isomer, respectively), and proper 
chromatographic conditions were required for their separation. The optimized 
chromatographic conditions for the separation of phenolic compounds in this study were 
reported in Section  6.2.5. The typical chromatographic peaks of the phenolic compounds are 
shown in XFigure  6.2X. 
In order to prevent the matrix effect and to avoid a decrease in sensitivity due to the 
contamination of the ion source by non-volatile components, a post-column switching valve, 
which directs the first minute column effluent to the waste, was used to maintain instrument 
sensitivity and signal reliability over long periods of analysis.
235 
6.3.2 146BOptimization of SPME coating 
Five different extractive phases (including PS-DVB-PAN, PBA-PAN, C18-PAN, 
mixed–mode-PAN, and diol-PAN in 96-blade formats) were evaluated for the extraction of 
pheolic compounds under study. The evaluation of the recovery of the coatings was 
performed in tartaric buffer in two different pH (2.5 and 3.7) in order to mimic the pH and 
154 




Figure  6.2 Typical chromatographic peaks of the phenolic compounds under study. 
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PS-DVB-PAN coatings had a significantly higher recovery for the extraction of 
phenolic compounds. No significant differences were observed in the extraction recovery of 
the compounds in both investigated pH. Therefore, PS-DVB-PAN was selected as the 
optimized coating for the remainder of the evaluations. XFigure  6.3X compares the percent of 
absolute extraction recovery of different coatings for the extraction of the phenolic 
compounds from tartaric buffer (pH = 3.7).  
 
 
 Figure  6.3 Evaluation of optimized coatings for the extraction of (200 ng/mL) phenolic 
compounds from tartaric buffer (pH = 3.7). 
 
6.3.3 147BOptimization of automated 96-blade SPME system 
Preconditioning: The extraction recoveries of two sets of PS-DVB-PAN coatings were 































50:50, v/v). No statistical differences were found in the amount of recovery of both sets of 
coatings for the extraction from either tartaric buffer or synthetic wine. The evaluation of the 
preconditioning step for the extraction of the phenolic compounds from tartaric buffer (pH = 
3.7) is shown in XFigure  6.4X.  
 
Figure  6.4 Evaluation of the effect of preconditioning on phenolic compounds extraction recovery using 
PS-DVB-PAN coating (200 ng/mL phenolics in tartaric buffer, pH = 3.7).  
 
Extraction: An extraction time of 2 h was required to reach equilibrium extraction for 
all eight phenolic compounds in all the matrixes under study (i.e., tartaric buffer (pH = 2.5 
and 3.7), synthetic wine, elderberry, grape, and wine matrixes). As a result, 2 hours was used 
as the optimized equilibrium extraction time for the entire study. The extraction time profile 
for the extraction of the phenolic compounds from tartaric buffer (pH = 3.7) using PS-DVB-
PAN 96-blade SPME coating is shown in XFigure  6.5X. The highest applicable speed that did 
not risk spilling (1000 rpm, 2.5 mm amplitude) was used as the optimized agitation speed. 

















One mL of sample was used for the extraction volume, and accurately controlled during the 
entire study. 
Wash: A wash step, after extraction, can prevent possible ion suppression/enhancement 
caused by interfering components during LC–MS/MS analysis and can preserve the 
efficiency and reusability of the coating for long-term use via minimizing the transfer of the 
attached macromolecules and particulates on the coating surface to the final extract. In this 
study, a 20 s wash (agitation) in nanopure water was considered optimal for proper cleaning 
of the coatings’ surface from the food macromolecules. The evaluation of a possible wash 
loss during the 20 s wash step showed less than 1% loss of phenolic compounds. 
 
Figure  6.5 Extraction time profile for the extraction of (200 ng/mL) phenolic compounds from tartaric 
buffer (pH = 3.7). 
 
 
Desorption: The evaluation of three different desorption solvents showed that the 
acetonitrile/water 50:50 (v/v) had the best recovery and the lowest carryover; therefore, it 































rpm agitation speed, 1 mm amplitude) was the optimal duration for the desorption of the 




Figure  6.6 Evaluation of desorption solvent for PS-DVB-PAN coating for the equilibrium extraction of 
200 ng/mL phenolic compounds from tartaric buffer (pH = 3.7). 
 
The amount of carryover of the analytes on the coating from the previous desorption 
was evaluated through a second desorption step. A 40 min desorption with the optimized 
desorption conditions was established as optimal for the complete desorption of the residual 
analytes from the PS-DVB-PAN coating. The evaluation of a third desorption did not result 
in any detectable signal. The formula for the calculation of the carryover was discussed in 
X Chapter 2X (Section X 2.2.8X). The amount of carryover of the phenolic compounds on the PS-
































Table  6.3 Evaluation of the percent carryover of the phenolic compounds on PS-DVB-PAN coating (after 90 
min first desorption). 








Rutin Catechin Epicatechin 
Carryover 
(%) 
4 2 3 2 3 3 2 2 
 
6.3.4 148BExtraction recovery and reproducibility of PS-DVB-PAN for the extraction of 
phenolics from tartaric buffer and synthetic wine 
The extraction recovery of the PS-DVB-PAN coating for the extraction of phenolics 
from tartaric buffer (pH = 3.7) is shown in XTable  6.4X. As previously discussed, no significant 
differences were observed in the extraction recoveries in pH of 3.7 and 2.5.  
Previous studies have shown that the alcohol content in the sample matrix may affect 
the recovery of the SPME coating
236
 due to the changes in distribution of the analytes 
between the coating and the sample matrix.
35
 Since Madeira wine contains ethanol, as a 
matrix component it can induce some variations on the distribution constant of analytes 
between the coating and the wine matrix, and therefore, on the extraction recovery of SPME 
coatings.  
As a result, the extraction recovery of PS-DVB-PAN coating for the extraction of 
phenolics was evaluated in synthetic wine (including 85% tartaric buffer and 15% ethanol, 
v/v) and was compared with that of pure tartaric buffer. As reported in Table  6.4, the alcohol 
content of synthetic wine caused a reduction in the absolute recovery of the phenolic 
compounds.  
160 
In addition, the reproducibility of the assay was studied through an evaluation of inter- 
and intra-day RSD. XTable  6.4X shows that the intra- and inter-day RSDs for all eight 
compounds (n = 6 coatings and four experiments) were in the range of 4-8% and 7-13%, 
respectively.  
The maximum saturation level of the adsorptive PS-DVB-PAN coating was studied 
through the evaluation of the calibration curve in a wide range of concentrations (0.05-40 
mg/L) for the simultaneous extraction of all phenolic compounds from tartaric buffer (pH = 
3.7). The results of the studies show that the limit of saturation for PS-DVB-PAN coating for 
the extraction of phenolics is at least 25 mg/L, except for quercetin-3-D-glactoside and rutin 
which had saturation limits of 15 and 10 mg/L, respectively (possibly due to their higher 
polarity). As a result, proper dilution volumes were adjusted for the preparation of freeze-dried 
samples prior to the extraction of the compounds with the SPME coating. 
Table  6.4 Evaluation of % absolute recovery and reproducibility for the equilibrium extraction of 
200 ng/mL phenolic compounds from tartaric buffer and synthetic wine (pH = 3.7). 
 Tartaric buffer Synthetic wine 
Analyte  %Absolute 
recovery 
% Intra-day 
RSD (n = 6) 
% Inter- day 




RSD (n = 6) 
% Inter- day 
RSD (4 trials) 
Naringenin 80 5 8 69 6 9 
Taxifolin 99 6 11 80 7 10 
Quercetin-3-
D-galactoside 
96 8 13 74 5 13 
Caffeic acid 95 4 7 82 5 8 
trans-
Resveratrol 
93 4 8 77 4  10 
Catechin 96 6 12 70 8 11 
Epicatechin 97 7 9 78 8 10 
Rutin 96 5 8 75 7 9 
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6.3.5 149BMethod validation for PS-DVB-PAN 96-blade SPME-LC–MS/MS system 
The linearity, sensitivity, LOD, and LOQ of the SPME-LC–MS/MS method were 
studied through the evaluation of the calibration curves for the extraction of phenolic 
compounds from tartaric buffer and synthetic wine (pH = 3.7). Ten–point concentration-
response curves were used for constructing the extraction calibration of the compounds 
under study (3 replicates for each calibration point). The concentration of the calibration 
points were chosen in the ranges of the expected concentration of phenolics in the grape, 
berry, and wine samples. The least square linear regression method was used for the 
construction of the calibration curves.  
Table  6.5X illustrates the linearity range, sensitivity (curve slope), linear regression 
coefficient (R
2
), LOD, and LOQ for the SPME-LC–MS/MS analysis of the phenolic 
compounds under study. The methods for calculating the LOD and LOQ were reported in 
X‎Chapter 2X (Section X‎2.2.8 X). The LOD and LOQ levels for both matrixes were obtained in a 
range of 0.2–3 and 0.5–10 ng/mL, respectively, indicating the proper sensitivity of the 
SPME-LC–MS/MS method for determining phenolic compounds from the matrixes under 
study.  
The linear range was evaluated based on the applicable linear response when using 
LC–MS/MS for analysis. The upper limit of quantitation (ULOQ) is usually limited by the 
MS detector. For the analysis of those compounds whose concentrations exceed this limit, 
the final extracts were precisely diluted to fit to the linear concentration response of the 
detector. Then, the corresponding dilution factor was applied to normalize the quantitative 




values were higher than 0.9963 for both 
matrixes. 
162 
Table  6.5 Sensitivity, linear regression coefficient, linearity, LOD, and LOQ for the PS-PAN-DVB SPME-
LC–MS/MS.  
 
6.3.6 Evaluation of the matrix effect (ion suppression/enhancement) 
When dealing with LC–MS/MS analysis, the phenomenon of the matrix effect is one 
of the most challenging issues for the quantitation of the phenolic compounds in complex 
food samples.
237
 Necessary strategies must be employed to minimize the matrix effect in the 
first place, followed by the evaluation of the possibility of matrix effect during sample 
analysis. Many studies have reported on the applicable strategies for preventing the matrix 
effect in quantitative LC–MS analyses. These strategies include: the application of improved 

























0.84 0.9997 0.5 1.5 1.0-500 0.70 0.9989 0.5 2.0 2.0-500 
Taxifolin 
 





0.97 0.9975 0.2 0.5 0.5-1000 0.75 0.9986 0.5 1.0 1.0-1000 
Caffeic acid 
 




0.95 0.9986 1.0 3.0 3.0-500 0.78 0.9978 1.5 5.0 5.0-500 
Catechin 
 





0.98 0.9989 0.5 1.5 1.5-1000 0.78 0.9971 0.5 2.0 2.0-1000 
Rutin 0.96 0.9964 0.2 1.0 1.0-1000 0.75 0.9984 0.5 1.5 1.5-1000 
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sample injection volume, the employment of a post column switching valve, and the 
application of appropriate calibration techniques.
206, 235, 238, 239 
 
In this study, several approaches were applied to minimize this phenomenon, 
including: (i) applying selective biocompatible SPME coatings for improved isolation of the 
analytes from the complex matrixes, (ii) optimizing the chromatographic separation and 
utilizing post-column switching to reduce co-elution of interfering components, and (iii) 
using the standard addition calibration method as a proper quantitation technique for 
compensating any possible matrix effects.  
The possibility of suppression/enhancement of the ionization of the phenolic 
compounds in this study were evaluated by calculating the absolute matrix effect, post-
column infusion method,
7
 and “sample extract dilution” technique.
234
 Due to the 
unavailability of the blank grape, berry, and wine samples, tartaric buffer and synthetic wine 
were considered as analyte-free representative matrixes for the post-column infusion method 
and the absolute matrix effect evaluation.  
Absolute matrix effect: A detailed description of the evaluation of the absolute matrix 
effect was discussed in X Chapter 4 X (Section X 4.1.10 X). In this study, the evaluation was 
performed by comparing the response of the blank sample extract spiked with 150 ng/mL of 
phenolic compounds to the response of standard solution with the same concentration of. As 
shown in XFigure  6.7X, the results of this evaluation demonstrated that no significant matrix 
effect exists in the analysis of the phenolic compounds from tartaric buffer and synthetic 
wine (pH = 3.7). 
Post-column infusion method: The details of the experimental procedure for this 
method have already been reported in several studies.
7 
In this thesis, the evaluation was 
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performed through the simultaneous T-infusion of the mixture of (a) a 20 µl/min flow rate of 
1 mg/L of analyte standard (in acetonitrile/water 1:1 v/v) and (b) LC effluent of the SPME 
extract of the blank sample, to the MS interface. 
 
 
Figure  6.7 Evaluation of the absolute matrix effect for phenolic compounds in synthetic wine and tartaric 
buffer (pH = 3.7). 
 
The comparison of T-infusion signals for both total and extracted ion chromatograms 
of the blank extracts (synthetic wine/tartaric buffer) with those of a pure mobile phase 
showed comparable results in the retention time of the analytes under study. No matrix 
effects were observed when extracting phenolic compounds using the optimized SPME-LC 
system. 
“Sample extract dilution” method: The total number of ions formed during 
electrospray ionization (ESI) per unit of time is approximately constant. As a result, through 
sample dilution, the competition for ion evaporation from the droplet surface originated by 
the co-eluting compounds can be reduced significantly. For the evaluation of the matrix 









% Absolute matrix effect 
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effect using the sample extract dilution method, the final sample extracts are diluted with 
different dilution factors (1:0, 1:1, 1:2, 1:4, 1:9, 1:19, 1:49, and 1:99) using acetonitrile/water 
1:1 v/v. Next, for each of the analytes under study, the plots of the normalized peak areas 
(peak area multiplied by dilution factor) were constructed against the corresponding dilution 
factor.
234, 240
 When there is no matrix effect, the normalized response is the same for all the 
applied dilution factors (within the experimental error). The evaluation of the matrix effect 
using this method was studied for the final extract of the SPME method and it was compared 
to the solvent extraction method as a conventional sample preparation technique for food 
samples. 
XTable  6.6X shows a comparison of the minimum dilution level required for the reliable 
analysis of the final sample extracts obtained from SPME and solvent extraction methods 
with no matrix effects. For many of the phenolic compounds under study extreme dilution of 
the final extract (up to 1:49 dilution in some cases) was required for the solvent extraction 
technique, indicating a significantly higher ion suppression/enhancement of the analytes. 
This high matrix effect for the solvent extraction method can be explained by the complexity 
of the final extract and inefficient isolation of the analytes from the interfering components.  
The results of the solvent extraction were compared with that of SPME with the 
consideration of the initial dilution volume for the preparation of extraction samples for each 
technique. In the case of SPME, in many cases reliable quantitative results were obtained 
with no need for the sample dilution; however, in some other cases the final extracts required 
a maximum dilution of 1:4 (< 15% cases). The application of a selective biocompatible 
extractive phase and utilization of the wash step in SPME minimizes the transfer of 
interfering macromolecules (such as polysaccharide, proteins, and particulates) into the final 
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extract and decreases the possibility of ion suppression/enhancement of the analytes. 
However, analysis of complex matrixes through further dilution of the final extracts should 
be considered, when necessary. 
 
Table  6.6 Comparison of the matrix effect of SPME and solvent extraction methods using sample extract 
dilution method: the minimum dilution level required for the final sample extracts obtained from SPME 









Catechin Epicatechin Rutin 
SPME SE SPME SE SPME SE SPME SE SPME SE SPME SE SPME SE SPME SE 
Madeira 
wine 
NA£ 1:4§ NA* 1:1* NA 1:4 NA 1:1 ND ND ND ND ND ND NA£ 1:4 
Red Grape NA§ NA NA¥ 1:1 1:1 NA NA 1:9 1:1 1:9 1:4 1:9 1:4 1:4 1:1 1:9 
White 
grape 
NA¥ 1:1 NA£ ND NA 1:4 NA 1:19 NA 1:9 NA 1:19 NA 1:19 1:1 1:4 
Elderberry  NA¥ 1:49 1:4 1:9 NA 1:49 NA 1:19 1:1 1:19 NA 1:9 1:1 1:49 NA 1:49 
Skin red 
grape 
1:2¥ 1:19 NA 1:19 1:1 1:49 1:1 1:9 NA 1:9 1:4 1:4 1:2 1:9 1:4 1:19 
* Signal was detected for up to 1:1 dilution 
* *Signal was detected for up to 1:2 dilution 
£ Signal was detected for up to 1:4 dilution 
§ Signal was detected for up to 1:9 dilution 
¥ Signal was detected for up to 1:19 dilution 
SE=Solvent extraction 
ND=Not detected 
NA=Not applicable (No dilution was required) 
 
 
6.3.7 Quantitation of the phenolic compounds from grape, berry, and wine samples 
Standard addition calibration is the best applicable quantitative method when an 
appropriate blank matrix (ideally the same as the sample) is unavailable, and is known as the 
most appropriate calibration method that compensates for any variation in analysis of 
complex matrixes.
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 The quantitation of phenolics in the grape, berry, and wine samples in 
this study was performed using standard addition calibration. For covering low and high 
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ranges of concentration of the analytes, depending on the expected concentration in the 
matrix, 10 concentration points were used to construct the standard addition calibration 
curves for each compound. Then, from the calibration curves, the unknown amounts of 
phenolics in grape, berry, and wine samples were extrapolated and quantified. The organic 
content volume of the added standard solutions was kept at <1% to avoid any variation of the 
sample. The concentration of analytes in pure sample (0 added) and the standard added 
calibration points were kept within the linear range of the adsorptive coating. After SPME 
analysis, the final extracts were diluted, as needed, before LC–MS/MS analysis in order to 
conform to the linear concentration response of the LC–MS/MS instrument and to prevent 
matrix effect. The calculated amounts of the phenolic compounds in grape, berry, and wine 
samples using SPME-LC–MS/MS analysis and its comparison with the solvent extraction-
LC–MS/MS analysis are shown in XTable  6.7X. 
In 60% of cases there was complete agreement between the results of the SPME and 
solvent extraction techniques (in the range of experimental error). In almost all other cases 
the calculated amounts for solvent extraction were larger than that of SPME. The following 
paragraphs discuss the interpretation of the obtained data. 
The data showed that there is a chance for binding and adsorption/conjugation 
interactions between the analytes and the binding matrix of the food samples. The affinity 
and availability of the number of binding sites are different for various matrixes and 
analytes. For example, the binding mechanisms of the phenolics to the protein and sugar 
contents of fruits have been reported in previous studies.
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 Solvent extraction is a sample 
preparation method which involves the swelling of the matrix by the addition of an organic 
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solvent which aids to release the bound concentration of the analytes by disturbing the 
analyte-receptor bindings and adsorption/conjugations. 
Comparatively, in SPME the amount extracted is proportional to the free concentration 
of analytes in the sample. In the complex matrixes under study, there is a possibility that 
different bindings/adsorption sites and mechanisms exist for the analytes. It is also possible 
that there is a chance for saturation of the high affinity binding sites with the initial 
concentration of the analytes in the pure sample. As a result of the saturation of high affinity 
binding sites (which can be irreversible), for the standard added concentration points of the 
standard addition calibration the binding/adsorption would occur in less specific sites with 
lower binding/adsorption affinities, or the added concentration may remain unbound. 
Therefore, the portion of free concentration extracted by SPME for the standard added points 
is much higher compared with that of pure sample (0 added). The larger % of free masses for 
the higher points of calibration cause variation in the slope of the standard addition 
calibration curve, and consequently, the final extrapolated concentration would be smaller 
than the total concentration (total minus high affinity bounded). In the other words, in cases 
of those analytes and matrixes where SPME shows disagreement with the solvent extraction, 
the standard addition method in SPME could be calibrated for only free concentration plus 
bound concentration to less specific binding/adsorption sites (the high affinity 
binding/adsorption sites are saturated). 
To confirm the SPME results and the proposed hypothesis for the interpretation of the 
data, centrifugation of the samples was performed. In this part of the study, samples plus all 
the concentration points of their standard addition calibration were centrifuged at 14000 rpm 
for 25 min. As a result, the available binding matrix (macromolecules and particulates) in the 
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sample were precipitated along with the bound fractions of the compounds. Then, the 
supernatants, which only contained the free fraction of the analytes, were separated and after 
the required dilution were injected into the LC–MS/MS system for analysis. The results 
obtained from the centrifugation experiment closely matched those of the SPME analysis, 
indicating a validation of the data and proposed hypothesis.  
Determining the free concentration is one of the advantages of the SPME method since 
it determines the bioavailable concentration of the phenolic compounds, which are extracted 
biologically. In contrast, traditional methods can only determine the total concentration of 
compounds; however, the bound concentration of the compounds would not be biologically 
available. 
6.4 40BConclusions and future directions 
The proposed biocompatible SPME system can be used for quantitative analysis of other 
types of foods through direct immersion extraction without the need for any additional pre-
treatment of the sample. Using the 96-blade SPME method, automated high-throughput 
analysis of the phenolic compounds in 96 food samples was achieved in 210 min (<2.2 min 
per sample). This method addresses the limitations of time-consuming sample preparation 
techniques for the analysis of large numbers of food samples. In addition, the developed 
method provided a good degree of recovery, reproducibility, and quantitation for the analysis 
of the compounds under study. 
The matrix effect (ion suppression/enhancement) evaluation for SPME analysis was 
compared with that of solvent extraction, and the results indicated a significant reduction of 
matrix effects when using the SPME method. This reduction highlights the importance of the 
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sample preparation method for the isolation of analytes from interfering components in order 
to obtain reliable quantitative results. 
 
Table  6.7 Calculated concentrations of the phenolic compounds using SPME (standard addition 
calibration method) and the comparison with solvent extraction, the value in brackets reports the % 
RSD for the SPME-LC–MS/MS analysis. 




























































































































































































*As described in text, due to the complexity of binding interactions, in some cases the standard addition 
method can only be calibrated for free plus less specific binding/adsorption sites (high affinity 





The study of determining the total concentration of analytes using standard addition 
calibration techniques provides valuable insights on the availability of different affinity 
binding sites and diverse interaction mechanisms in complex food matrixes, and 
consequently the bioavailable concentration of the analytes in foods. When standard addition 
calibrations are used for calculating the total concentration of analytes in a complex binding 
matrix, special care should be taken for microextraction methods where the amount extracted 
is proportional to the free concentration of the analytes. 
6.5 Addendum 
The text of this chapter was rewritten in comparison to the accepted manuscript. The 




6BSummary and future directions  
7.1 41BSummary 
Since its introduction in 1990, theoretical and practical aspects of SPME have 
improved drastically, resulting in the production of new SPME devices, the 
commercialization of more robust and stable fiber assemblies, the discovery of new 
stationary phases, and the development of high-throughput automated SPME systems.
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However, to date, SPME has been used more predominantly in GC applications rather 
than LC. There are two main reasons for this trend: the lack of automation of SPME in LC 
applications, and the lack of proper stationary phases for those polarity ranges of analytes 
used in LC studies. 
The first prototype 96-autosampler for SPME was designed by PAS Technology 
several years ago for evaluation by the Pawliszyn research group.
74
 During the last few 
years, several in-house multi-fiber devices were modified and improved to develop the 
current Concept 96-blade device. However, the widespread application of an automated 
high-throughput SPME system in industrial and research labs is dependent upon ability of 
the system to fully address all the requirements of consumers in various fields. This 
dependency necessitates the design and development of various extractive phases (for 
different applications) with a focus on high quality, efficiency, and long-term reusability (to 
make it commercially economical). In addition, the system should be fully evaluated and 
validated to be ready for commercialization. 
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This thesis, to some extent, addresses the above-mentioned requirements for the 
commercial 96-blade SPME system through the following studies discussed: (i) the 
evaluation of different strategies for the development of highly stable coatings; (ii) the 
development of various chemistries of coatings to address the efficient extraction of analytes 
with different polarities; (iii) the evaluation of the proposed systems in terms of stability, 
sensitivity, reproducibility, and matrix effects; (iv) the evaluation of strategies to improve 
long-term reusability and biocompatibility for the extraction from complex biological 
samples; (v) the evaluation of different sampling strategies (i.e., direct immersion and spot 
sampling); and (vi) the validation of the system though its application for the analysis of 
complex food samples. 
The evaluation of different coating preparation strategies showed that spraying method 
results in a highly stable coating with long-term reusability (more than 100 times) in 
biological samples. The spraying method spreads fine particles of the coating slurry on the 
pores of the pre-treated rough surface of the blades. Multi-layer spraying, followed by 
thermal curing at high temperature after each layer, provides a strong attachment of the 
coating to the stainless steel substrate.  
The thin-film geometry of the blades resulted in significant improvements in the 
extraction recovery of the system. As a result, low levels of LOD and LOQ were obtained, 
enabling the successful and reliable analysis of trace concentrations of compounds from 
complex matrixes when coupled with LC–MS/MS systems.  
The state-of-the-art 96-blade SPME system is comparable with the automated SPE and 
LLE techniques in terms of analysis time and precision. High-throughput simultaneous 
preparation of up to 96 samples takes ~1-2 min per sample for equilibrium extraction. 
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However, with the application of an automated highly sensitive 96-blade SPME system, this 
analysis time can be significantly reduced via pre-equilibrium extraction without sacrificing 
precision or limitation with sensitivity. 
Utilization of polyacrylonitrile as a biocompatible binder with high mechanical and 
chemical stability provided long-term reusability of the coatings. This reusability can address 
the lack of inter-lot reproducibility that is common in disposable commercial SPME fibers. 
The cost of materials for the preparation of each thin-film coating in the lab was in the range 
of $1-6, depending on the type of coating. The coating’s high degree of reusability (100-
times) further reduces the cost for each coating down to a few cents. The cost of 
manufacturing and human labor should be added to this material cost, but even with these 
added costs, the final estimated cost of the 96-blade coatings would be still much cheaper 
than reusable/disposable commercial SPME fibers.  
In addition, the open-bed biocompatible SPME system facilitates the efficient and 
reliable analysis of compounds from complex matrixes containing particulate matters (e.g., 
biological sample and food homogenates) without any need for sample pre-treatment.  
The introduced extracted blood spot sampling method integrates sampling and sample 
preparation into a single step. It takes advantage of the beneficial features of the spot 
sampling method (e.g. uses a small blood volume and features easy storage and shipment) 
and presents solutions for the limitations of the conventional dried blood spot sampling 
technique. Using a SPME coating for the extraction of analytes in EBS sampling prevents 
the limitations of chromatographic, hematocrit, and matrix effects which are common in 
DBS. The automated high-throughput system facilitates the preparation of 96 EBS samples 
in approximately 42 min (which corresponds to < 0.5 min per sample). EBS presents a fast 
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sampling/sample preparation method for DART–MS/MS analysis and improves the 
reliability of DART by cleaning up the interfering matrix without sacrificing time (1.4 min 
per sample, for a simultaneous run of 10 samples). 
Finally, the 96-blade SPME system was used for the extraction of phenolic compounds 
from grape, berry, and wine samples. The evaluation of the matrix effect (ion 
suppression/enhancement) for SPME versus solvent extraction resulted in a significant 
reduction of matrix effects by SPME.  
Additionally, the use of standard addition calibration techniques to determine the 
concentration of the phenolic compounds in grape, berry, and wine samples provides 
valuable insights into the availability of different affinity binding sites and interaction 
mechanisms for the analytes in complex food matrixes. Furthermore, SPME method offers 
important information on bioavailable concentration of the analytes in food samples. 
 
7.2 42BFuture directions 
Although the developed SPME coatings in this thesis were prepared manually, 
excellent inter-blade reproducibility was achieved for the systems under study. This 
reproducibility and precision can be further improved via the automation of the coating 
preparation procedures. For instance, the future approach for enhanced accuracy and 
reproducibility of the system includes the automation of dipping and withdrawing steps for 
the preparation of thin-film silica gel coatings, and the mechanization of the multi-layer 
spraying process for the preparation of particle-based coatings. 
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In future, the 96-well format SPME could be expanded to 384 and even larger formats 
in order to further increase the throughput of the system and shorten the required time for the 
analysis of each sample. 
The information obtained on the fabrication of high-quality sol-gel based SPME 
coatings can be used for the preparation of other sol-gel-derived coatings such as entrapped 
biomolecular sol-gel coatings, which would be valuable for sample preparation approaches 
or ligand-receptor binding studies. Through the development of an appropriate methodology, 
the automated 96-blade SPME system can be used to obtain information on both free and 
total concentrations from a single bio-fluid sample. This possibility could provide accurate 
binding data such as binding curves and binding constants in a single automated experiment. 
In addition, it significantly increases the sample throughput and efficiency of the 
experiments of ligand-binding studies.  
In cases where obtaining information about the total concentration is sufficient for the 
study, the sensitivity of the extraction from biological samples containing binding matrix can 
be significantly improved through this thesis’s proposed method of disturbing ligand-
receptor binding, without the need for any significant dilution or complicated sample pre-
treatment steps.  
The developed 96-blade SPME systems have the potential to be applied in various 
areas of research including biological, clinical, pharmaceutical, environmental, food, and 
metabolomics studies. The PS-DVB-PAN and PBA-PAN 96-blade SPME systems can be 
successfully applied for high-throughput analysis of different polarity ranges of analytes and 
exo- and endogenous compounds from a single biological sample. As the next step for this 
study, the PS-DVB-PAN 96-blade SPME system is being used for the sample preparation of 
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biological samples for the global analysis of metabolites, and the PBA-PAN 96-blade SPME 
system is under study for the extraction of proteins from biological samples. A future step of 
this thesis, which is currently under process in our laboratory, is the development and 
evaluation of other SPME coatings with more hydrophilic properties for selective extraction 
of highly polar compounds. 
Based on the promising initial results of EBS sampling obtained in the study of this 
thesis, there is potential for various additional studies in the future. In order to increase the 
efficiency and sensitivity of the analysis, a larger volume of the blood can be used with the 
newly proposed square thin-film geometry described in this thesis (2-fold enhancement in 
surface area). In addition, in order to accelerate the kinetics of the extraction, the thickness of 
the coating for EBS sampling can be optimized to be prepared as thin as possible for future 
studies. This optimization will provide faster kinetics of the desorption and higher desorption 
efficiency for EBS-DART applications (resulting in less carryover and higher sensitivity) in 
a short period of time (10-30 s). In addition, the throughput of the EBS-DART system can be 
significantly improved via the application of 96-format DART systems.  
The EBS-DART–MS/MS system can be used for monitoring/determining unstable 
compounds and short-lived metabolites for on-site and at vivo clinical and biological 
applications. The next step is the evaluation of developed EBS methodology for the analysis 
of other classes of compounds with different polarities. The extracted spot sampling 
approach can be used for the analysis of other types of biological samples such as plasma, 
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